https://evidence-hub.com/study/130000-influence-of-homocysteine-on-the-interaction-between-circulating2026-10-18 https://evidence-hub.com/study/130001-effect-of-oral-heparin-on-homocysteine-induced-changes-in-hemodynamic2026-10-18 https://evidence-hub.com/study/130002-restoring-mitochondrial-homeostasis-therapeutic-strategies-for2026-10-18 https://evidence-hub.com/study/130003-nutritional-essentiality-of-sulfur-in-health-and-disease2026-10-18 https://evidence-hub.com/study/130004-use-of-nmr-based-metabonomics-to-study-animal-models-and-human-disease2026-10-18 https://evidence-hub.com/study/130005-personalised-whole-body-modelling-links-gut-microbiota-to-metabolic2026-10-18 https://evidence-hub.com/study/130006-taming-fatty-liver-can-taurine-combat-metabolic-dysfunction-in-masld2026-10-18 https://evidence-hub.com/study/130007-phenotypic-studies-in-mice-deficient-in-methylenetetrahydrofolate2026-10-18 https://evidence-hub.com/study/130008-the-role-of-folate-in-non-alcoholic-fatty-liver-disease2026-10-18 https://evidence-hub.com/study/130009-vitamin-b12-deficiency-and-the-nervous-system-beyond-metabolic2026-10-18 https://evidence-hub.com/study/130010-genetic-evolutionary-and-genomic-analysis-of-homocysteine-and-folate2026-10-18 https://evidence-hub.com/study/130011-gene-expression-and-dna-methylation-alterations-in-the-glycine-n2026-10-18 https://evidence-hub.com/study/130012-pharmacokinetic-effects-of-different-models-of-nonalcoholic-fatty2026-10-18 https://evidence-hub.com/study/130013-new-insights-into-the-roles-of-cysteine-and-homocysteine-in2026-10-18 https://evidence-hub.com/study/130014-environmental-pollutants-as-risk-factors-for-neurodegenerative2026-10-18 https://evidence-hub.com/study/130015-application-of-metabolomics-in-alzheimer-s-disease2026-10-18 https://evidence-hub.com/study/130017-metabolic-syndrome-updates-on-pathophysiology-and-management-in-20212026-10-18 https://evidence-hub.com/study/130018-methionine-metabolism-in-yucatan-miniature-swine2026-10-18 https://evidence-hub.com/study/130019-diet-s-role-in-modifying-risk-of-alzheimer-s-disease-history-and2026-10-18 https://evidence-hub.com/study/130020-relevance-of-metabolic-profiles-in-children-with-cardiac-disease2026-10-18 https://evidence-hub.com/study/130021-lean-body-mass-harbors-sensing-mechanisms-that-allow-safeguarding-of2026-10-18 https://evidence-hub.com/study/130022-ammonium-ion-binding-to-dna-g-quadruplexes-do-electrospray-mass2026-10-18 https://evidence-hub.com/study/130023-low-dose-ethanol-has-impacts-on-plasma-levels-of-metabolites-relating2026-10-18 https://evidence-hub.com/study/130024-triad-of-homocysteine-rock2-and-vimentin-as-a-convergent-biomarker2026-10-18 https://evidence-hub.com/study/130025-gnmt-and-its-regulatory-micrornas-as-biomarkers-and-therapeutic2026-10-18 https://evidence-hub.com/study/130026-antioxidants-inflammation-and-cardiovascular-disease2026-10-18 https://evidence-hub.com/study/130027-targeted-metabolomic-analysis-in-alzheimer-s-disease-plasma-and-brain2026-10-18 https://evidence-hub.com/study/130028-effect-of-l-methionine-on-rbcs-metabolism-during-storage2026-10-18 https://evidence-hub.com/study/130029-subnormal-serum-liver-enzyme-levels-a-review-of-pathophysiology-and2026-10-18 https://evidence-hub.com/study/130031-nutritional-importance-of-carotenoids-and-their-effect-on-liver2026-10-18 https://evidence-hub.com/study/130032-trends-in-alcoholic-liver-disease-research-clinical-and-scientific2026-10-18 https://evidence-hub.com/study/130033-effects-of-temperature-on-stability-of-blood-homocysteine-in2026-10-18 https://evidence-hub.com/study/130035-a-comprehensive-guide-to-non-alcoholic-fatty-liver-disease2026-10-18 https://evidence-hub.com/study/130036-serum-metabolites-and-their-association-with-risk-of-type-2-diabetes2026-10-18 https://evidence-hub.com/study/130037-effect-of-gentiopicroside-on-endogenous-formaldehyde-homocysteine2026-10-18 https://evidence-hub.com/study/130038-049-physiological-and-molecular-mechanisms-associated-with2026-10-18 https://evidence-hub.com/study/130039-intake-of-polyphenols-in-european-adolescents-and-its-association2026-10-18 https://evidence-hub.com/study/130040-restoring-epigenetic-reprogramming-with-diet-and-exercise-to-improve2026-10-18 https://evidence-hub.com/study/130041-early-origins-of-adult-disease-approaches-for-investigating-the2026-10-18 https://evidence-hub.com/study/130130-detection-and-analysis-of-illegally-added-sildenafil-and-its2026-10-19 https://evidence-hub.com/study/130131-overview-on-spectrophotometric-and-chromatographic-methods-for2026-10-19 https://evidence-hub.com/study/130132-an-eco-friendly-solid-state-electrode-modified-with-zno-nanoparticles2026-10-19 https://evidence-hub.com/study/130133-symptoms-and-quality-of-life-in-hiv-infected-patients-with-benign2026-10-19 https://evidence-hub.com/study/130134-therapeutic-applications-of-alpha-blockers-pharmacology-clinical2026-10-19 https://evidence-hub.com/study/130135-endothelfunktion-bei-patienten-mit-systemischer-sklerose-ein-marker2026-10-19 https://evidence-hub.com/study/130136-influence-of-residual-disease-on-the-efficacy-of-parp-inhibitors-in2026-10-19 https://evidence-hub.com/study/130137-p0619-comparative-efficacy-of-all-available-pharmaceutical-therapies2026-10-19 https://evidence-hub.com/study/130138-efficacy-of-acupuncture-for-whiplash-injury-a-systematic-review-and2026-10-19 https://evidence-hub.com/study/130139-comparing-the-safety-and-efficacy-of-remimazolam-based-total2026-10-19 https://evidence-hub.com/study/130140-efficacy-of-herbal-medicine-treatment-based-on-syndrome2026-10-19 https://evidence-hub.com/study/130141-a-meta-analysis-on-efficacy-and-complications-of-bone-morphogenetic2026-10-19 https://evidence-hub.com/study/130143-different-axis-approaches-for-ultrasound-guided-centrally-inserted2026-10-19 https://evidence-hub.com/study/130144-prevention-and-treatment-of-radiation-induced-esophagitis-with-oral2026-10-19 https://evidence-hub.com/study/130145-efficacy-of-manual-therapy-for-fibromyalgia-syndrome-a-systematic2026-10-19 https://evidence-hub.com/study/130146-model-based-meta-analysis-of-the-relationship-between-pioglitazone2026-10-19 https://evidence-hub.com/study/130148-family-based-therapy-for-internet-addiction-among-adolescents-and2026-10-19 https://evidence-hub.com/study/130169-efficacy-and-safety-of-buyang-huanwu-tang-boyang-hwano-tang-in2026-10-19 https://evidence-hub.com/study/130170-balance-interventions-to-improve-upright-balance-control-and-balance2026-10-19 https://evidence-hub.com/study/130171-survival-benefit-of-adjuvant-treatment-for-ampullary-cancer-with2026-10-19 https://evidence-hub.com/study/130172-efficacy-and-feasibility-of-surgery-and-external-radiotherapy-for2026-10-19 https://evidence-hub.com/study/130173-efficacy-of-scalp-acupuncture-for-migraine-a-protocol-for-systematic2026-10-19 https://evidence-hub.com/study/130175-efficacy-and-tolerability-of-evogliptin-in-patients-with-type-22026-10-19 https://evidence-hub.com/study/130176-the-effect-of-laminaria-japonica-on-metabolic-syndrome-a-systematic2026-10-19 https://evidence-hub.com/study/130177-effectiveness-of-bee-venom-injection-for-parkinson-s-disease-a2026-10-19 https://evidence-hub.com/study/130178-comparative-efficacy-of-antihypertensive-drugs-in-dogs-a-systematic2026-10-19 https://evidence-hub.com/study/130179-recurrence-free-survival-dynamics-following-adjuvant-chemotherapy-for2026-10-19 https://evidence-hub.com/study/130180-efficacy-of-nonaugmented-static-augmented-and-dynamic-augmented2026-10-19 https://evidence-hub.com/study/130181-video-versus-direct-laryngoscope-for-pediatric-intubation-during2026-10-19 https://evidence-hub.com/study/130182-efficacy-of-porcine-epidemic-diarrhea-vaccines-a-systematic-review2026-10-19 https://evidence-hub.com/study/130183-a-systematic-review-on-artificial-liver-for-implantation2026-10-19 https://evidence-hub.com/study/130184-bone-marrow-aspirate-concentrate-versus-human-umbilical-cord-blood2026-10-19 https://evidence-hub.com/study/130185-acupuncture-for-the-treatment-of-trigeminal-neuralgia-a-systematic2026-10-19 https://evidence-hub.com/study/130186-effect-on-lipid-profile-and-clinical-outcomes-of-obeticholic-acid-for2026-10-19 https://evidence-hub.com/study/130188-acupuncture-for-the-treatment-of-overactive-bladder-a-systematic2026-10-19 https://evidence-hub.com/study/130189-non-vitamin-k-antagonist-oral-anticoagulants-have-better-efficacy-and2026-10-19 https://evidence-hub.com/study/130190-acupuncture-treatment-for-emotional-problems-in-women-with2026-10-19 https://evidence-hub.com/study/130191-acupuncture-treatment-for-hip-pain-a-systematic-review-and-meta2026-10-19 https://evidence-hub.com/study/130192-therapeutic-effectiveness-of-probiotics-for-atopic-dermatitis-a2026-10-19 https://evidence-hub.com/study/130193-effectiveness-and-safety-of-ultrasound-guided-needle-knife-therapy2026-10-19 https://evidence-hub.com/study/130194-effectiveness-and-safety-of-scalp-acupuncture-for-treating-migraine-a2026-10-19 https://evidence-hub.com/study/130195-the-systematic-review-of-the-efficacy-and-safety-of-immune-checkpoint2026-10-19 https://evidence-hub.com/study/130199-clinical-efficacy-evaluation-of-a-continuous-glucose-monitoring2026-10-19 https://evidence-hub.com/study/130200-efficacy-of-a-theory-based-and-setting-based-intervention-in2026-10-19 https://evidence-hub.com/study/130201-efficacy-of-bifidobacterium-longum-and-lactobacillus-plantarum-nvp2026-10-19 https://evidence-hub.com/study/130202-efficacy-of-a-mobile-based-intervention-for-newly-graduated-nurses-a2026-10-19 https://evidence-hub.com/study/130203-efficacy-and-safety-of-tadalafil-once-daily-in-the-treatment-of-men2026-10-19 https://evidence-hub.com/study/130204-virtual-reality-based-emotion-to-emotion-therapy-for-post-traumatic2026-10-19 https://evidence-hub.com/study/130205-efficacy-and-safety-of-ginseng-berry-extract-sirtberrytm-in-treating2026-10-19 https://evidence-hub.com/study/130207-efficacy-and-safety-of-mucous-fistula-refeeding-in-preterm-infants-an2026-10-19 https://evidence-hub.com/study/130209-comparison-of-the-analgesic-efficacy-between-arthroscopically-placed2026-10-19 https://evidence-hub.com/study/130210-clinical-efficacy-and-safety-of-the-intra-articular-injection-of2026-10-19 https://evidence-hub.com/study/130213-porcine-placenta-peptide-as-a-complementary-functional-food-for-skin2026-10-19 https://evidence-hub.com/study/130215-re-efficacy-and-safety-of-tadalafil-once-daily-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/130218-efficacy-and-safety-of-antarctic-krill-oil-extract-fjh-ko-on-platelet2026-10-19 https://evidence-hub.com/study/130219-efficacy-and-safety-of-lythrum-salicaria-extract-on-body-fat2026-10-19 https://evidence-hub.com/study/130220-efficacy-and-safety-of-bojungikgi-tang-for-persistent-allergic2026-10-19 https://evidence-hub.com/study/130221-evaluation-of-the-efficacy-and-safety-of-controlled-release2026-10-19 https://evidence-hub.com/study/130222-efficacy-and-safety-of-green-lipped-mussel-powder-supplementation-in2026-10-19 https://evidence-hub.com/study/130223-totally-laparoscopic-versus-laparoscopy-assisted-distal-gastrectomy2026-10-19 https://evidence-hub.com/study/130224-indocyanine-green-icg-fluorescence-angiography-guided-arthroscopic2026-10-19 https://evidence-hub.com/study/130225-evaluation-of-the-efficacy-and-safety-of-yukwool-tang-for-major2026-10-19 https://evidence-hub.com/study/130227-efficacy-and-safety-of-novel-hemostatic-gel-in-endoscopic2026-10-19 https://evidence-hub.com/study/130228-effectiveness-and-safety-of-motion-style-acupuncture-treatment-using2026-10-19 https://evidence-hub.com/study/130229-pilot-study-of-a-mobile-virtual-reality-based-digital-therapeutic-for2026-10-19 https://evidence-hub.com/study/130230-effectiveness-and-safety-of-hominis-placental-pharmacopuncture-for2026-10-19 https://evidence-hub.com/study/130231-efficacy-of-adjuvant-application-of-platelet-rich-plasma-after-needle2026-10-19 https://evidence-hub.com/study/130232-impact-of-model-informed-precision-dosing-in-adults-receiving2026-10-19 https://evidence-hub.com/study/130233-efficacy-and-safety-of-ecklonia-cava-kjellman-extract-complex-in2026-10-19 https://evidence-hub.com/study/130237-efficacy-and-safety-of-virtual-reality-based-versus-traditional2026-10-19 https://evidence-hub.com/study/130238-influence-of-psychological-factors-and-pain-sensitivity-on-the2026-10-19 https://evidence-hub.com/study/130239-efficacy-and-safety-of-mobile-app-based-metamemory-cognitive-training2026-10-19 https://evidence-hub.com/study/130240-efficacy-and-safety-of-1-l-polyethylene-glycol-with-low-ascorbic-acid2026-10-19 https://evidence-hub.com/study/130241-efficacy-and-safety-of-a-single-pill-triple-combination-of-olmesartan2026-10-19 https://evidence-hub.com/study/130242-a-phase-3-randomized-clinical-trial-to-compare-efficacy-and-safety2026-10-19 https://evidence-hub.com/study/130243-laparoscopic-versus-open-pancreatoduodenectomy-for-periampullary2026-10-19 https://evidence-hub.com/study/130244-response-analysis-for-injected-and-non-injected-lesions-and-of-the2026-10-19 https://evidence-hub.com/study/130245-cedirogant-in-adults-with-psoriasis-a-phase-2-randomized-placebo2026-10-19 https://evidence-hub.com/study/130247-efficacy-and-safety-of-a-standardized-soy-and-hop-extract-on2026-10-19 https://evidence-hub.com/study/130248-efficacy-and-safety-of-the-plook-fire-thatu-recipe-on-breast-milk2026-10-19 https://evidence-hub.com/study/130249-clinical-trial-to-reconfirm-the-efficacy-and-safety-of-cefetamet2026-10-19 https://evidence-hub.com/study/130250-efficacy-and-tolerability-of-pitavastatin-versus-pitavastatin2026-10-19 https://evidence-hub.com/study/130251-dronedarone-vs-class-ic-agents-for-early-af-protocol-for-the-drive-af2026-10-19 https://evidence-hub.com/study/130252-functional-electrical-stimulation-combined-with-reactive-balance2026-10-19 https://evidence-hub.com/study/130253-the-efficacy-of-a-brief-intervention-to-reduce-alcohol-use-in-persons2026-10-19 https://evidence-hub.com/study/130254-the-efficacy-and-safety-of-sipjeondaebo-tang-in-korean-patients-with2026-10-19 https://evidence-hub.com/study/130255-efficacy-and-safety-of-gyejigachulbutang-gui-zhi-jia-shu-fu-tang2026-10-19 https://evidence-hub.com/study/130257-clinical-trial-to-evaluate-the-efficacy-of-botulinum-toxin-type-a2026-10-19 https://evidence-hub.com/study/130258-efficacy-and-safety-of-caec-canavalia-gladiata-arctium-lappa-extract2026-10-19 https://evidence-hub.com/study/130259-efficacy-and-safety-of-omega-3-fatty-acids-in-patients-treated-with2026-10-19 https://evidence-hub.com/study/130260-short-term-outcomes-of-early-versus-conventional-adjuvant2026-10-19 https://evidence-hub.com/study/130261-a-study-protocol-for-a-multicenter-pragmatic-randomized-controlled2026-10-19 https://evidence-hub.com/study/130262-diffusion-characteristics-and-efficacy-of-letibotulinum-toxin-a-in2026-10-19 https://evidence-hub.com/study/130263-efficacy-of-sinus-crestal-elevation-with-demineralized-dentin-matrix2026-10-19 https://evidence-hub.com/study/130264-effects-of-plant-extracts-on-growth-promotion-antioxidant-enzymes-and2026-10-19 https://evidence-hub.com/study/130265-editorial-comment-to-efficacy-and-safety-of-tadalafil-5-mg-once-daily2026-10-19 https://evidence-hub.com/study/130266-efficacy-of-fully-covered-self-expanding-metal-stents-removal-versus2026-10-19 https://evidence-hub.com/study/130267-bemarituzumab-as-first-line-treatment-for-locally-advanced-or2026-10-19 https://evidence-hub.com/study/130268-evaluation-of-the-efficacy-and-safety-of-dw1903-in-patients-with2026-10-19 https://evidence-hub.com/study/130269-a-single-dose-trial-of-mizagliflozin-for-the-treatment-of2026-10-19 https://evidence-hub.com/study/130270-bemarituzumab-plus-mfolfox6-as-first-line-treatment-in-east-asian2026-10-19 https://evidence-hub.com/study/130271-clip-based-endoscopic-anastomotic-reduction-in-patients-with-dumping2026-10-19 https://evidence-hub.com/study/130272-efficacy-and-safety-of-rebamipide-versus-its-new-formulation-ad-2032026-10-19 https://evidence-hub.com/study/130274-real-world-data-analysis-on-effectiveness-of-integrative-therapies-a2026-10-19 https://evidence-hub.com/study/130275-or03-4-efficacy-and-safety-of-avexitide-for-treatment-of-hypoglycemia2026-10-19 https://evidence-hub.com/study/130276-defect-size-based-comparative-analysis-of-treatment-modalities-for2026-10-19 https://evidence-hub.com/study/130277-phase-ii-study-of-dabrafenib-and-trametinib-in-patients-with-tumors2026-10-19 https://evidence-hub.com/study/130278-the-efficacy-and-safety-of-polydeoxyribonucleotide-for-the-treatment2026-10-19 https://evidence-hub.com/study/130279-rationale-design-and-efficacy-of-a-smartphone-application-for2026-10-19 https://evidence-hub.com/study/130280-stereotactic-ablative-radiotherapy-for-pulmonary-oligometastases-from2026-10-19 https://evidence-hub.com/study/130281-evaluation-of-measurement-reliability-and-agreement-of-a-wearable-ecg2026-10-19 https://evidence-hub.com/study/130282-efficacy-and-safety-of-ui05msp015ct-in-functional-dyspepsia-a2026-10-19 https://evidence-hub.com/study/130283-reducing-healing-period-with-ddm-rhbmp-2-grafting-for-early-loading2026-10-19 https://evidence-hub.com/study/130284-ep4-antagonist-ono-4578-plus-nivolumab-and-chemotherapy-in-her22026-10-19 https://evidence-hub.com/study/130285-is-early-mobilization-after-volar-locking-plate-fixation-in-distal2026-10-19 https://evidence-hub.com/study/130286-effectiveness-and-safety-of-low-dose-intraoperative-tranexamic-acid2026-10-19 https://evidence-hub.com/study/130287-cabozantinib-as-subsequent-therapy-to-an-immune-checkpoint-based2026-10-19 https://evidence-hub.com/study/130288-combination-of-selpercatinib-and-trametinib-overcomes-resistance-to2026-10-19 https://evidence-hub.com/study/130289-start-adolescents-study-protocol-of-a-randomised-controlled-trial-to2026-10-19 https://evidence-hub.com/study/130290-salvage-external-beam-radiotherapy-after-incomplete-transarterial2026-10-19 https://evidence-hub.com/study/130291-trifocal-versus-bifocal-diffractive-intraocular-lens-implantation2026-10-19 https://evidence-hub.com/study/130292-korean-multicenter-registry-of-transcatheter-arterial2026-10-19 https://evidence-hub.com/study/130293-comparing-1-l-and-2-l-polyethylene-glycol-with-ascorbic-acid-for2026-10-19 https://evidence-hub.com/study/130294-cardiorespiratory-exercise-and-self-management-early-after-stroke-to2026-10-19 https://evidence-hub.com/study/130295-efficacy-and-safety-of-thread-embedding-acupuncture-on-knee2026-10-19 https://evidence-hub.com/study/130296-effect-of-treatment-delay-stroke-type-and-thrombolysis-on-the-effect2026-10-19 https://evidence-hub.com/study/130297-dabrafenib-and-trametinib-in-patients-with-tumors-with-brafv600e2026-10-19 https://evidence-hub.com/study/130298-clinical-efficacy-and-safety-of-early-adjuvant-chemotherapy-for-stage2026-10-19 https://evidence-hub.com/study/130299-feasibility-and-efficacy-of-eribulin-mesilate-in-korean-patients-with2026-10-19 https://evidence-hub.com/study/130301-stereotactic-body-radiotherapy-for-centrally-located-primary-non2026-10-19 https://evidence-hub.com/study/130302-long-term-outcome-of-intraoperative-radiofrequency-ablation-for2026-10-19 https://evidence-hub.com/study/130303-phenobarbital-versus-benzodiazepines-for-alcohol-withdrawal-in-the2026-10-19 https://evidence-hub.com/study/130304-efficacy-of-large-language-models-in-detecting-postoperative-delirium2026-10-19 https://evidence-hub.com/study/130305-covid-19-infection-and-efficacy-of-vaccination-in-patients-with2026-10-19 https://evidence-hub.com/study/130306-abstract-17136-prospective-cohort-study-for-evaluating-the-safety-and2026-10-19 https://evidence-hub.com/study/130309-patient-factors-influencing-participation-in-aerobic-exercise-during2026-10-19 https://evidence-hub.com/study/130310-staged-endovascular-management-for-non-maturing-arteriovenous2026-10-19 https://evidence-hub.com/study/130311-impact-of-amlodipine-on-clinical-outcomes-for-heart-failure-in2026-10-19 https://evidence-hub.com/study/130312-differential-organ-specific-tumor-response-to-first-line-immune2026-10-19 https://evidence-hub.com/study/130313-long-term-efficacy-of-s-1-monotherapy-or-capecitabine-plus2026-10-19 https://evidence-hub.com/study/130314-effectiveness-of-paravertebral-block-in-patients-with-herpes-zoster2026-10-19 https://evidence-hub.com/study/130315-efficacy-and-treatment-related-adverse-events-of-gemcitabine-plus-nab2026-10-19 https://evidence-hub.com/study/130316-comparison-of-the-efficacy-of-nafcillin-and-glycopeptides-as2026-10-19 https://evidence-hub.com/study/130317-or08-04-efficacy-and-safety-of-the-sglt1-inhibitor-mizagliflozin-in2026-10-19 https://evidence-hub.com/study/130318-an-observational-multicenter-cohort-study-evaluating-the-antiviral2026-10-19 https://evidence-hub.com/study/130319-long-term-survival-outcomes-of-elderly-patients-treated-with-s-1-or2026-10-19 https://evidence-hub.com/study/130320-cervical-cerclage-performed-at-24-32-0-weeks-in-twin-pregnancies-a2026-10-19 https://evidence-hub.com/study/130322-ultrasound-guided-anterior-quadratus-lumborum-block-reduces2026-10-19 https://evidence-hub.com/study/130323-folfirinox-vs-gemcitabine-nab-paclitaxel-for-treatment-of-metastatic2026-10-19 https://evidence-hub.com/study/130324-efficacy-and-safety-of-cabozantinib-plus-nivolumab-in-advanced-non2026-10-19 https://evidence-hub.com/study/130325-efficacy-of-wearable-single-lead-ecg-monitoring-during-exercise2026-10-19 https://evidence-hub.com/study/130327-therapeutic-potential-of-escherichia-coli-nissle-1917-in-clinically2026-10-19 https://evidence-hub.com/study/130328-initial-efficacy-and-safety-of-rp1-nivolumab-in-patients-with-anti-pd2026-10-19 https://evidence-hub.com/study/130329-efficacy-and-safety-of-sofosbuvir-velpatasvir-and-sofosbuvir2026-10-19 https://evidence-hub.com/study/130330-a-phase-1-2-study-to-investigate-the-safety-and-efficacy-of-obx-1152026-10-19 https://evidence-hub.com/study/130331-pos0730-prognostic-factors-and-efficacy-of-dmard-use-in-gca-results2026-10-19 https://evidence-hub.com/study/130332-clinical-outcomes-of-sedation-during-emergency-endoscopic-band2026-10-19 https://evidence-hub.com/study/130333-clinical-efficacy-of-plant-derived-nano-exosomes-for-skin-regeneration2026-10-19 https://evidence-hub.com/study/130334-current-status-of-off-pump-coronary-artery-bypass-grafting-in2026-10-19 https://evidence-hub.com/study/130335-abstract-ct285-trial-in-progress-a-phase-1-2-study-to-investigate-the2026-10-19 https://evidence-hub.com/study/130336-tenofovir-based-combination-therapy-or-monotherapy-for-multidrug2026-10-19 https://evidence-hub.com/study/130337-management-of-clevudine-resistant-chronic-hepatitis-b-a-multicenter2026-10-19 https://evidence-hub.com/study/130338-combined-pd-1-and-ctla-4-blockade-in-an-international-cohort-of2026-10-19 https://evidence-hub.com/study/130340-efficacy-of-atropine-eye-drops-for-suppressing-myopia-progression-in2026-10-19 https://evidence-hub.com/study/130341-posttreatment-pulse-rate-reduction-and-not-baseline-pulse-rate-as-an2026-10-19 https://evidence-hub.com/study/130342-1983-lb-a-phase-1-study-of-id110521156-a-small-molecule-glucagon-like2026-10-19 https://evidence-hub.com/study/130343-comparative-evaluation-of-medial-septal-fat-excision-during-infrabrow2026-10-19 https://evidence-hub.com/study/130344-impact-of-adjuvant-therapy-on-resected-invasive-intraductal-papillary2026-10-19 https://evidence-hub.com/study/130346-early-clinical-outcome-of-hyperopic-small-incision-lenticule2026-10-19 https://evidence-hub.com/study/130347-evaluating-early-macrolide-therapy-in-pediatric-campylobacter2026-10-19 https://evidence-hub.com/study/130348-reduced-dose-radiotherapy-for-stage-ie-gastric-mucosa-associated2026-10-19 https://evidence-hub.com/study/130350-effect-of-biologic-therapies-on-quality-of-life-in-severe-asthma2026-10-19 https://evidence-hub.com/study/130351-abstract-ct244-trial-in-progress-phase-1-2-study-of-obx-1152026-10-19 https://evidence-hub.com/study/130352-clinical-features-of-herpes-simplex-keratitis-in-a-korean-tertiary2026-10-19 https://evidence-hub.com/study/130353-radt-30-radiotherapy-alone-with-reduced-volume-and-dose-for-pure2026-10-19 https://evidence-hub.com/study/130354-promoting-early-aerobic-exercise-initiation-post-concussion-a-pilot2026-10-19 https://evidence-hub.com/study/130355-hypercontractile-esophagus-clinical-and-manometric-features-from-a2026-10-19 https://evidence-hub.com/study/130356-safety-and-efficacy-of-lifileucel-ln-144-an-autologous-tumor2026-10-19 https://evidence-hub.com/study/130357-clinical-and-transcriptomic-response-to-secukinumab-in-korean2026-10-19 https://evidence-hub.com/study/130358-combined-use-of-energy-based-interventions-with-low-dose-isotretinoin2026-10-19 https://evidence-hub.com/study/130359-association-of-ndrg4-gene-methylation-in-peripheral-blood-leukocytes2026-10-19 https://evidence-hub.com/study/130361-clinical-research-study-on-sowa-rigpa-medicine-zla-bdud-d7-and-se2026-10-19 https://evidence-hub.com/study/130362-recurrent-acute-coronary-syndrome-in-young-man-with-familial2026-10-19 https://evidence-hub.com/study/130363-safety-and-efficacy-of-immune-checkpoint-inhibitor-cancer-therapy-in2026-10-19 https://evidence-hub.com/study/130364-etanercept-treatment-for-pediatric-toxic-epidermal-necrolysis-induced2026-10-19 https://evidence-hub.com/study/130366-a-multicenter-randomized-open-label-study-to-compare-the-efficacy-and2026-10-19 https://evidence-hub.com/study/130367-ps-bpc12-2-efficacy-and-safety-of-single-pill-combination-of-olomax2026-10-19 https://evidence-hub.com/study/130370-a-real-world-study-of-long-term-safety-and-efficacy-of-lobeglitazone2026-10-19 https://evidence-hub.com/study/130371-effect-of-extraocular-muscle-motion-style-acupuncture-treatment-on-a2026-10-19 https://evidence-hub.com/study/130372-clinical-outcome-of-rifabutin-based-treatment-for-pulmonary2026-10-19 https://evidence-hub.com/study/130373-p-2315-clinical-outcome-of-rifabutin-based-treatment-for-pulmonary2026-10-19 https://evidence-hub.com/study/130374-safety-and-efficacy-of-neoadjuvant-sabr-in-pancreatic-cancer-effect2026-10-19 https://evidence-hub.com/study/130375-potential-application-of-brain-gut-axis-based-treatments-in-long2026-10-19 https://evidence-hub.com/study/130376-a-novel-approach-to-the-management-of-levodopa-induced-dyskinesia2026-10-19 https://evidence-hub.com/study/130377-sun-703-post-bariatric-hypoglycemia-successfully-treated-with-glp-12026-10-19 https://evidence-hub.com/study/130378-robot-assisted-rehabilitation-therapy-for-adhesive-capsulitis2026-10-19 https://evidence-hub.com/study/130379-clinical-application-of-autogenous-demineralized-dentin-matrix-loaded2026-10-19 https://evidence-hub.com/study/130380-safety-and-efficacy-of-stereotactic-body-radiation-therapy-sbrt-for2026-10-19 https://evidence-hub.com/study/130381-intracranial-efficacy-of-systemic-therapy-in-patients-with2026-10-19 https://evidence-hub.com/study/130382-complexities-with-diagnosis-and-management-of-symptomatic2026-10-19 https://evidence-hub.com/study/130383-bevacizumab-based-triplet-versus-doublet-chemotherapy-as-first-line2026-10-19 https://evidence-hub.com/study/130384-the-efficacy-and-safety-of-montelukast-sodium-in-the-prevention-of2026-10-19 https://evidence-hub.com/study/130385-efficacy-and-safety-of-fentanyl-in-combination-with-midazolam-in2026-10-19 https://evidence-hub.com/study/130386-efficacy-and-safety-of-pioglitazone-versus-glimepiride-after2026-10-19 https://evidence-hub.com/study/130387-efficacy-of-endoscopic-vacuum-assisted-closure-treatment-for2026-10-19 https://evidence-hub.com/study/130388-discovery-of-2-6-naphthyridine-analogues-as-selective-fgfr42026-10-19 https://evidence-hub.com/study/130389-a-curriculum-embedded-two-session-ai-chatbot-based-history-taking2026-10-19 https://evidence-hub.com/study/130390-abstract-ps5-08-06-a-prospective-multicenter-comparative-pilot-study2026-10-19 https://evidence-hub.com/study/130391-matrix-a-randomized-phase-ii-trial-of-tuvusertib-atr-inhibitor-with2026-10-19 https://evidence-hub.com/study/130392-clinical-evidence-of-bee-venom-acupuncture-for-ankle-pain-a-review-of2026-10-19 https://evidence-hub.com/study/130393-current-role-of-endoscopic-ablation-in-the-management-of-pancreatic2026-10-19 https://evidence-hub.com/study/130394-the-tumor-control-according-to-radiation-dose-of-gamma-knife2026-10-19 https://evidence-hub.com/study/130396-preoperative-radiation-dose-escalation-for-rectal-cancer-using-a2026-10-19 https://evidence-hub.com/study/130398-direct-analysis-of-aberrant-glycosylation-on-haptoglobin-in-patients2026-10-19 https://evidence-hub.com/study/130399-complete-obstruction-a-real-risk-factor-a-comprehensive-study-on2026-10-19 https://evidence-hub.com/study/130400-statement-on-chronotherapy-for-the-treatment-of-hypertension2026-10-19 https://evidence-hub.com/study/130401-efficacy-of-predefined-homoeopathic-medicines-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/130402-trial-registration-as-a-safeguard-against-outcome-reporting-bias-and2026-10-19 https://evidence-hub.com/study/130403-protocol-for-efficacy-of-individualised-homoeopathic-medicine-in2026-10-19 https://evidence-hub.com/study/130404-effectiveness-of-motion-style-acupuncture-treatment-for-patients-with2026-10-19 https://evidence-hub.com/study/130406-tumor-mutational-burden-tmb-in-immune-checkpoint-inhibitor-ici-naive2026-10-19 https://evidence-hub.com/study/130408-m1-derived-extracellular-vesicles-enhance-photodynamic-therapy-and2026-10-19 https://evidence-hub.com/study/130409-data-driven-non-linear-current-controller-based-on-deep-symbolic2026-10-19 https://evidence-hub.com/study/130410-the-fate-of-antibiotic-impregnated-cement-space-in-treatment-for2026-10-19 https://evidence-hub.com/study/130412-nutrition-quotient-and-dietary-self-efficacy-according-to-the2026-10-19 https://evidence-hub.com/study/130413-community-responses-during-the-early-phase-of-the-covid-19-epidemic2026-10-19 https://evidence-hub.com/study/130415-a-steerable-and-expandable-magnetic-aspiration-catheter-for-enhanced2026-10-19 https://evidence-hub.com/study/130416-comparative-study-for-predictability-of-type-1-gastric-variceal2026-10-19 https://evidence-hub.com/study/130417-1783-p-hm17321-a-crfr2-selective-ucn2-analog-prevents-muscle-loss-and2026-10-19 https://evidence-hub.com/study/130418-knowledge-and-attitude-toward-emergency-contraceptive-pills-among2026-10-19 https://evidence-hub.com/study/130419-knowledge-and-health-beliefs-of-gdm-associated-with-breastfeeding2026-10-19 https://evidence-hub.com/study/130420-the-association-of-sociodemographic-factors-and-needs-of2026-10-19 https://evidence-hub.com/study/130421-correlates-of-health-behaviors-in-patients-with-coronary-artery2026-10-19 https://evidence-hub.com/study/130422-dyadic-effects-of-individual-and-friend-on-physical-activity-in2026-10-19 https://evidence-hub.com/study/130423-comparison-of-wells-score-d-dimer-and-combination-of-wells-score-and2026-10-19 https://evidence-hub.com/study/130424-validation-of-conductivity-tensor-imaging-using-giant-vesicle2026-10-19 https://evidence-hub.com/study/130425-effect-of-acupuncture-on-gut-brain-axis-parameters-in-patients-with2026-10-19 https://evidence-hub.com/study/130430-faster-smooth-muscle-cell-coverage-in-ultrathin-strut-drug-eluting2026-10-19 https://evidence-hub.com/study/130431-nesidioblastosis-in-patients-with-severe-postbariatric-hypoglycemia-a2026-10-19 https://evidence-hub.com/study/130432-alveolar-ridge-preservation-of-an-extraction-socket-using-autogenous2026-10-19 https://evidence-hub.com/study/130433-tirzepatide-for-treatment-of-postbariatric-hypoglycemia-after-roux-en2026-10-19 https://evidence-hub.com/study/130435-spinal-cord-stimulation-in-the-treatment-of-postherpetic-neuralgia-in2026-10-19 https://evidence-hub.com/study/130436-efficacy-of-fixed-dosing-aflibercept-for-treating-polypoidal2026-10-19 https://evidence-hub.com/study/130439-canadian-society-of-pharmacology-and-therapeutics2026-10-19 https://evidence-hub.com/study/130440-clinical-outcomes-of-igg4-related-ophthalmic-disease-and-idiopathic2026-10-19 https://evidence-hub.com/study/130441-does-lymphovenous-anastomosis-effect-mammalian-target-of-rapamycin2026-10-19 https://evidence-hub.com/study/130443-minimally-invasive-surgery-for-remnant-gastric-cancer-a-comparison2026-10-19 https://evidence-hub.com/study/130446-xxiv-world-allergy-congress-20152026-10-19 https://evidence-hub.com/study/130447-intravitreal-bevacizumab-injection-for-choroidal-neovascularization2026-10-19 https://evidence-hub.com/study/130448-re-the-risk-of-sexual-dysfunction-and-effectiveness-of-treatment-of2026-10-19 https://evidence-hub.com/study/130449-management-of-carbapenem-resistant-acinetobacter-baumannii-epidemic2026-10-19 https://evidence-hub.com/study/130450-optimal-aerobic-exercise-intensity-and-its-influence-on-the2026-10-19 https://evidence-hub.com/study/130452-reduced-exacerbation-frequency-and-prednisone-dose-in-patients-with2026-10-19 https://evidence-hub.com/study/130453-treatment-outcomes-of-facial-rejuvenation-with-a-novel-hyaluronic2026-10-19 https://evidence-hub.com/study/130454-comparison-of-the-20-gauge-conventional-vitrectomy-technique-with-the2026-10-19 https://evidence-hub.com/study/130458-recommended-articles2026-10-19 https://evidence-hub.com/study/130459-artificial-intelligence-in-drug-development-clinical-pharmacologist2026-10-19 https://evidence-hub.com/study/130460-holmes-tremors-in-a-60-year-old-woman-following-primary-brainstem2026-10-19 https://evidence-hub.com/study/130461-efficacy-of-fat-and-perifascial-areolar-tissue-graft-in-refractory2026-10-19 https://evidence-hub.com/study/130462-dexmedetomidine-and-nitrous-oxide-as-anesthetic-agents-for2026-10-19 https://evidence-hub.com/study/130463-a-case-report-on-delayed-hypoxic-encephalopathy-after-carbon-monoxide2026-10-19 https://evidence-hub.com/study/130464-effect-of-repeated-intra-articular-administration-of-collagen-as-a2026-10-19 https://evidence-hub.com/study/130465-efficacy-of-afatinib-in-a-previously-treated-patient-with-non-small2026-10-19 https://evidence-hub.com/study/130466-a-case-report-korean-medicine-treatment-for-miller-fisher-syndrome2026-10-19 https://evidence-hub.com/study/130467-a-case-report-of-a-drug-resistant-epilepsy-patient-complaining2026-10-19 https://evidence-hub.com/study/130468-long-term-survival-after-ccrt-and-haic-followed-by-alpps-for2026-10-19 https://evidence-hub.com/study/130469-case-report-a-case-of-ultra-late-recurrence-of-kif13a-ret-fusion-non2026-10-19 https://evidence-hub.com/study/130470-strategy-for-dealing-with-unfamiliar-and-thick-vessels-during2026-10-19 https://evidence-hub.com/study/130471-0971-case-report-sleep-related-painful-erections-treated-with-sodium2026-10-19 https://evidence-hub.com/study/130472-consumptive-disease-and-chronic-fatigue-improved-by-nokyonggunbi-tang2026-10-19 https://evidence-hub.com/study/130474-a-case-report-of-a-premature-ventricular-contraction-patient-with2026-10-19 https://evidence-hub.com/study/130475-efficacy-of-imatinib-mesylate-sti571-in-chronic-neutrophilic-leukemia2026-10-19 https://evidence-hub.com/study/130477-330-comparing-pde5is-efficacy-for-erectile-dysfunction-treatment2026-10-19 https://evidence-hub.com/study/130478-mp34-19-clinical-efficacy-and-safety-of-silodosin-in-women-with-lower2026-10-19 https://evidence-hub.com/study/130479-a-case-of-successful-pediatric-heat-stroke-treatment-using2026-10-19 https://evidence-hub.com/study/130480-outpatient-treatment-of-postbariatric-hypoglycemia-with-canagliflozin2026-10-19 https://evidence-hub.com/study/130481-successful-puncture-and-drainage-of-primary-brainstem-hemorrhage-with2026-10-19 https://evidence-hub.com/study/130482-physical-therapy-combined-with-corticosteroid-intervention-for2026-10-19 https://evidence-hub.com/study/130483-implementation-of-low-glycemic-index-diet-together-with-cornstarch-in2026-10-19 https://evidence-hub.com/study/130486-safety-and-efficacy-of-allogeneic-umbilical-cord-blood-therapy-for2026-10-19 https://evidence-hub.com/study/130487-efficacy-of-a-1-day-rifaximin-and-metronidazole-regimen-and2026-10-19 https://evidence-hub.com/study/130488-sun-619-outpatient-treatment-of-post-bariatric-hypoglycemia-with2026-10-19 https://evidence-hub.com/study/130489-pd21-09-daily-tadalafil-therapy-a-new-treatment-option-for-peyronie-s2026-10-19 https://evidence-hub.com/study/130490-continuous-renal-replacement-therapy-increased-plasma-cholinesterase2026-10-19 https://evidence-hub.com/study/130491-detection-of-a-tadalafil-analogue-as-an-adulterant-in-a-dietary2026-10-19 https://evidence-hub.com/study/130492-gs-441524-treatment-in-a-cat-with-feline-infectious-peritonitis-virus2026-10-19 https://evidence-hub.com/study/130493-c63-03-successful-long-term-pharmacotherapy-in-pulmonary-capillary2026-10-19 https://evidence-hub.com/study/130494-supramolecular-strategy-for-reducing-the-cardiotoxicity-of2026-10-19 https://evidence-hub.com/study/130497-f3-a-case-of-leukocytosis-associated-with-clozapine-treatment-for-the2026-10-19 https://evidence-hub.com/study/130498-incorporating-moldable-demineralized-dentin-matrix-into-treatment-for2026-10-19 https://evidence-hub.com/study/130499-inactivated-mycobacterium-paragordonae-delivered-via-microneedle2026-10-19 https://evidence-hub.com/study/130500-non-pharmacological-and-pharmacological-treatments-for-non-acute2026-10-19 https://evidence-hub.com/study/130502-the-first-report-of-k-umbrella-gastric-cancer-study-an-open-label2026-10-19 https://evidence-hub.com/study/130505-efficacy-and-safety-of-prolonged-release-versus-immediate-release2026-10-19 https://evidence-hub.com/study/130506-sod1-inhibition-enhances-sorafenib-efficacy-in-hbv-related2026-10-19 https://evidence-hub.com/study/130507-the-effect-of-herbal-medicine-on-rheumatoid-arthritis-animal-model-a2026-10-19 https://evidence-hub.com/study/130508-protective-efficacy-of-a-zika-purified-inactivated-virus-vaccine2026-10-19 https://evidence-hub.com/study/130509-evaluation-of-anti-cancer-efficacy-of-potassium-usnate-using-nir2026-10-19 https://evidence-hub.com/study/130510-990-p-therapeutic-effect-of-a-novel-long-acting-glp-1-gip-glucagon2026-10-19 https://evidence-hub.com/study/130511-the-effect-of-low-dose-gamma-irradiation-on-the-uptake-of2026-10-19 https://evidence-hub.com/study/130512-coptis-chinensis-extract-loaded-mouthwash-antimicrobial-efficacy2026-10-19 https://evidence-hub.com/study/130513-trends-in-research-on-the-efficacy-of-herbal-medicines-for-particular2026-10-19 https://evidence-hub.com/study/130514-analysis-of-plasma-cortisol-from-nursery-pigs-in-outdoor-efficacy2026-10-19 https://evidence-hub.com/study/130517-enhancement-of-rotator-cuff-regeneration-via-injectable-spheroidal2026-10-19 https://evidence-hub.com/study/130518-esophageal-reconstruction-with-myogenesis-inducing-gene-transfected2026-10-19 https://evidence-hub.com/study/130519-il-1-promotes-disc-degeneration-and-inflammation-through-direct2026-10-19 https://evidence-hub.com/study/130520-analgesic-effect-of-auricular-vagus-nerve-stimulation-on-oxaliplatin2026-10-19 https://evidence-hub.com/study/130521-776-p-potent-weight-loss-and-favorable-glycemic-control-effects-of-a2026-10-19 https://evidence-hub.com/study/130522-implantation-of-the-clinical-grade-human-neural-stem-cell-line2026-10-19 https://evidence-hub.com/study/130523-dimethysiloxane-polymer-for-the-effective-transdermal-delivery-of2026-10-19 https://evidence-hub.com/study/130524-development-of-mesenchymal-stem-cell-encoded-with-myogenic-gene-for2026-10-19 https://evidence-hub.com/study/130525-immune-checkpoint-inhibition-combined-with-targeted-therapy-using-a2026-10-19 https://evidence-hub.com/study/130526-efficacy-evaluation-of-surgiguard-in-partially-hepatectomized-pigs2026-10-19 https://evidence-hub.com/study/130527-intestinal-anti-inflammatory-activity-of-ulva-ohnoi-oil-in-dss2026-10-19 https://evidence-hub.com/study/130528-time-course-characterization-of-protective-immune-responses-following2026-10-19 https://evidence-hub.com/study/130529-842-p-a-novel-crfr2-selective-ucn2-analog-hm17321-improves-glycemic2026-10-19 https://evidence-hub.com/study/130530-design-and-immunogenicity-of-a-quadrivalent-mrna-vaccine-targeting2026-10-19 https://evidence-hub.com/study/130532-orthotopic-model-of-pancreatic-cancer-using-cd34-humanized-mice-and2026-10-19 https://evidence-hub.com/study/130533-acupotomy-alleviates-perineural-fibrosis-adhesion-and-inflammation-in2026-10-19 https://evidence-hub.com/study/130534-a-bivalent-inactivated-vaccine-prevents-enterovirus-71-and2026-10-19 https://evidence-hub.com/study/130535-method-evaluation-of-liquid-biopsy-proteomics-for-limited-plasma2026-10-19 https://evidence-hub.com/study/130536-development-of-novel-biliary-metal-stent-with-coil-spring-structure2026-10-19 https://evidence-hub.com/study/130537-histological-and-functional-assessment-of-the-efficacy-of-constraint2026-10-19 https://evidence-hub.com/study/130538-engineered-deletions-of-hiv-replicate-conditionally-to-reduce-disease2026-10-19 https://evidence-hub.com/study/130539-gabalagen-facilitates-pentobarbital-induced-sleep-by-modulating-the2026-10-19 https://evidence-hub.com/study/130540-disruption-of-the-catenin-destruction-complex-via-ephexin1-axin12026-10-19 https://evidence-hub.com/study/130541-the-role-of-natural-products-in-the-improvement-of-cancer-associated2026-10-19 https://evidence-hub.com/study/130542-gabalagen-alleviates-stress-induced-sleep-disorders-in-rats2026-10-19 https://evidence-hub.com/study/130543-modified-saengmaeksan-an-herbal-formula-containing-six-herbs-improves2026-10-19 https://evidence-hub.com/study/130544-establishment-of-a-chicken-challenge-model-of-fowl-adenovirus2026-10-19 https://evidence-hub.com/study/130546-safety-and-efficacy-evaluations-of-an-adeno-associated-virus-variant2026-10-19 https://evidence-hub.com/study/130547-protective-effects-of-dendropanax-morbifera-against-cisplatin-induced2026-10-19 https://evidence-hub.com/study/130548-2-hydroxy-4-methylbenzoic-anhydride-inhibits-neuroinflammation-in2026-10-19 https://evidence-hub.com/study/130549-engineering-probiotics-for-therapeutic-applications-recent-examples2026-10-19 https://evidence-hub.com/study/130550-allogeneic-epithelial-cell-sheet-transplantation-for-preventing2026-10-19 https://evidence-hub.com/study/130551-094-synergy-between-orally-administered-phosphodiesterase-type-52026-10-19 https://evidence-hub.com/study/130552-extension-of-the-in-vivo-half-life-of-endostatin-and-its-improved2026-10-19 https://evidence-hub.com/study/130553-pde5-inhibitors-in-type-2-diabetes-cardiovascular-complications2026-10-19 https://evidence-hub.com/study/130554-therapeutic-potential-of-mesenchymal-stem-cells-mscs-and-msc-derived2026-10-19 https://evidence-hub.com/study/130555-the-protective-effects-of-statins-towards-vessel-wall-injury-caused2026-10-19 https://evidence-hub.com/study/130558-establishment-of-multicenter-covid-19-therapeutics-preclinical-test2026-10-19 https://evidence-hub.com/study/130561-593-pi3k-inhibitor-combined-with-radiation-enhances-the-antitumor2026-10-19 https://evidence-hub.com/study/130563-chemoembolization-with-vascular-disrupting-agent-ckd-516-dissolved-in2026-10-19 https://evidence-hub.com/study/130564-gelatin-microgel-coated-balloon-catheter-with-enhanced-delivery-of2026-10-19 https://evidence-hub.com/study/130565-the-intratumoral-administration-of-ferucarbotran-conjugated-with2026-10-19 https://evidence-hub.com/study/130567-anti-influenza-virus-activity-of-green-tea-by-products-in-vitro-and2026-10-19 https://evidence-hub.com/study/130568-1830-p-therapeutic-effect-of-a-novel-long-acting-glp-1-gip-glucagon2026-10-19 https://evidence-hub.com/study/130569-in-vitro-activity-of-dnf-3-against-drug-resistant-mycobacterium2026-10-19 https://evidence-hub.com/study/130570-in-vitro-and-in-vivo-evaluation-of-a-novel-polymer-free-everolimus2026-10-19 https://evidence-hub.com/study/130573-enhanced-anticancer-efficacy-of-trail-conjugated-and-odanacatib2026-10-19 https://evidence-hub.com/study/130574-abstract-6318-development-of-an-anti-pd-l1-car-t-therapeutic-treating2026-10-19 https://evidence-hub.com/study/130575-efficacy-and-safety-of-newly-developed-ganirelix-acetate-in-infertile2026-10-19 https://evidence-hub.com/study/130576-antioxidant-efficacy-and-the-upregulation-of-nrf2-mediated-ho-12026-10-19 https://evidence-hub.com/study/130580-inhibition-of-dickkopf-1-enhances-the-anti-tumor-efficacy-of2026-10-19 https://evidence-hub.com/study/130581-treatment-efficacy-of-thunbergia-laurifolia-curcuma-longa-garcinia2026-10-19 https://evidence-hub.com/study/130582-the-effect-of-a-tlr4-agonist-cationic-liposome-adjuvant-on-varicella2026-10-19 https://evidence-hub.com/study/130583-in-vitro-and-in-vivo-metabolism-of-n-adamantyl-substituted-urea-based2026-10-19 https://evidence-hub.com/study/130584-preparation-of-hot-melt-extruded-solid-dispersion-based-on-pre2026-10-19 https://evidence-hub.com/study/130585-in-vivo-tracking-of-bioorthogonally-labeled-t-cells-for-predicting2026-10-19 https://evidence-hub.com/study/130586-determining-the-efficacy-of-27-commercially-available-disinfectants2026-10-19 https://evidence-hub.com/study/130587-therapeutic-efficacy-of-ct-p59-against-p-1-variant-of-sars-cov-22026-10-19 https://evidence-hub.com/study/130588-a-robustly-supported-extracellular-matrix-improves-the-intravascular2026-10-19 https://evidence-hub.com/study/130591-pseudomonas-aeruginosa-invades-human-aortic-endothelial-cells-and2026-10-19 https://evidence-hub.com/study/130592-endogenous-akt-activity-promotes-virus-entry-and-predicts-efficacy-of2026-10-19 https://evidence-hub.com/study/130594-eflapegrastim-enhanced-efficacy-compared-to-pegfilgrastim-in2026-10-19 https://evidence-hub.com/study/130595-characterization-of-novel-erwinia-amylovora-specific-phieasp1-phage2026-10-19 https://evidence-hub.com/study/130596-a-systemic-evaluation-of-the-effect-of-dsrna-contamination-on-mrna2026-10-19 https://evidence-hub.com/study/130597-accelerated-cartilage-regeneration-via-chondrocyte-metabolic2026-10-19 https://evidence-hub.com/study/130598-lactobacillus-reuteri-nchbl-005-improves-wound-healing-by-promoting2026-10-19 https://evidence-hub.com/study/130600-therapeutic-potential-of-bold-100-a-grp78-inhibitor-enhanced-by-atr2026-10-19 https://evidence-hub.com/study/130601-enhancement-of-exfoliating-efficacy-of-l-carnitine-with-ion-pair2026-10-19 https://evidence-hub.com/study/130602-macrophage-targeting-precision-nanomedicine-utilizing-ros-responsive2026-10-19 https://evidence-hub.com/study/130603-synergistic-anti-obesity-effects-of-lactiplantibacillus-plantarum2026-10-19 https://evidence-hub.com/study/130604-mitigation-of-radiation-induced-esophageal-fibrosis-by-macrophage2026-10-19 https://evidence-hub.com/study/130606-a-novel-carboxamide-bromodomain-inhibitor-attenuates-osteoarthritis2026-10-19 https://evidence-hub.com/study/130607-yn1548-a-novel-small-molecule-agonist-of-human-glucagon-like-peptide2026-10-19 https://evidence-hub.com/study/130608-synergistic-attenuation-of-complete-freund-s-adjuvant-induced2026-10-19 https://evidence-hub.com/study/130609-pharmacological-evaluation-of-araliadiol-as-a-novel-anti-inflammatory2026-10-19 https://evidence-hub.com/study/130610-osteogenic-potential-of-adult-stem-cells-from-human-maxillary-sinus2026-10-19 https://evidence-hub.com/study/130611-a-novel-cell-penetrating-peptide-supports-hair-follicle-growth2026-10-19 https://evidence-hub.com/study/130612-diacerein-improves-liver-fibrosis-steatosis-and-atherosclerosis-in2026-10-19 https://evidence-hub.com/study/130613-therapeutic-targeting-of-mir-21-restores-sash1-and-sensitizes-hbv-hcc2026-10-19 https://evidence-hub.com/study/130614-medical-advancements-in-benign-prostatic-hyperplasia-treatments2026-10-19 https://evidence-hub.com/study/130615-a-review-of-the-use-of-tadalafil-in-the-treatment-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130616-evidence-for-the-efficacy-and-safety-of-tadalafil-and-finasteride-in2026-10-19 https://evidence-hub.com/study/130617-phosphodiesterase-pde-inhibitors-in-the-treatment-of-lower-urinary2026-10-19 https://evidence-hub.com/study/130618-the-role-of-combination-medical-therapy-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/130619-pharmacological-approaches-in-managing-symptomatic-relief-of-benign2026-10-19 https://evidence-hub.com/study/130620-phosphodiesterase-5-inhibitors-and-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130621-role-of-phosphodiesterase-type-5-inhibitors-for-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/130622-efficacy-and-safety-of-tadalafil-5-mg-once-daily-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/130623-safety-and-efficacy-of-the-combination-of-once-daily-tadalafil-and2026-10-19 https://evidence-hub.com/study/130624-cyclic-nucleotide-metabolism-including-nitric-oxide-and2026-10-19 https://evidence-hub.com/study/130625-the-efficacy-and-safety-of-tadalafil-5-mg-once-daily-in-korean-men2026-10-19 https://evidence-hub.com/study/130626-inhibition-of-adrenergic-and-non-adrenergic-smooth-muscle-contraction2026-10-19 https://evidence-hub.com/study/130627-soluble-guanylate-cyclase-activators-to-treat-benign-prostatic2026-10-19 https://evidence-hub.com/study/130628-pharmacological-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130629-food-administration-and-not-genetic-variants-causes-pharmacokinetic2026-10-19 https://evidence-hub.com/study/130630-trends-in-drug-treatment-of-benign-prostatic-hyperplasia-in-japan2026-10-19 https://evidence-hub.com/study/130631-tadalafil-once-daily-for-lower-urinary-tract-symptoms-suggestive-of2026-10-19 https://evidence-hub.com/study/130632-efficacy-and-safety-of-tadalafil-5-mg-once-daily-for-lower-urinary2026-10-19 https://evidence-hub.com/study/130633-tadalafil-5-mg-once-daily-is-a-rationale-option-for-simultaneous2026-10-19 https://evidence-hub.com/study/130634-a-randomized-controlled-study-of-the-efficacy-of-tadalafil2026-10-19 https://evidence-hub.com/study/130635-erratum-efficacy-of-tamsulosin-and-tadalafil-in-relieving-benign2026-10-19 https://evidence-hub.com/study/130636-phosphodiesterase-type-5-inhibitors-for-the-treatment-of-male-lower2026-10-19 https://evidence-hub.com/study/130637-comparative-efficacy-assessment-of-tamsulosin-vs-tamsulosin-plus2026-10-19 https://evidence-hub.com/study/130638-effects-of-tadalafil-on-lower-urinary-tract-symptoms-secondary-to2026-10-19 https://evidence-hub.com/study/130639-tadalafil-enhances-the-inhibitory-effects-of-tamsulosin-on-neurogenic2026-10-19 https://evidence-hub.com/study/130640-transperineal-laser-ablation-of-symptomatic-benign-prostatic2026-10-19 https://evidence-hub.com/study/130641-isosorbide-dinitrate-as-an-effective-adjunct-therapy-for-acute2026-10-19 https://evidence-hub.com/study/130642-do-patients-rezum-medications-a-real-world-analysis-of-medical2026-10-19 https://evidence-hub.com/study/130643-efficacy-and-safety-of-xialiqi-for-the-treatment-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130644-voiding-symptoms-aggravate-with-decreasing-stromal-epithelial-ratio2026-10-19 https://evidence-hub.com/study/130646-comparison-of-durability-between-rezum-water-vapor-therapy-and2026-10-19 https://evidence-hub.com/study/130647-chronic-inflammation-in-benign-prostatic-hyperplasia-pathophysiology2026-10-19 https://evidence-hub.com/study/130648-vardenafil-and-tamsulosin-in-the-management-of-ureteral-stent-related2026-10-19 https://evidence-hub.com/study/130649-benign-prostatic-hyperplasia-and-sexual-dysfunction-review-of-the2026-10-19 https://evidence-hub.com/study/130650-protective-and-antioxidant-effects-of-quercetin-loaded-black-cumin2026-10-19 https://evidence-hub.com/study/130651-water-vapor-energy-therapy-safely-reduces-urinary-medication-use-a2026-10-19 https://evidence-hub.com/study/130652-japan-s-perspective-on-facilitating-drug-development-through-asian2026-10-19 https://evidence-hub.com/study/130653-prostate-size-and-its-effect-on-lower-urinary-tract-symptoms-benign2026-10-19 https://evidence-hub.com/study/130654-robot-assisted-radical-prostatectomy-in-a-patient-with-zinner-syndrome2026-10-19 https://evidence-hub.com/study/130655-phytomedicines-in-pharmacotherapy-of-luts-bph-what-do-patients-think2026-10-19 https://evidence-hub.com/study/130656-management-of-prolonged-post-operative-pelvic-pain-after2026-10-19 https://evidence-hub.com/study/130657-a-brief-overview-of-cholinergic-and-phosphodiesterase-5-inhibitors-in2026-10-19 https://evidence-hub.com/study/130658-holmium-laser-enucleation-of-the-prostate-as-a-secondary-surgery2026-10-19 https://evidence-hub.com/study/130659-health-care-resource-utilization-and-treatment-patterns-in-men-with2026-10-19 https://evidence-hub.com/study/130660-efficacy-and-safety-of-dutasteride-with-tadalafil-add-on-therapy-in2026-10-19 https://evidence-hub.com/study/130661-how-would-you-manage-this-patient-with-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130662-nanotechnology-for-reproductive-healthcare-a-comprehensive-review2026-10-19 https://evidence-hub.com/study/130663-erectile-dysfunction-expert-panel-recommendations-for-evaluation-and2026-10-19 https://evidence-hub.com/study/130664-smooth-muscle-contractility-of-laser-enucleated-prostate-tissues-and2026-10-19 https://evidence-hub.com/study/130665-ixeris-polycephala-extract-alleviates-progression-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130666-association-between-baseline-neutrophil-to-lymphocyte-ratio-and-short2026-10-19 https://evidence-hub.com/study/130667-postoperative-pain-management-after-ureteroscopy-focused-approaches2026-10-19 https://evidence-hub.com/study/130668-enhancing-medication-appropriateness-insights-from-the-stopp2026-10-19 https://evidence-hub.com/study/130669-efficacy-of-combination-therapy-tadalafil-plus-tamsulosin-in-ureteral2026-10-19 https://evidence-hub.com/study/130670-acute-dual-therapeutic-effects-of-the-bkca-channel-opener-ldd175-on2026-10-19 https://evidence-hub.com/study/130671-two-cases-of-pelvic-hematoma-after-prostatic-urethral-lift-surgery2026-10-19 https://evidence-hub.com/study/130673-trends-in-experimental-autoimmune-prostatitis-insights-into2026-10-19 https://evidence-hub.com/study/130674-safety-and-effectiveness-of-vibegron-in-japanese-patients-with2026-10-19 https://evidence-hub.com/study/130675-safety-and-efficacy-of-silodosin-versus-tadalafil-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/130676-comparing-the-efficacy-and-safety-of-treatment-with-fixed-dose-of2026-10-19 https://evidence-hub.com/study/130677-comparative-assessment-of-efficacy-of-tadalafil-and-tamsulosin-alone2026-10-19 https://evidence-hub.com/study/130678-the-use-of-tadalafil-in-the-treatment-of-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/130679-the-effect-of-tadalafil-5-mg-on-outflow-obstruction-due-to-benign2026-10-19 https://evidence-hub.com/study/130680-alfuzosin-monotherapy-versus-alfuzosin-plus-tadalafil-combination-in2026-10-19 https://evidence-hub.com/study/130686-re-efficacy-and-safety-of-tadalafil-5-mg-once-daily-in-the-treatment2026-10-19 https://evidence-hub.com/study/130688-tadalafil-versus-tadalafil-with-sildosin-in-the-management-of2026-10-19 https://evidence-hub.com/study/130689-prospective-comparative-study-between-silodosin-8-mg-versus2026-10-19 https://evidence-hub.com/study/130691-efficacy-and-safety-of-fixed-dose-combination-of-tamsulosin-and2026-10-19 https://evidence-hub.com/study/130692-028-efficacy-and-safety-of-fixed-dose-combination-of-tamsulosin-and2026-10-19 https://evidence-hub.com/study/130694-editorial-comment-from-dr-tanaka-to-tadalafil-is-sufficiently2026-10-19 https://evidence-hub.com/study/130695-editorial-comment-from-dr-amano-to-tadalafil-is-sufficiently2026-10-19 https://evidence-hub.com/study/130696-evaluating-the-effects-of-switching-from-dutasteride-to-tadalafil-in2026-10-19 https://evidence-hub.com/study/130697-pd24-01-double-blind-randomized-placebo-controlled-study-of-tadalafil2026-10-19 https://evidence-hub.com/study/130699-effect-of-tadalafil-that-was-additionally-administered-to-patients2026-10-19 https://evidence-hub.com/study/130700-evaluation-of-efficacy-of-pde5-inhibiter-by-penile-blood-pressure-for2026-10-19 https://evidence-hub.com/study/130703-1973-a-multicenter-placebo-controlled-trial-investigating-the-safety2026-10-19 https://evidence-hub.com/study/130704-1370-safety-and-efficacy-of-tadalafil-5mg-dosed-once-daily-in2026-10-19 https://evidence-hub.com/study/130705-956-efficacy-of-tadalafil-dosed-once-a-day-to-treat-erectile2026-10-19 https://evidence-hub.com/study/130706-tadalafil-once-daily-in-the-treatment-of-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/130708-a-phase-3b-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/130709-double-blind-placebo-controlled-study-on-men-with-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/130710-a-phase-3-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/130711-a-phase-3-randomized-double-blind-placebo-controlled-parallel-design2026-10-19 https://evidence-hub.com/study/130712-a-randomized-double-blind-placebo-controlled-parallel-design-pilot2026-10-19 https://evidence-hub.com/study/130713-a-randomized-double-blind-placebo-controlled-parallel-design-5-group2026-10-19 https://evidence-hub.com/study/130714-1636-the-efficacy-and-safety-of-tadalafil-administered-once-a-day-for2026-10-19 https://evidence-hub.com/study/130715-a-comparison-of-safety-and-efficacy-between-silodosin-monotherapy2026-10-19 https://evidence-hub.com/study/130716-tadalafil-administered-once-daily-for-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/130719-treatment-of-benign-prostatic-hyperplasia-and-erectile-dysfunction2026-10-19 https://evidence-hub.com/study/130721-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130722-clinical-use-of-low-dose-tadalafil-in-combination-with-alpha-blocker2026-10-19 https://evidence-hub.com/study/130723-the-role-of-tadalafil-in-the-treatment-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130724-safety-and-efficacy-of-silodosin-for-the-treatment-of-benign2026-10-19 https://evidence-hub.com/study/130725-effect-of-combination-of-tamsulosin-and-tadalafil-in-benign-prostate2026-10-19 https://evidence-hub.com/study/130726-tamsulosin-and-tadalafil-in-relieving-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130727-silodosin-in-the-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130728-the-efficacy-and-safety-of-mirabegron-on-overactive-bladder-induced2026-10-19 https://evidence-hub.com/study/130729-model-based-meta-analysis-of-individual-international-prostate2026-10-19 https://evidence-hub.com/study/130730-systematic-review-and-meta-analysis-on-phosphodiesterase-5-inhibitors2026-10-19 https://evidence-hub.com/study/130731-comparison-of-silodosin-to-tamsulosin-for-medical-expulsive-treatment2026-10-19 https://evidence-hub.com/study/130732-efficacy-and-tolerability-outcomes-of-minimally-invasive-surgical2026-10-19 https://evidence-hub.com/study/130734-the-efficacy-and-safety-of-jeoryeong-tang-zhu-ling-tang-for2026-10-19 https://evidence-hub.com/study/130735-efficacy-and-safety-of-urethral-sparing-versus-other-robot-assisted2026-10-19 https://evidence-hub.com/study/130736-efficacy-and-safety-of-combination-tamsulosin-and-dutasteride-versus2026-10-19 https://evidence-hub.com/study/130737-comparative-efficacy-and-safety-of-alpha-blockers-as-monotherapy-for2026-10-19 https://evidence-hub.com/study/130738-comparative-efficacy-of-commercial-oral-poly-herbal-traditional2026-10-19 https://evidence-hub.com/study/130739-efficacy-and-safety-of-oral-chinese-patent-medicine-for-benign2026-10-19 https://evidence-hub.com/study/130741-efficacy-and-safety-of-electroacupuncture-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/130742-the-efficacy-and-safety-of-prostatic-urethral-lift-as-a-minimally2026-10-19 https://evidence-hub.com/study/130743-a-systematic-review-and-single-arm-meta-analysis-on-the-efficacy-of2026-10-19 https://evidence-hub.com/study/130744-comparative-efficacy-and-safety-of-180-w-xps-vs-120-w-hps-greenlight2026-10-19 https://evidence-hub.com/study/130745-efficacy-and-safety-of-endourological-surgery-for-managing-overactive2026-10-19 https://evidence-hub.com/study/130746-the-efficacy-of-tranexamic-acid-in-reducing-intraoperative-bleeding2026-10-19 https://evidence-hub.com/study/130747-efficacy-and-safety-of-1-adrenergic-receptor-antagonists-in-managing2026-10-19 https://evidence-hub.com/study/130748-efficacy-and-safety-of-tranexamic-acid-in-endoscopic-surgery-for2026-10-19 https://evidence-hub.com/study/130749-efficacy-and-safety-of-blue-laser-vaporization-of-the-prostate-for2026-10-19 https://evidence-hub.com/study/130750-efficacy-and-safety-of-blockers-plus-5-reductase-inhibitors-for2026-10-19 https://evidence-hub.com/study/130751-comprehensive-efficacy-of-different-prostate-resection-volumes-for2026-10-19 https://evidence-hub.com/study/130752-comparative-efficacy-and-safety-of-low-power-versus-high-power2026-10-19 https://evidence-hub.com/study/130753-efficacy-and-safety-of-1470-nm-diode-laser-enucleation-of-the2026-10-19 https://evidence-hub.com/study/130758-comparison-on-the-efficacy-and-safety-of-bipolar-transurethral2026-10-19 https://evidence-hub.com/study/130760-the-efficacy-and-safety-of-holep-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130761-comparative-analysis-of-holmium-laser-enucleation-of-the-prostate-and2026-10-19 https://evidence-hub.com/study/130762-comparison-of-the-efficacy-and-safety-of-transurethral-laser-versus2026-10-19 https://evidence-hub.com/study/130764-the-efficacy-and-safety-of-desmopressin-acetate-applied-for-nocturia2026-10-19 https://evidence-hub.com/study/130765-the-efficacy-and-safety-of-dutasteride-and-finasteride-in-patients2026-10-19 https://evidence-hub.com/study/130766-transurethral-surgical-treatment-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130767-comparative-efficacy-of-different-drugs-for-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/130768-a-meta-analysis-comparing-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130769-holmium-laser-enucleation-of-the-prostate-versus-transurethral2026-10-19 https://evidence-hub.com/study/130770-comparing-outcomes-of-aquablation-versus-holmium-laser-enucleation-of2026-10-19 https://evidence-hub.com/study/130771-systematic-review-and-meta-analysis-on-the-effectiveness-of2026-10-19 https://evidence-hub.com/study/130772-comparative-efficacy-and-safety-of-prostatic-urethral-lift-vs2026-10-19 https://evidence-hub.com/study/130773-the-efficacy-and-safety-of-holmium-laser-enucleation-of-prostate2026-10-19 https://evidence-hub.com/study/130775-comparative-efficacy-and-safety-of-new-surgical-treatments-for-benign2026-10-19 https://evidence-hub.com/study/130776-comparison-on-the-efficacy-and-safety-of-different-surgical2026-10-19 https://evidence-hub.com/study/130777-an-updated-meta-analysis-of-the-efficacy-and-safety-of-prostatic2026-10-19 https://evidence-hub.com/study/130778-prostatic-artery-embolization-with-cyanoacrylate-glue-for-benign2026-10-19 https://evidence-hub.com/study/130779-transperineal-laser-ablation-for-benign-prostatic-hyperplasia-a2026-10-19 https://evidence-hub.com/study/130780-preoperative-prostatic-artery-embolization-combined-with2026-10-19 https://evidence-hub.com/study/130781-challenges-of-salvage-holmium-laser-enucleation-of-the-prostate2026-10-19 https://evidence-hub.com/study/130784-comparative-outcomes-of-holmium-laser-enucleation-of-the-prostate2026-10-19 https://evidence-hub.com/study/130786-a-systematic-review-and-meta-analysis-of-efficacy-and-safety2026-10-19 https://evidence-hub.com/study/130789-efficacy-and-safety-of-dutasteride-compared-with-finasteride-in2026-10-19 https://evidence-hub.com/study/130790-efficacy-and-safety-of-combination-comprising-tamsulosin-and-pde5-is2026-10-19 https://evidence-hub.com/study/130791-efficacy-and-safety-of-water-vapor-thermal-therapy-in-the-treatment2026-10-19 https://evidence-hub.com/study/130792-meta-analysis-of-the-efficacy-and-safety-of-imidafenacin-for2026-10-19 https://evidence-hub.com/study/130793-efficacy-and-safety-of-transurethral-split-of-prostate-for-benign2026-10-19 https://evidence-hub.com/study/130794-meta-analysis-of-the-efficacy-and-safety-of-combination-of-tamsulosin2026-10-19 https://evidence-hub.com/study/130796-efficacy-and-safety-of-a-hexanic-extract-of-serenoa-repens-permixon2026-10-19 https://evidence-hub.com/study/130797-efficacy-and-safety-of-initial-combination-treatment-of-an-alpha2026-10-19 https://evidence-hub.com/study/130798-systematic-review-and-meta-analysis-of-efficacy-and-safety-of2026-10-19 https://evidence-hub.com/study/130800-efficacy-and-safety-of-5-alpha-reductase-inhibitor-monotherapy-in2026-10-19 https://evidence-hub.com/study/130801-re-comparative-efficacy-and-safety-of-new-surgical-treatments-for2026-10-19 https://evidence-hub.com/study/130802-acupuncture-and-moxibustion-treating-lower-urinary-tract-symptoms-due2026-10-19 https://evidence-hub.com/study/130804-efficacy-and-safety-of-hexanic-lipidosterolic-extract-of-serenoa2026-10-19 https://evidence-hub.com/study/130806-pd56-04-comparative-efficacy-of-novel-surgical-treatments-for-benign2026-10-19 https://evidence-hub.com/study/130807-letter-to-the-editor-commentary-on-evidence-is-enough-a-systematic2026-10-19 https://evidence-hub.com/study/130808-prostate-artery-embolization-on-lower-urinary-tract-symptoms-related2026-10-19 https://evidence-hub.com/study/130809-role-of-antimuscarinics-combined-with-alpha-blockers-in-the2026-10-19 https://evidence-hub.com/study/130810-beneficial-effects-of-pumpkin-seed-soft-extract-on-lower-urinary2026-10-19 https://evidence-hub.com/study/130812-comparison-of-holmium-laser-enucleation-and-transurethral-resection2026-10-19 https://evidence-hub.com/study/130813-holmium-laser-enucleation-of-the-prostate-versus-transurethral2026-10-19 https://evidence-hub.com/study/130814-serenoa-repens-for-the-treatment-of-lower-urinary-tract-symptoms-due2026-10-19 https://evidence-hub.com/study/130815-n-butyl-cyanoacrylate-glue-application-in-prostate-artery2026-10-19 https://evidence-hub.com/study/130816-surgical-and-interventional-management-of-bladder-outlet-obstruction2026-10-19 https://evidence-hub.com/study/130818-ejaculatory-function-after-robotic-waterjet-ablation-for-the2026-10-19 https://evidence-hub.com/study/130819-head-to-head-comparison-of-rezum-vs-urolift-for-patient-with-benign2026-10-19 https://evidence-hub.com/study/130821-to-rezum-or-not-to-rezum-a-narrative-review-of-water-vapor-thermal2026-10-19 https://evidence-hub.com/study/130822-minimally-invasive-surgical-therapies-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/130824-212-minimally-invasive-surgical-therapies-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/130825-efficacy-and-safety-of-chinese-herbal-medicine-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/130826-efficacy-and-safety-of-serenoa-repens-in-benign-prostatic-disorders-a2026-10-19 https://evidence-hub.com/study/130827-nutraceutical-treatment-and-prevention-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130828-modern-surgical-techniques-for-the-treatment-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130829-holep-vs-turp-in-benign-prostatic-hyperplasia-a-systematic-review2026-10-19 https://evidence-hub.com/study/130830-exploring-the-use-of-phytotherapy-in-benign-prostatic-hyperplasia-bph2026-10-19 https://evidence-hub.com/study/130831-a-systematic-review-of-novel-surgical-treatments-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/130832-acupuncture-for-benign-prostatic-hyperplasia-in-the-elderly-a2026-10-19 https://evidence-hub.com/study/130833-the-efficacy-and-safety-of-silodosin-for-the-treatment-of-benign2026-10-19 https://evidence-hub.com/study/130834-the-systematic-review-of-the-efficacy-and-safety-of-minimally2026-10-19 https://evidence-hub.com/study/130835-comparative-analysis-of-the-long-term-efficacy-and-safety-of2026-10-19 https://evidence-hub.com/study/130836-radiation-dose-of-prostatic-artery-embolization-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/130837-minimally-invasive-treatments-for-benign-prostatic-hyperplasia-a2026-10-19 https://evidence-hub.com/study/130838-effectiveness-of-contemporary-treatments-for-iatrogenic-urethral2026-10-19 https://evidence-hub.com/study/130839-a-randomized-comparative-open-label-study-of-efficacy-and2026-10-19 https://evidence-hub.com/study/130840-mirabegron-add-on-therapy-to-tamsulosin-in-men-with-overactive2026-10-19 https://evidence-hub.com/study/130841-urox-containing-concentrated-extracts-of-crataeva-nurvala-stem-bark2026-10-19 https://evidence-hub.com/study/130842-efficacy-of-tadalafil-in-egyptian-and-turkish-men-with-erectile2026-10-19 https://evidence-hub.com/study/130843-effects-of-tissue-cultured-mountain-ginseng-panax-ginseng-ca-meyer2026-10-19 https://evidence-hub.com/study/130846-holmium-laser-enucleation-versus-bipolar-plasmakinetic-resection-for2026-10-19 https://evidence-hub.com/study/130847-urtica-dioica-root-extract-on-clinical-and-biochemical-parameters-in2026-10-19 https://evidence-hub.com/study/130848-efficacy-and-safety-of-vibegron-for-persistent-symptoms-of-overactive2026-10-19 https://evidence-hub.com/study/130849-efficacy-and-safety-of-pelvic-floor-magnetic-stimulation-combined2026-10-19 https://evidence-hub.com/study/130851-transcutaneous-tibial-nerve-stimulation-combined-mirabegron-therapy2026-10-19 https://evidence-hub.com/study/130852-bladder-function-and-safety-of-vibegron-in-men-with-overactive2026-10-19 https://evidence-hub.com/study/130853-efficacy-and-safety-of-mirabegron-and-tamsulosin-combination-therapy2026-10-19 https://evidence-hub.com/study/130857-comparative-analysis-of-low-power-versus-high-power-holmium-laser2026-10-19 https://evidence-hub.com/study/130858-transurethral-anatomical-enucleation-of-the-prostate-using-a-1470-nm2026-10-19 https://evidence-hub.com/study/130859-bipolar-resection-versus-enucleation-of-the-prostate-in-management-of2026-10-19 https://evidence-hub.com/study/130860-pd08-13-efficacy-of-the-urocross-expander-a-non-permanent-device-for2026-10-19 https://evidence-hub.com/study/130861-efficacy-and-safety-of-deep-acupuncture-at-qugu-point-cv2-for-benign2026-10-19 https://evidence-hub.com/study/130862-efficacy-of-a-polyherbal-formulation-in-the-management-of-benign2026-10-19 https://evidence-hub.com/study/130863-efficacy-and-safety-of-serenoa-repens-extract-among-patients-with2026-10-19 https://evidence-hub.com/study/130864-randomized-controlled-trial-of-aquablation-versus-transurethral2026-10-19 https://evidence-hub.com/study/130865-efficacy-evaluation-of-chinese-herbal-medicine-vgh-bph1-for-patients2026-10-19 https://evidence-hub.com/study/130866-holmium-laser-enucleation-versus-bipolar-resection-in-the-management2026-10-19 https://evidence-hub.com/study/130867-plasma-kinetic-enucleation-vs-holmium-laser-enucleation-for-treating2026-10-19 https://evidence-hub.com/study/130868-efficacy-and-safety-of-afalaza-in-men-with-symptomatic-benign2026-10-19 https://evidence-hub.com/study/130870-pd24-03-efficacy-and-safety-of-afalaza-in-men-with-symptomatic-benign2026-10-19 https://evidence-hub.com/study/130871-the-pinnacle-study-a-double-blind-randomized-sham-controlled-study2026-10-19 https://evidence-hub.com/study/130872-holmium-laser-enucleation-vs-bipolar-plasmakinetic-enucleation-of-a2026-10-19 https://evidence-hub.com/study/130873-comparison-of-diode-laser-980-nm-enucleation-vs-holmium-laser2026-10-19 https://evidence-hub.com/study/130875-single-versus-double-dose-tamsulosin-for-patients-with-moderate-or2026-10-19 https://evidence-hub.com/study/130879-randomized-controlled-trial-of-laser-vs-bipolar-plasma-vaporization2026-10-19 https://evidence-hub.com/study/130881-randomized-controlled-trial-on-the-efficacy-of-bladder-training2026-10-19 https://evidence-hub.com/study/130887-homoeopathic-treatment-for-lower-urinary-tract-symptoms-in-men-with2026-10-19 https://evidence-hub.com/study/130888-efficacy-of-tamsulosin-in-patients-with-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130890-mp09-12-a-prospective-multicenter-clinical-trial-for-efficacy-of2026-10-19 https://evidence-hub.com/study/130893-a-clinical-investigation-to-determine-the-safety-and-efficacy-of-a2026-10-19 https://evidence-hub.com/study/130894-the-latest-in-clinical-trial-results-of-5-alpha-reductase-inhibitors2026-10-19 https://evidence-hub.com/study/130896-a-prospective-single-center-randomized-clinical-trial-to-evaluate-the2026-10-19 https://evidence-hub.com/study/130897-a-controlled-clinical-trial-to-evaluate-the-efficacy-of-tilanala2026-10-19 https://evidence-hub.com/study/130898-comparison-of-combination-therapy-with-tamsulosin-and-dutasteride-or2026-10-19 https://evidence-hub.com/study/130899-safety-and-efficacy-of-vibegron-in-men-with-overactive-bladder2026-10-19 https://evidence-hub.com/study/130900-safety-and-clinical-efficacy-of-prostatic-artery-embolization-in2026-10-19 https://evidence-hub.com/study/130901-aquablation-therapy-in-large-prostates-80-150-ml-for-lower-urinary2026-10-19 https://evidence-hub.com/study/130902-079-predictors-of-failed-trial-of-void-after-rezum-water-vapor2026-10-19 https://evidence-hub.com/study/130903-one-year-clinical-outcomes-of-water-vapor-thermal-therapy-for-benign2026-10-19 https://evidence-hub.com/study/130904-the-role-of-prostatic-artery-embolization-in-the-management-of-benign2026-10-19 https://evidence-hub.com/study/130905-efficacy-of-silodosin-vs-tamsulosin-in-patients-with-benign-prostatic2026-10-19 https://evidence-hub.com/study/130908-074-rezum-therapy-for-catheter-dependent-patients-with-benign2026-10-19 https://evidence-hub.com/study/130909-efficacy-and-safety-of-transurethral-columnar-balloon-dilation-of-the2026-10-19 https://evidence-hub.com/study/130911-impact-of-cyp3a4-22-genetic-variant-and-plasma-microrna-mir-27b2026-10-19 https://evidence-hub.com/study/130913-oxidative-stress-in-benign-prostatic-hyperplasia-mechanisms-clinical2026-10-19 https://evidence-hub.com/study/130914-randomised-clinical-trial-of-prostatic-artery-embolisation-versus-a2026-10-19 https://evidence-hub.com/study/130915-efficacy-and-safety-of-thermobalancing-therapy-in-men-with-lower2026-10-19 https://evidence-hub.com/study/130916-efficacy-of-prunus-africana-urtica-dioica-and-epilobium-angustifolium2026-10-19 https://evidence-hub.com/study/130917-greenlight-hps-laser-120-w-vs-diode-laser-300-w-vaporization-of-the2026-10-19 https://evidence-hub.com/study/130918-exploring-the-efficacy-of-the-traditional-chinese-medicine-compound2026-10-19 https://evidence-hub.com/study/130919-a-short-scale-trial-to-study-and-evaluate-the-safety-and-efficacy-of2026-10-19 https://evidence-hub.com/study/130920-low-dose-finasteride-in-benign-prostatic-hyperplasia-a-comprehensive2026-10-19 https://evidence-hub.com/study/130921-xia-li-qi-capsules-improve-symptoms-and-urodynamic-parameters-in2026-10-19 https://evidence-hub.com/study/130922-pharmacology-efficacy-and-safety-of-different-extracts-of-serenoa2026-10-19 https://evidence-hub.com/study/130923-evaluation-of-the-effect-of-the-oral-formulation-prepared-from-the2026-10-19 https://evidence-hub.com/study/130924-clinical-guidance-and-expert-opinion-on-the-use-of-prostatic-urethral2026-10-19 https://evidence-hub.com/study/130926-prostatic-artery-embolization-versus-transurethral-resection-of-the2026-10-19 https://evidence-hub.com/study/130928-a-comparative-study-of-silodosin-vs-tamsulosin-in-the-management-of2026-10-19 https://evidence-hub.com/study/130929-effects-of-a-proprietary-mixture-of-extracts-from-sabal-serrulata2026-10-19 https://evidence-hub.com/study/130930-established-and-emerging-treatments-for-diabetes-associated-lower2026-10-19 https://evidence-hub.com/study/130931-a-novel-insight-into-the-immune-related-interaction-of-inflammatory2026-10-19 https://evidence-hub.com/study/130932-is-early-surgical-treatment-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130933-safety-and-effectiveness-of-mirabegron-in-male-patients-with2026-10-19 https://evidence-hub.com/study/130934-onychomycosis-in-diabetics-a-common-infection-with-potentially2026-10-19 https://evidence-hub.com/study/130935-alfuzosin-for-the-medical-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/130936-overview-of-bph-symptom-relief-with-dietary-polyphenols-vitamins-and2026-10-19 https://evidence-hub.com/study/130937-systematic-review-of-safety-of-selective-androgen-receptor-modulators2026-10-19 https://evidence-hub.com/study/130938-application-of-hydrophilic-polymers-for-the-preparation-of-tadalafil2026-10-19 https://evidence-hub.com/study/130939-the-effect-of-pharmacotherapy-on-prostate-volume-prostate-perfusion2026-10-19 https://evidence-hub.com/study/130940-modern-best-practice-in-the-management-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130941-association-between-inflammatory-indexes-and-erectile-dysfunction-in2026-10-19 https://evidence-hub.com/study/130942-pharmacological-and-interventional-treatment-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130943-new-medical-treatments-for-lower-urinary-tract-symptoms-due-to-benign2026-10-19 https://evidence-hub.com/study/130944-advances-in-pharmacotherapy-for-the-treatment-of-overactive-bladder2026-10-19 https://evidence-hub.com/study/130945-safety-and-efficacy-of-tamsulosin-alfuzosin-or-silodosin-as2026-10-19 https://evidence-hub.com/study/130946-benign-prostatic-hyperplasia-and-lower-urinary-tract-symptom2026-10-19 https://evidence-hub.com/study/130947-lower-urinary-tract-symptoms-in-men2026-10-19 https://evidence-hub.com/study/130948-the-new-era-of-cancer-immunotherapy-targeting-myeloid-derived2026-10-19 https://evidence-hub.com/study/130949-contemporary-approaches-to-modulating-the-nitric-oxide-cgmp-pathway2026-10-19 https://evidence-hub.com/study/130950-udenafil-for-the-treatment-of-erectile-dysfunction2026-10-19 https://evidence-hub.com/study/130951-a-clinical-review-of-hiv-integrase-strand-transfer-inhibitors-instis2026-10-19 https://evidence-hub.com/study/130952-prevalence-burden-and-treatment-of-lower-urinary-tract-symptoms-in2026-10-19 https://evidence-hub.com/study/130953-medical-therapy-options-for-aging-men-with-benign-prostatic2026-10-19 https://evidence-hub.com/study/130954-a-systematic-review-of-the-correlates-and-management-of-nonpremature2026-10-19 https://evidence-hub.com/study/130955-revitalise-a-large-observational-study-assessing-the-safety-and2026-10-19 https://evidence-hub.com/study/130956-the-recommendations-of-a-consensus-panel-for-the-screening-diagnosis2026-10-19 https://evidence-hub.com/study/130957-vardenafil-for-the-treatment-of-erectile-dysfunction-an-overview-of2026-10-19 https://evidence-hub.com/study/130958-ip03-22-efficacy-of-rezum-therapy-in-acute-urinary-retention-due-to2026-10-19 https://evidence-hub.com/study/130960-short-to-mid-term-safety-and-efficacy-of-prostatic-artery2026-10-19 https://evidence-hub.com/study/130961-comparative-study-of-the-efficacy-and-tolerability-of-palmex2026-10-19 https://evidence-hub.com/study/130962-transurethral-cylindrical-water-sac-prostate-enlargement-surgery-for2026-10-19 https://evidence-hub.com/study/130963-transurethral-water-vapor-therapy-for-treatment-of-lower-urinary2026-10-19 https://evidence-hub.com/study/130965-the-double-decking-method-for-rezum-water-vapor-therapy-in-benign2026-10-19 https://evidence-hub.com/study/130966-prostatic-artery-embolization-versus-standard-surgical-treatment-for2026-10-19 https://evidence-hub.com/study/130967-prostate-artery-embolization-pae-in-the-treatment-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/130968-a-systematic-review-and-meta-analysis-of-prostatic-urethral-lift-for2026-10-19 https://evidence-hub.com/study/130971-outcomes-and-complications-of-naftopidil-versus-tamsulosin-for2026-10-19 https://evidence-hub.com/study/130972-efficacy-of-dexamethasone-in-reducing-the-postembolisation-syndrome2026-10-19 https://evidence-hub.com/study/130973-the-role-of-oxybutynin-chloride-in-the-management-of-patientswith2026-10-19 https://evidence-hub.com/study/130979-prostatic-artery-embolisation-versus-transurethral-resection-of-the2026-10-19 https://evidence-hub.com/study/130980-which-drug-to-discontinue-3-months-after-combination-therapy-of2026-10-19 https://evidence-hub.com/study/130981-combination-of-1-blockers-and-phosphodiesterase-type-5-inhibitor-in2026-10-19 https://evidence-hub.com/study/130982-efficacy-safety-and-adverse-effects-of-finasteride-and-dutasteride-in2026-10-19 https://evidence-hub.com/study/130983-efficacy-of-symptoms-of-lower-urinary-tract-dysfunction-research2026-10-19 https://evidence-hub.com/study/130984-blue-laser-vaporization-for-benign-prostatic-hyperplasia-a2026-10-19 https://evidence-hub.com/study/130986-comparative-analysis-of-enucleation-techniques-for-large-benign2026-10-19 https://evidence-hub.com/study/130987-real-world-long-term-outcomes-of-rezum-therapy-for-large-volume2026-10-19 https://evidence-hub.com/study/130988-clinical-efficacy-and-complication-trends-of-turp-in-managing-benign2026-10-19 https://evidence-hub.com/study/130989-i-tind-for-the-treatment-of-lower-urinary-tract-symptoms-secondary-to2026-10-19 https://evidence-hub.com/study/130990-effect-of-biofeedback-electrical-stimulation-combined-with-holep-on2026-10-19 https://evidence-hub.com/study/130992-a-comparative-study-of-transurethral-resection-of-the-prostate-turp2026-10-19 https://evidence-hub.com/study/130993-rezum-a-water-vapor-thermal-therapy-as-a-minimal-invasive-technique2026-10-19 https://evidence-hub.com/study/130994-efficacy-feasibility-and-safety-of-aquablation-after-previous-urolift2026-10-19 https://evidence-hub.com/study/130995-comparative-effectiveness-of-silodosin-vs-tamsulosin-in-treating2026-10-19 https://evidence-hub.com/study/130997-comparative-efficacy-and-safety-of-b-tuvp-vs-b-turp-for-benign2026-10-19 https://evidence-hub.com/study/130998-the-efficacy-and-safety-profile-of-urolift-for-management-of-benign2026-10-19 https://evidence-hub.com/study/131000-predicting-surgical-efficacy-and-diagnosing-histological-inflammation2026-10-19 https://evidence-hub.com/study/131001-multicenter-prospective-comparative-cohort-study-evaluating-the2026-10-19 https://evidence-hub.com/study/131003-a-case-series-on-the-efficacy-and-safety-of-transperineal-laser2026-10-19 https://evidence-hub.com/study/131004-association-between-benign-prostatic-hyperplasia-and-suicide-in-south2026-10-19 https://evidence-hub.com/study/131005-the-p-r-os-t-a-t-e-nomogram-for-the-preoperative-prediction-of2026-10-19 https://evidence-hub.com/study/131007-0905-effects-of-benign-prostatic-hyperplasia-surgery-on-positive2026-10-19 https://evidence-hub.com/study/131008-effects-of-prostatic-inflammation-on-clinical-outcomes-in-patients2026-10-19 https://evidence-hub.com/study/131009-one-year-outcomes-after-water-vapor-thermal-therapy-for-symptomatic2026-10-19 https://evidence-hub.com/study/131010-predicting-the-pathological-subdiagnosis-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131011-effects-on-ejaculation-preservation-using-low-energy-pulsed-thulium2026-10-19 https://evidence-hub.com/study/131012-holmium-laser-enucleation-of-the-prostate-improves-the-renal2026-10-19 https://evidence-hub.com/study/131013-rezum-therapy-outcomes-of-symptom-relief-and-quality-of-life-in2026-10-19 https://evidence-hub.com/study/131014-efficacy-of-using-voiding-time-as-a-uroflow-parameter-for-detecting2026-10-19 https://evidence-hub.com/study/131015-comparative-analysis-of-greenlight-laser-photovaporization-and2026-10-19 https://evidence-hub.com/study/131017-analysis-of-gene-polymorphisms-in-benign-prostate-hyperplasia2026-10-19 https://evidence-hub.com/study/131018-a-novel-metal-free-sling-approach-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131019-clinical-efficacy-of-transurethral-resection-of-the-prostate-combined2026-10-19 https://evidence-hub.com/study/131020-function-preserving-plasma-kinetic-enucleation-of-the-prostate-with2026-10-19 https://evidence-hub.com/study/131021-outcome-and-safety-of-intraoperative-tranexamic-acid-use-in-reducing2026-10-19 https://evidence-hub.com/study/131023-role-of-5-alpha-reductase-inhibitor-dutasteride-in-decreasing-blood2026-10-19 https://evidence-hub.com/study/131024-comparison-of-the-efficacy-and-safety-of-alfuzosin-and-tamsulosin-in2026-10-19 https://evidence-hub.com/study/131025-effect-of-siddha-medicines-in-benign-prostatic-hyperplasia-presenting2026-10-19 https://evidence-hub.com/study/131026-the-efficacy-of-transurethral-holmium-laser-enucleation-of-the2026-10-19 https://evidence-hub.com/study/131028-the-efficacy-of-tamsulosin-monotherapy-and-its-combination-with2026-10-19 https://evidence-hub.com/study/131030-determinant-of-post-transurethral-resection-of-the-prostate-acute2026-10-19 https://evidence-hub.com/study/131033-clinical-application-of-huang-e-capsule-after-surgery-for-prostatic2026-10-19 https://evidence-hub.com/study/131035-impact-of-metabolic-syndrome-on-combination-therapy-efficacy-in-luts2026-10-19 https://evidence-hub.com/study/131039-a-propensity-score-matched-comparison-of-medium-to-long-term-outcomes2026-10-19 https://evidence-hub.com/study/131044-prostate-artery-embolization-in-the-treatment-of-massive-intractable2026-10-19 https://evidence-hub.com/study/131046-benign-prostatic-hyperplasia-and-kidney-stone-disease-thermobalancing2026-10-19 https://evidence-hub.com/study/131047-benign-prostate-hyperplasia-over-150cc-should-we-perform-an2026-10-19 https://evidence-hub.com/study/131057-diagnostic-efficacy-of-grey-zone-serum-prostate-specific-antigen2026-10-19 https://evidence-hub.com/study/131058-impact-of-benign-prostatic-hyperplasia-medications-on-post-void2026-10-19 https://evidence-hub.com/study/131059-clinical-outcomes-of-transurethral-thulium-laser-enucleation-of-the2026-10-19 https://evidence-hub.com/study/131060-quality-of-life-and-influencing-factors-in-older-adults-with-benign2026-10-19 https://evidence-hub.com/study/131062-evaluating-patient-preferences-in-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131065-is-transition-zone-index-useful-in-assessing-bladder-outflow2026-10-19 https://evidence-hub.com/study/131066-the-use-of-e-module-learning-media-and-nursing-students-self-efficacy2026-10-19 https://evidence-hub.com/study/131068-identification-of-characteristic-metabolic-panels-for-different2026-10-19 https://evidence-hub.com/study/131069-right-lateral-digital-rectal-examination-in-men-with-suspected2026-10-19 https://evidence-hub.com/study/131071-ethnopharmacological-survey-of-medicinal-plants-practiced-by2026-10-19 https://evidence-hub.com/study/131072-knowledge-and-prevalence-of-use-of-saw-palmetto-and-other-herbal2026-10-19 https://evidence-hub.com/study/131075-treatment-algorithm-for-management-of-benign-prostatic-obstruction-an2026-10-19 https://evidence-hub.com/study/131076-therapeutic-approaches-for-urologic-chronic-pelvic-pain-syndrome2026-10-19 https://evidence-hub.com/study/131077-sexual-health-in-cancer-care-a-narrative-review-and-position2026-10-19 https://evidence-hub.com/study/131078-beneficial-extracardiac-effects-of-cardiovascular-medications2026-10-19 https://evidence-hub.com/study/131079-urea-cycle-dysregulation-and-arginine-pathways-in-the-pathogenesis-of2026-10-19 https://evidence-hub.com/study/131080-contemporary-management-of-chronic-prostatitis2026-10-19 https://evidence-hub.com/study/131081-established-and-emerging-therapeutic-uses-of-pde-type-5-inhibitors-in2026-10-19 https://evidence-hub.com/study/131082-immune-mediated-organ-specific-reactions-to-covid-19-vaccines-a2026-10-19 https://evidence-hub.com/study/131083-redo-db-the-repurposing-drugs-in-oncology-database2026-10-19 https://evidence-hub.com/study/131084-anorectal-and-pelvic-pain2026-10-19 https://evidence-hub.com/study/131085-medical-management-of-ischemic-stuttering-priapism-a-contemporary2026-10-19 https://evidence-hub.com/study/131086-integrative-review-on-the-non-invasive-management-of-lower-urinary2026-10-19 https://evidence-hub.com/study/131087-central-serous-chorioretinopathy-update-on-pathophysiology-and2026-10-19 https://evidence-hub.com/study/131089-efficacy-of-homeopathic-medicines-and-treatment-protocol-in-managing2026-10-19 https://evidence-hub.com/study/131090-transurethral-intraprostatic-botulinum-toxin-a-injection-in-patients2026-10-19 https://evidence-hub.com/study/131092-prostatic-artery-embolization-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131093-multiple-prostatic-calculi-a-case-series-and-literature-review2026-10-19 https://evidence-hub.com/study/131094-electrolyte-imbalance-monitoring-following-transurethral-resection-of2026-10-19 https://evidence-hub.com/study/131095-feasibility-of-water-vapor-thermal-therapy-for-treating-lower-urinary2026-10-19 https://evidence-hub.com/study/131096-epirubicin-loaded-beads-transarterial-prostatic-arterial2026-10-19 https://evidence-hub.com/study/131097-pathogenetic-approach-to-the-treatment-of-patients-with-benign2026-10-19 https://evidence-hub.com/study/131099-324-outcomes-of-prostate-artery-embolisation-in-catheterised-patients2026-10-19 https://evidence-hub.com/study/131106-feasibility-of-en-bloc-thulium-laser-enucleation-of-the-prostate-in-a2026-10-19 https://evidence-hub.com/study/131117-prostatic-artery-embolization-in-patients-with-prostate-cancer-a2026-10-19 https://evidence-hub.com/study/131119-prostatic-artery-embolization-is-safe-and-effective-for-medically2026-10-19 https://evidence-hub.com/study/131122-how-i-do-it-percutaneous-cystolitholapaxy-for-bladder-stones-with2026-10-19 https://evidence-hub.com/study/131124-safety-and-efficacy-of-endovascular-revascularization-of-single2026-10-19 https://evidence-hub.com/study/131125-ejaculation-preserving-holmium-laser-enucleation-of-the-prostate-a2026-10-19 https://evidence-hub.com/study/131127-supply-the-demand-assessment-of-the-feasibility-of-local2026-10-19 https://evidence-hub.com/study/131130-use-of-the-triple-coaxial-triaxial-microcatheter-system-in2026-10-19 https://evidence-hub.com/study/131134-re-predictors-of-nerve-stimulator-success-in-patients-with-overactive2026-10-19 https://evidence-hub.com/study/131136-significance-of-operative-parameters-on-outcomes-after-transurethral2026-10-19 https://evidence-hub.com/study/131139-re-spontaneous-voiding-is-surprisingly-recoverable-via-outlet2026-10-19 https://evidence-hub.com/study/131141-long-term-testosterone-supplementation-is-useful-for-ed-with2026-10-19 https://evidence-hub.com/study/131142-open-prostatectomy-the-results-of-a-series-of-320-cases-in-rural-area2026-10-19 https://evidence-hub.com/study/131143-medium-term-outcome-of-bipolar-plasma-vaporization-in-prostate-cancer2026-10-19 https://evidence-hub.com/study/131144-re-host-restriction-of-escherichia-coli-recurrent-urinary-tract2026-10-19 https://evidence-hub.com/study/131145-transactions-of-the-showa-university-society-the-349-th-meeting-12026-10-19 https://evidence-hub.com/study/131147-efficacy-of-majoon-rasheedi-in-benign-prostatic-hyperplasia-a-case2026-10-19 https://evidence-hub.com/study/131148-therapeutic-efficacy-of-unani-medicine-in-the-management-of-warme2026-10-19 https://evidence-hub.com/study/131149-a-patient-with-benign-prostatic-hyperplasia-treated-with-prostatic2026-10-19 https://evidence-hub.com/study/131150-classical-ayurvedic-therapy-for-benign-prostatic-enlargement-in-a2026-10-19 https://evidence-hub.com/study/131151-a-rare-case-of-recurrent-delayed-massive-hematuria-due-to-arterial2026-10-19 https://evidence-hub.com/study/131152-effect-of-paribhadra-paneeyakshara-in-mutraghata-caused-by-benign2026-10-19 https://evidence-hub.com/study/131153-exploring-sensitivity-and-significance-of-tamsulosin-as-modified2026-10-19 https://evidence-hub.com/study/131154-holmium-laser-prostatectomy-for-primary-bladder-neck-obstruction-pbno2026-10-19 https://evidence-hub.com/study/131155-success-study-of-vasthyamayanthakam-ghrutham-in-the-management-of2026-10-19 https://evidence-hub.com/study/131156-cowper-s-duct-syringocele-mimicking-prostatic-obstruction-a-case2026-10-19 https://evidence-hub.com/study/131157-minimally-invasive-treatment-in-benign-prostatic-hyperplasia-bph2026-10-19 https://evidence-hub.com/study/131158-herpes-zoster-ophthalmicus-following-recombinant-zoster-vaccine-a2026-10-19 https://evidence-hub.com/study/131159-single-port-transvesical-robot-assisted-simple-prostatectomy-with2026-10-19 https://evidence-hub.com/study/131160-chronic-visceral-pain-treated-with-10-khz-spinal-cord-stimulation-a2026-10-19 https://evidence-hub.com/study/131161-transurethral-bipolar-enucleation-vs-monopolar-enucleation-in-benign2026-10-19 https://evidence-hub.com/study/131162-urethral-sparing-laparoscopic-simple-prostatectomy-for-the-treatment2026-10-19 https://evidence-hub.com/study/131165-efficacy-and-safety-of-finasteride-5-alpha-reductase-inhibitor2026-10-19 https://evidence-hub.com/study/131167-preliminary-clinical-outcomes-of-irreversible-electroporation-in-the2026-10-19 https://evidence-hub.com/study/131168-efficacy-of-tamsulosin-alone-versus-tamsulosin-plus-tadalafil-in2026-10-19 https://evidence-hub.com/study/131170-rehabilitation-options-for-patients-with-different-types-of-urinary2026-10-19 https://evidence-hub.com/study/131172-aquablation-for-the-treatment-of-benign-prostatic-hyperplasia-in-a2026-10-19 https://evidence-hub.com/study/131175-a-huge-benign-prostatic-hyperplasia-presenting-with-renal-failure2026-10-19 https://evidence-hub.com/study/131181-the-expander-1-trial-introduction-of-the-novel-urocrosstm-expander2026-10-19 https://evidence-hub.com/study/131184-an-evidence-based-case-study-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131185-laser-technologies-in-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131202-management-of-lower-urinary-tract-symptoms-attributed-to-benign2026-10-19 https://evidence-hub.com/study/131203-management-of-lower-urinary-tract-symptoms-attributed-to-benign2026-10-19 https://evidence-hub.com/study/131206-potential-side-effects-of-currently-available-pharmacotherapies-in2026-10-19 https://evidence-hub.com/study/131207-effects-of-phosphodiesterase-type-5-inhibitors-on-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/131208-autonomic-neuropathy-in-diabetes2026-10-19 https://evidence-hub.com/study/131209-nanoreagents-against-the-blood-testis-barrier-a-strategy-for2026-10-19 https://evidence-hub.com/study/131210-current-applications-of-artificial-intelligence-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/131211-late-onset-hypogonadism-current-methods-of-clinical-diagnosis-and2026-10-19 https://evidence-hub.com/study/131212-evaluation-and-management-of-male-sexual-dysfunction-in-parkinson-s2026-10-19 https://evidence-hub.com/study/131213-erectile-dysfunction-causes-assessment-and-management-options2026-10-19 https://evidence-hub.com/study/131214-potential-therapeutic-targets-in-the-prevention-of-testicular2026-10-19 https://evidence-hub.com/study/131215-new-therapeutic-targets-to-prevent-benign-prostatic-enlargement-and2026-10-19 https://evidence-hub.com/study/131216-association-of-sexual-health-and-mental-health-in-erectile2026-10-19 https://evidence-hub.com/study/131217-advancements-in-phosphodiesterase-5-inhibitors-unveiling-present-and2026-10-19 https://evidence-hub.com/study/131218-update-on-the-management-of-benign-prostatic-hyperplasia-and-the-role2026-10-19 https://evidence-hub.com/study/131219-cyclic-nucleotide-phosphodiesterase-families-as-targets-to-treat2026-10-19 https://evidence-hub.com/study/131220-synergistic-autophagy-related-mechanisms-of-protection-against-brain2026-10-19 https://evidence-hub.com/study/131221-discovery-and-development-of-steroidal-enzyme-inhibitors-as-anti2026-10-19 https://evidence-hub.com/study/131222-narrative-review-the-fda-s-perfunctory-approach-of-dietary-supplement2026-10-19 https://evidence-hub.com/study/131223-updates-on-preprocedural-evaluation-and-patient-selection-for2026-10-19 https://evidence-hub.com/study/131224-male-accessory-gland-infection-magi-over-diagnosed-or-under-treated2026-10-19 https://evidence-hub.com/study/131225-interrogating-erectile-dysfunction-and-evaluating-novel-therapeutic2026-10-19 https://evidence-hub.com/study/131226-long-term-cardiovascular-safety-of-testosterone-therapy-a-review-of2026-10-19 https://evidence-hub.com/study/131227-a-practical-approach-for-primary-care-practitioners-to-evaluate-and2026-10-19 https://evidence-hub.com/study/131228-hexanic-extract-of-serenoa-repens-permixon-a-review-in-symptomatic2026-10-19 https://evidence-hub.com/study/131229-review-of-drug-drug-interactions-in-patients-with-prostate-cancer2026-10-19 https://evidence-hub.com/study/131230-obstructive-uropathy-overview-of-the-pathogenesis-etiology-and2026-10-19 https://evidence-hub.com/study/131231-microbiota-in-cancer-current-understandings-and-future-perspectives2026-10-19 https://evidence-hub.com/study/131232-should-all-men-with-type-2-diabetes-be-routinely-prescribed-a2026-10-19 https://evidence-hub.com/study/131233-molecular-regulation-of-concomitant-lower-urinary-tract-symptoms-and2026-10-19 https://evidence-hub.com/study/131234-phloretin-in-benign-prostate-hyperplasia-and-prostate-cancer-a2026-10-19 https://evidence-hub.com/study/131235-the-efficacy-and-safety-of-urtica-dioica-in-treating-benign-prostatic2026-10-19 https://evidence-hub.com/study/131236-aquablation-in-men-with-benign-prostate-hyperplasia-a-systematic2026-10-19 https://evidence-hub.com/study/131237-recent-advances-in-medical-management-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131238-negative-impact-of-benign-prostatic-hyperplasia-on-fertility-in-dogs2026-10-19 https://evidence-hub.com/study/131239-evidence-is-enough-a-systematic-review-and-network-meta-analysis-of2026-10-19 https://evidence-hub.com/study/131240-sexual-dysfunctions-related-to-drugs-used-in-the-management-of-lower2026-10-19 https://evidence-hub.com/study/131241-the-role-of-phosphodiesterase-5-inhibitors-in-prostatic-inflammation2026-10-19 https://evidence-hub.com/study/131242-prostatic-artery-embolization-a-systematic-review-article2026-10-19 https://evidence-hub.com/study/131243-a-systematic-review-and-meta-analysis-of-functional-outcomes-and2026-10-19 https://evidence-hub.com/study/131244-erectile-and-ejaculatory-outcomes-after-holmium-laser-enucleation-of2026-10-19 https://evidence-hub.com/study/131245-a-systematic-review-and-network-meta-analysis-comparing-rezum-with2026-10-19 https://evidence-hub.com/study/131246-a-meta-analysis-of-efficacy-and-safety-of-pde5-inhibitors-in-the2026-10-19 https://evidence-hub.com/study/131247-a-narrative-review-of-acupuncture-in-prostate-diseases-perspectives2026-10-19 https://evidence-hub.com/study/131248-effects-of-tamsulosin-combined-with-solifenacin-on-lower-urinary2026-10-19 https://evidence-hub.com/study/131249-5-reductase-inhibitors-and-the-risk-of-suicide-and-neuropsychiatric2026-10-19 https://evidence-hub.com/study/131250-a-meta-analysis-of-long-versus-short-acting-phosphodiesterase-52026-10-19 https://evidence-hub.com/study/131251-efficacy-of-pregabalin-solifenacin-or-combination-therapy-for2026-10-19 https://evidence-hub.com/study/131252-a-systematic-review-and-meta-analysis-of-the-efficacy-and-safety-of2026-10-19 https://evidence-hub.com/study/131254-impact-of-combination-therapy-5-alpha-reductase-inhibitors-5-ari-plus2026-10-19 https://evidence-hub.com/study/131256-the-role-of-silodosin-as-a-new-medical-expulsive-therapy-for-ureteral2026-10-19 https://evidence-hub.com/study/131258-lower-urinary-tract-symptoms-and-sexual-dysfunction-in-male-a2026-10-19 https://evidence-hub.com/study/131259-a-review-of-current-treatments-for-chronic-prostatitis-chronic-pelvic2026-10-19 https://evidence-hub.com/study/131260-pumpkin-seed-intervention-to-control-diabetes-mellitus-a-systematic2026-10-19 https://evidence-hub.com/study/131262-are-adrenergic-1-antagonists-beneficial-for-the-access-of-retrograde2026-10-19 https://evidence-hub.com/study/131263-the-protective-role-of-phosphodiesterase-inhibitors-in-preventing2026-10-19 https://evidence-hub.com/study/131267-effects-of-sexual-rehabilitation-on-sexual-dysfunction-in-patients2026-10-19 https://evidence-hub.com/study/131268-the-spinal-control-of-ejaculation-revisited-a-systematic-review-and2026-10-19 https://evidence-hub.com/study/131269-new-groups-of-neuroleptic-drugs-phosphodiesterase-inhibitors-10a2026-10-19 https://evidence-hub.com/study/131270-simultaneous-screening-of-21-potential-adulterants-in-dietary2026-10-19 https://evidence-hub.com/study/131271-effects-of-phosphodiesterase-inhibitors-on-tension-induced-by2026-10-19 https://evidence-hub.com/study/131272-correction-of-erectile-dysfunction-in-patients-with-benign-prostate2026-10-19 https://evidence-hub.com/study/131273-a-study-of-the-efficacy-of-the-additional-administration-of-tadalafil2026-10-19 https://evidence-hub.com/study/131274-standardization-of-the-ethanolic-extract-of-crinum-latifolium-leaves2026-10-19 https://evidence-hub.com/study/131275-toward-a-new-epoch-optimising-treatment-outcomes-with2026-10-19 https://evidence-hub.com/study/131276-impacts-of-medical-treatments-for-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/131278-modern-combination-therapy-of-tadalafil-and-tamsulosin-as-a-new2026-10-19 https://evidence-hub.com/study/131279-tadalafil-therapy-in-symptomatic-improvement-of-luts-due-to-bph-and2026-10-19 https://evidence-hub.com/study/131280-effects-of-a-single-dose-20-mg-tadalafil-on-resistive-index-value-of2026-10-19 https://evidence-hub.com/study/131284-effect-of-continuity-nursing-based-on-the-theory-of-knowledge2026-10-19 https://evidence-hub.com/study/131287-surgical-management-of-benign-prostatic-hyperplasia-in-elderly-and2026-10-19 https://evidence-hub.com/study/131288-efficacy-and-safety-of-prostatic-artery-embolization-in-the-treatment2026-10-19 https://evidence-hub.com/study/131289-safety-and-efficacy-of-prostatic-artery-embolization-for-large-benign2026-10-19 https://evidence-hub.com/study/131290-the-efficacy-and-safety-of-1470-nm-diode-laser-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/131291-management-options-for-the-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131292-treatment-of-benign-prostatic-hyperplasia-by-natural-drugs2026-10-19 https://evidence-hub.com/study/131293-urine-mir-21-5p-as-a-potential-biomarker-for-predicting-effectiveness2026-10-19 https://evidence-hub.com/study/131294-049-administration-of-daily-5mg-tadalafil-improves-not-only-lower2026-10-19 https://evidence-hub.com/study/131295-a-second-phase-iii-multicenter-placebo-controlled-study-of-2-dosages2026-10-19 https://evidence-hub.com/study/131296-the-study-of-tadalafil-and-tamsulosin-as-monotherapy-for-lower2026-10-19 https://evidence-hub.com/study/131297-benign-prostatic-hyperplasia-from-bench-to-clinic2026-10-19 https://evidence-hub.com/study/131298-comparative-study-of-tadalafil-and-tamsulosin-in-benign-hyperplasia2026-10-19 https://evidence-hub.com/study/131299-mp09-06-administration-of-daily-5mg-tadalafil-improves-not-only-lower2026-10-19 https://evidence-hub.com/study/131300-the-efficacy-of-l-arginine-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131301-outline-of-jua-clinical-guidelines-for-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131302-phosphodiesterase-type-5-inhibitor-attenuates-chronic-ischemia2026-10-19 https://evidence-hub.com/study/131303-ethanol-extract-of-cosmos-caudatus-attenuates-oxidative-stress-and2026-10-19 https://evidence-hub.com/study/131304-suppression-of-hypothalamic-pituitary-gonadal-function-by-linzagolix2026-10-19 https://evidence-hub.com/study/131305-heat-killed-and-live-enterococcus-faecalis-attenuates-enlarged2026-10-19 https://evidence-hub.com/study/131306-hydroxycitric-acid-inhibits-ferroptosis-and-ameliorates-benign2026-10-19 https://evidence-hub.com/study/131307-the-impact-of-vitamin-d-and-or-saw-palmetta-berry-extract-on-the2026-10-19 https://evidence-hub.com/study/131308-herbal-medicine-in-the-treatment-of-benign-prostate-hyperplasia-a2026-10-19 https://evidence-hub.com/study/131309-computer-prediction-and-experimental-verification-of-guizhi-fuling2026-10-19 https://evidence-hub.com/study/131310-assessing-the-safety-and-efficacy-of-the-clearringtm-implant-for-the2026-10-19 https://evidence-hub.com/study/131311-efficacy-of-mimosa-pudica-methanolic-extract-on-bpa-induces-benign2026-10-19 https://evidence-hub.com/study/131313-prostatic-artery-occlusion-versus-prostatic-artery-embolization-for2026-10-19 https://evidence-hub.com/study/131316-a-phytosterol-enriched-saw-palmetto-supercritical-co2-extract2026-10-19 https://evidence-hub.com/study/131317-effect-of-rape-flower-on-benign-prostatic-hyperplasia-in-rats2026-10-19 https://evidence-hub.com/study/131318-comparison-of-different-doses-of-petroleum-ether-extracts-of2026-10-19 https://evidence-hub.com/study/131319-inhibitory-effects-of-pycnogenol-a-pine-bark-extract-in-a-rat-model2026-10-19 https://evidence-hub.com/study/131320-peanut-sprout-extracts-cultivated-with-fermented-sawdust-medium2026-10-19 https://evidence-hub.com/study/131321-chebulinic-acid-enriched-fraction-ameliorates-benign-prostatic2026-10-19 https://evidence-hub.com/study/131322-scientific-evaluation-of-a-unani-pharmacopoeia-based-formulation-on2026-10-19 https://evidence-hub.com/study/131323-fertility-factors-d-hormone-in-prevention-of-reproducopathies-caused2026-10-19 https://evidence-hub.com/study/131324-relative-influence-of-ageratum-conyzoides-l-plant-extracts-on2026-10-19 https://evidence-hub.com/study/131325-exploring-the-effects-and-mechanism-of-peony-pollen-in-treating2026-10-19 https://evidence-hub.com/study/131326-mp06-18-phosphodiesterase-type-5-inhibitor-attenuates-chronic2026-10-19 https://evidence-hub.com/study/131328-effects-of-larval-extracts-from-identified-protaetia-brevitarsis2026-10-19 https://evidence-hub.com/study/131329-testosterone-induced-benign-prostatic-hyperplasia-rat-and-dog-as2026-10-19 https://evidence-hub.com/study/131330-calamagrostis-arundinacea-extract-mitigates-testosterone-induced2026-10-19 https://evidence-hub.com/study/131331-benign-prostatic-hyperplasia-obstruction-ameliorated-using-a-soluble2026-10-19 https://evidence-hub.com/study/131338-combined-sabal-and-urtica-extracts-ws-1541-exert-anti-proliferative2026-10-19 https://evidence-hub.com/study/131339-rapatar-a-nanoformulation-of-rapamycin-decreases-chemically-induced2026-10-19 https://evidence-hub.com/study/131340-inhibitory-effect-of-yukmijihwang-tang-a-traditional-herbal-formula2026-10-19 https://evidence-hub.com/study/131344-curcumin-inhibits-prostate-cancer-by-upregulating-mir-483-3p-and2026-10-19 https://evidence-hub.com/study/131346-efficacy-of-resveratrol-in-male-urogenital-tract-dysfunctions-an2026-10-19 https://evidence-hub.com/study/131348-the-use-of-pde5-inhibitors-in-the-treatment-of-benign-prostate2026-10-19 https://evidence-hub.com/study/131349-potential-efficacy-of-polyphenols-and-isothiocyanates-in-the2026-10-19 https://evidence-hub.com/study/131350-cepharanthine-may-inhibit-the-proliferation-of-prostate-cells-by2026-10-19 https://evidence-hub.com/study/131355-promise-and-the-pharmacological-mechanism-of-botulinum-toxin-a-in2026-10-19 https://evidence-hub.com/study/131358-pharmacological-substantiation-of-development-of-suppositories-with2026-10-19 https://evidence-hub.com/study/131359-research-progress-and-clinical-evaluation-of-histotripsy-a-narrative2026-10-19 https://evidence-hub.com/study/131361-repurposing-phosphodiesterase-5-inhibitors-as-chemoadjuvants2026-10-19 https://evidence-hub.com/study/131362-mp06-13-inhibition-of-human-prostate-stromal-cell-growth-and2026-10-19 https://evidence-hub.com/study/131363-experimental-evaluation-of-the-influence-of-isobornylphenols-on-the2026-10-19 https://evidence-hub.com/study/131373-evaluation-of-biomaterials-for-bladder-augmentation-using-cystometric2026-10-19 https://evidence-hub.com/study/131375-inhibitors-of-sa-reductase2026-10-19 https://evidence-hub.com/study/131378-novel-drug-targets-for-the-pharmacotherapy-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131379-mechanism-of-androgen-independent-stromal-proliferation-in-benign2026-10-19 https://evidence-hub.com/study/131380-epidemiology-and-risk-factors-of-lower-urinary-tract-symptoms-benign2026-10-19 https://evidence-hub.com/study/131381-pharmacotherapy-and-herbal-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131382-benign-prostatic-hyperplasia-a-new-metabolic-disease-of-the-aging2026-10-19 https://evidence-hub.com/study/131384-reproductive-and-endocrinological-effects-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131385-benign-prostatic-hyperplasia-basic-research-pathophysiology-mp062026-10-19 https://evidence-hub.com/study/131386-additive-effect-of-oral-ldd175-to-tamsulosin-and-finasteride-in-a2026-10-19 https://evidence-hub.com/study/131387-finasteride-and-erectile-dysfunction-in-patients-with-benign2026-10-19 https://evidence-hub.com/study/131388-prostatic-arterial-embolization-for-the-treatment-of-lower-urinary2026-10-19 https://evidence-hub.com/study/131389-comparing-the-effect-of-alpha-blocker-silodosin-and-phosphodiesterase2026-10-19 https://evidence-hub.com/study/131390-nanomedicine-for-benign-prostatic-hyperplasia-pathological-axes-and2026-10-19 https://evidence-hub.com/study/131391-role-of-phosphodiesterase-type-5-inhibitor-on-benign-prostatic2026-10-19 https://evidence-hub.com/study/131392-effect-of-sildenafil-citrate-in-testosterone-induced-benign-prostate2026-10-19 https://evidence-hub.com/study/131393-current-benign-prostatic-hyperplasia-treatment-impact-on-sexual2026-10-19 https://evidence-hub.com/study/131394-inhibitory-effects-of-calocybe-indica-macrofungi-on-experimental2026-10-19 https://evidence-hub.com/study/131395-omentin-1-inhibits-the-development-of-benign-prostatic-hyperplasia-by2026-10-19 https://evidence-hub.com/study/131396-innovative-approaches-to-benign-prostatic-hyperplasia-management2026-10-19 https://evidence-hub.com/study/131397-comprehensive-rna-seq-analysis-of-benign-prostatic-hyperplasia-bph-in2026-10-19 https://evidence-hub.com/study/131398-a-prospective-longitudinal-survey-of-erectile-function-status-in2026-10-19 https://evidence-hub.com/study/131399-benign-prostatic-hyperplasia-after-prostatic-arterial-embolization-in2026-10-19 https://evidence-hub.com/study/131400-adme-studies-and-preliminary-safety-pharmacology-of-ldt5-a-lead2026-10-19 https://evidence-hub.com/study/131401-activation-of-cgmp-pkg-p65-signaling-associated-with-pde5-is2026-10-19 https://evidence-hub.com/study/131402-a-review-of-the-prostatic-urethral-lift-for-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/131403-biochemical-evaluation-of-ceiba-pentandra-leaf-on-the-amelioration-of2026-10-19 https://evidence-hub.com/study/131404-combination-therapy-with-curcumin-plus-tamsulosin-and-finasteride-in2026-10-19 https://evidence-hub.com/study/131405-quisqualis-indica-extract-ameliorates-low-urinary-tract-symptoms-in2026-10-19 https://evidence-hub.com/study/131406-decoding-benign-prostatic-hyperplasia-at-single-cell-resolution2026-10-19 https://evidence-hub.com/study/131407-evaluation-of-serum-alpha-1b-glycoprotein-and-c-reactive-protein2026-10-19 https://evidence-hub.com/study/131408-effect-of-cuscuta-reflexa-extract-in-mitigating-testosterone-induced2026-10-19 https://evidence-hub.com/study/131409-ethanol-extract-of-ceiba-pentandra-leaf-ameliorates-some-lipids2026-10-19 https://evidence-hub.com/study/131410-chrysophanic-acid-reduces-testosterone-induced-benign-prostatic2026-10-19 https://evidence-hub.com/study/131411-effect-of-the-ethanol-extract-of-syzygium-aromaticum-clove-leaves-on2026-10-19 https://evidence-hub.com/study/131412-prospective-ameliorating-effect-of-paeoniflorin-against2026-10-19 https://evidence-hub.com/study/131413-mp06-17-urinary-ngf-and-mmp-1-levels-are-associated-with-persistence2026-10-19 https://evidence-hub.com/study/131414-pathogenetic-significance-of-oxidative-stress-in-canine-prostatic2026-10-19 https://evidence-hub.com/study/131415-testosterone-does-not-affect-lower-urinary-tract-symptoms-while2026-10-19 https://evidence-hub.com/study/131416-international-cohort-study-indicates-no-association-between-alpha-12026-10-19 https://evidence-hub.com/study/131417-effect-of-allium-cepa-onion-bulb-and-annona-muricata-soursop-pulp2026-10-19 https://evidence-hub.com/study/131418-changes-in-specific-serum-biomarkers-during-the-induction-of2026-10-19 https://evidence-hub.com/study/131420-exploring-the-mechanism-of-action-of-qian-lie-xing-fang-during-the2026-10-19 https://evidence-hub.com/study/131421-flavonoids-in-benign-prostate-hypertrophy-identification-in-herbal2026-10-19 https://evidence-hub.com/study/131422-peer-review-report-for-innovative-approaches-to-benign-prostatic2026-10-19 https://evidence-hub.com/study/131423-add-on-therapy-with-the-blockers-tamsulosin-and-naftopidil-improves2026-10-19 https://evidence-hub.com/study/131424-testosterone-and-erectile-function-in-hypogonadal-men-unresponsive-to2026-10-19 https://evidence-hub.com/study/131425-mir-143-3p-integrates-contractility-and-growth-in-benign-prostate2026-10-19 https://evidence-hub.com/study/131426-identification-of-lurasidone-as-a-potent-inhibitor-of-severe-fever2026-10-19 https://evidence-hub.com/study/131427-effect-of-daily-tadalafil-5-mg-on-lower-urinary-tract-symptoms-and2026-10-19 https://evidence-hub.com/study/131428-application-of-modern-analytical-techniques-for-quantification-of2026-10-19 https://evidence-hub.com/study/131429-liver-function-as-a-determinant-of-antioxidant-therapeutic-efficacy2026-10-19 https://evidence-hub.com/study/131430-prostatic-artery-embolization-in-elderly-comorbid-patients-with2026-10-19 https://evidence-hub.com/study/131431-efficacy-and-safety-of-high-frequency-irreversible-electroporation-in2026-10-19 https://evidence-hub.com/study/131432-efficacy-and-reliability-of-mobile-uroflowmetry-in-patients-with2026-10-19 https://evidence-hub.com/study/131433-transurethral-holmium-laser-enucleation-of-prostate-shows-remarkable2026-10-19 https://evidence-hub.com/study/131434-genetic-modulation-of-silodosin-exposure-and-efficacy-the-role-of2026-10-19 https://evidence-hub.com/study/131435-safety-and-efficacy-of-bipolar-versus-monopolar-transurethral2026-10-19 https://evidence-hub.com/study/131436-autonomic-modulation-and-symptomatic-efficacy-of-transurethral2026-10-19 https://evidence-hub.com/study/131437-efficacy-of-serenoa-repens-extract-combined-with-alfuzosin-versus2026-10-19 https://evidence-hub.com/study/131438-impact-of-cyp2d6-polymorphisms-on-the-pharmacokinetics-efficacy-and2026-10-19 https://evidence-hub.com/study/131439-prostatic-artery-embolization-in-treatment-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131440-clinical-efficacy-and-safety-of-transurethral-prostate-blue-laser2026-10-19 https://evidence-hub.com/study/131441-clinical-efficacy-study-of-transurethral-thulium-laser-enucleation-of2026-10-19 https://evidence-hub.com/study/131443-postoperative-efficacy-of-transurethral-resection-of-the-prostate2026-10-19 https://evidence-hub.com/study/131444-assessment-of-the-tolerability-and-efficacy-of-prostoptima-in2026-10-19 https://evidence-hub.com/study/131445-sexual-safety-and-efficacy-of-a-pollen-extract-and-teupolioside-based2026-10-19 https://evidence-hub.com/study/131446-bipolar-radiofrequency-ablation-treatment-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/131447-efficacy-of-internal-administration-of-tilakanda-kshara-in-the2026-10-19 https://evidence-hub.com/study/131448-comparison-of-the-first-dose-and-efficacy-of-alfuzosin-tamsulosin-and2026-10-19 https://evidence-hub.com/study/131449-efficacy-of-embolic-microspheres-of-different-sizes-for-the-treatment2026-10-19 https://evidence-hub.com/study/131450-comparative-evaluation-of-the-efficacy-and-safety-of-surgical-methods2026-10-19 https://evidence-hub.com/study/131451-doppler-ultrasonography-in-the-diagnosis-of-dogs-with-benign2026-10-19 https://evidence-hub.com/study/131453-application-of-dual-parameter-mri-based-radiomics-in-the2026-10-19 https://evidence-hub.com/study/131454-analysis-of-the-efficacy-of-transurethral-resection-of-prostate2026-10-19 https://evidence-hub.com/study/131455-rezum-water-vapor-thermal-therapy-in-the-treatment-of-benign2026-10-19 https://evidence-hub.com/study/131457-cyp2d6-genetic-polymorphisms-impact-on-tamsulosin-efficacy-and-safety2026-10-19 https://evidence-hub.com/study/131458-long-term-functional-outcomes-and-predictors-of-efficacy-in-thulium2026-10-19 https://evidence-hub.com/study/131459-nomogram-predicting-the-efficacy-of-transurethral-surgery-in-benign2026-10-19 https://evidence-hub.com/study/131462-benign-prostatic-hyperplasia-personalizing-medical-management2026-10-19 https://evidence-hub.com/study/131463-medical-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131464-efficacy-of-buzhong-yiqi-decoction-on-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131465-risks-and-side-effects-in-the-medical-management-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131466-efficacy-of-combination-of-daily-tadalafil-and-solifenacin-in2026-10-19 https://evidence-hub.com/study/131467-what-is-new-in-the-pharmacotherapy-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131468-a-multicenter-retrospective-study-of-transurethral-prostate-split-for2026-10-19 https://evidence-hub.com/study/131469-benign-prostatic-hyperplasia-epidemiology-pathophysiology-and2026-10-19 https://evidence-hub.com/study/131470-benign-prostatic-hyperplasia-and-its-effect-on-male-infertility2026-10-19 https://evidence-hub.com/study/131471-peculiarities-of-dysuria-treatment-in-men-with-benign-prostatic2026-10-19 https://evidence-hub.com/study/131472-determining-the-optimal-timing-for-surgery-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/131473-erectile-dysfunction-after-transuretheral-resection-of-the-prostate2026-10-19 https://evidence-hub.com/study/131474-options-of-medical-management-for-benign-prostatic-hyperplasia-review2026-10-19 https://evidence-hub.com/study/131475-survey-of-urologists-over-the-management-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131476-evaluation-of-the-clinical-efficacy-of-transurethral-bipolar-surgery2026-10-19 https://evidence-hub.com/study/131477-the-correlation-of-metabolic-syndrome-with-the-natural-history-of2026-10-19 https://evidence-hub.com/study/131478-lifestyle-habits-to-prevent-the-development-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131479-interventional-exploration-of-pharmacoeconomics-and-medication2026-10-19 https://evidence-hub.com/study/131480-evaluation-of-intermittent-tamsulosin-in-treating-symptomatic2026-10-19 https://evidence-hub.com/study/131481-a-scientometric-visualization-analysis-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/131482-the-oxytocin-antagonist-cligosiban-reduces-human-prostate2026-10-19 https://evidence-hub.com/study/131483-comparative-analysis-of-the-safety-and-efficacy-of-1470-nm-diode2026-10-19 https://evidence-hub.com/study/131484-changes-of-resistance-indices-after-medication-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/131485-prostatic-artery-embolisation-versus-medical-treatment-in-patients2026-10-19 https://evidence-hub.com/study/131486-new-frontiers-in-the-treatment-of-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131487-relevance-of-stim-orai-calcium-entry-system-hyperactivation-in-human2026-10-19 https://evidence-hub.com/study/131488-the-efficacy-of-nano-water-in-combination-with-tamsulosin-dutasteride2026-10-19 https://evidence-hub.com/study/131489-persistence-to-medications-for-benign-prostatic-hyperplasia-benign2026-10-19 https://evidence-hub.com/study/131490-tert-expression-in-human-prostate-tissue-reveals-a-potential2026-10-19 https://evidence-hub.com/study/131491-an-approach-to-the-management-of-lower-urinary-tract-symptoms2026-10-19 https://evidence-hub.com/study/131492-analysis-of-frailty-status-and-associated-factors-in-elderly-patients2026-10-19 https://evidence-hub.com/study/131493-comparative-efficacy-of-tadalafil-versus-tamsulosin-as-the-medical2026-10-19 https://evidence-hub.com/study/131494-adverse-effects-of-testosterone-replacement-therapy-an-update-on-the2026-10-19 https://evidence-hub.com/study/131497-the-authors-reply-reply-on-evidence-is-enough-a-systematic-review-and2026-10-19 https://evidence-hub.com/study/131501-moxibustion-for-benign-prostatic-hyperplasia-a-systematic-review-and2026-10-19 https://evidence-hub.com/study/131502-initial-experiences-with-a-980-nm-diode-laser-for-photoselective2026-10-19 https://evidence-hub.com/study/131503-in-vitro-and-in-vivo-assessment-of-metabolic-drug-interaction2026-10-19 https://evidence-hub.com/study/131504-twelve-month-follow-up-results-of-photoselective-vaporization-of-the2026-10-19 https://evidence-hub.com/study/131508-treatment-of-benign-prostatic-hyperplasia-in-hypertensive-men2026-10-19 https://evidence-hub.com/study/131509-efficacy-and-side-effects-of-drugs-commonly-used-for-the-treatment-of2026-10-19 https://evidence-hub.com/study/131510-silodosin-for-the-treatment-of-clinical-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131511-regulation-of-pde-5-expression-in-normal-prostate-benign-prostatic2026-10-19 https://evidence-hub.com/study/131512-the-impact-and-management-of-sexual-dysfunction-secondary-to2026-10-19 https://evidence-hub.com/study/131513-new-approaches-to-management-of-erectile-dysfunction-and-lower2026-10-19 https://evidence-hub.com/study/131514-open-label-intermittent-dose-prospective-study-evaluating-the-effects2026-10-19 https://evidence-hub.com/study/131515-impact-of-alfuzosin-on-sexual-function-in-taiwanese-men-with-benign2026-10-19 https://evidence-hub.com/study/131516-an-evidence-based-review-of-nx1207-and-its-potential-in-the-treatment2026-10-19 https://evidence-hub.com/study/131517-can-we-use-the-silodosin-as-second-line-treatment-of-benign-prostate2026-10-19 https://evidence-hub.com/study/131519-common-biological-factors-implicated-in-benign-prostatic-hyperplasia2026-10-19 https://evidence-hub.com/study/131520-predictors-and-predictive-performance-of-immune-inflammation-indices2026-10-19 https://evidence-hub.com/study/131521-benign-prostatc-hyperplasia-medicamentous-treatment2026-10-19 https://evidence-hub.com/study/131522-mir-16-5p-mediates-e2-induced-cell-proliferation-and-emt-in-benign2026-10-19 https://evidence-hub.com/study/131523-expert-opinion-on-the-prescription-practices-of-silodosin-and2026-10-19 https://evidence-hub.com/study/131525-use-of-tamsulosin-and-dutasteride-combination-for-the-management-of2026-10-19 https://evidence-hub.com/study/131526-efficacy-of-tadalafil-add-on-treatment-for-men-with-lower-urinary2026-10-19 https://evidence-hub.com/study/131527-effects-of-shrna-mediated-silencing-of-pde5a3-on-intracellular-cgmp2026-10-19 https://evidence-hub.com/study/131528-anti-hyperplastic-effects-of-acmella-oleracea-flower-and-leaf2026-10-19 https://evidence-hub.com/study/131529-nanoemulsion-formulation-based-delivery-system-enhances-anticancer2026-10-19 https://evidence-hub.com/study/131530-phosphodiesterase-sequence-variants-may-predispose-to-prostate-cancer2026-10-19 https://evidence-hub.com/study/131531-therapeutic-and-pharmacological-properties-of-pumpkin-seeds-a2026-10-19 https://evidence-hub.com/study/131532-drug-repositioning-of-the-1-adrenergic-receptor-antagonist-naftopidil2026-10-19 https://evidence-hub.com/study/131533-phytochemical-phosphodiesterase-inhibitors-a-comprehensive-review-of2026-10-19 https://evidence-hub.com/study/131534-genistein-an-integrative-overview-of-its-mode-of-action2026-10-19 https://evidence-hub.com/study/131536-nanotechnology-in-reproductive-medicine-opportunities-for-clinical2026-10-19 https://evidence-hub.com/study/131537-global-research-landscape-of-natural-medicines-for-lower-urinary2026-10-19 https://evidence-hub.com/study/131538-drug-repurposing-approach-potential-drugs-and-novel-drug-targets-for2026-10-19 https://evidence-hub.com/study/131539-not-all-maca-is-created-equal-a-review-of-colors-nutrition2026-10-19 https://evidence-hub.com/study/131540-aphrodisiac-effectiveness-of-70-ethanol-extract-of-caulis-lelak2026-10-19 https://evidence-hub.com/study/131542-in-vitro-assessment-of-anti-breast-cancer-potential-of-pumpkin-seed2026-10-19 https://evidence-hub.com/study/131544-understanding-human-aging-and-the-fundamental-cell-signaling-link-in2026-10-19 https://evidence-hub.com/study/131545-repurposing-existing-drugs-for-covid-19-an-endocrinology-perspective2026-10-19 https://evidence-hub.com/study/131546-covid-19-therapeutics-clinical-application-of-repurposed-drugs-and2026-10-19 https://evidence-hub.com/study/131547-self-assembly-of-new-cobalt-complexes-based-on-co-scn-4-synthesis2026-10-19 https://evidence-hub.com/study/131548-bioinformatics-cerna-analysis-for-the-study-of-stem-factor-sox2-in2026-10-19 https://evidence-hub.com/study/131549-hplc-analysis-of-nine-corticosteroids-in-natural-creams-for-atopic2026-10-19 https://evidence-hub.com/study/131551-molecular-docking-and-identification-of-g-protein-coupled-receptor2026-10-19 https://evidence-hub.com/study/131552-op19-comparative-effectiveness-of-common-treatment-options-for-benign2026-10-19 https://evidence-hub.com/study/131553-clinical-efficacy-of-prostatic-apex-preservation-vs-the-non2026-10-19 https://evidence-hub.com/study/131556-a-comprehensive-analysis-of-clinical-quality-of-life-and-cost2026-10-19 https://evidence-hub.com/study/131557-the-safety-and-efficacy-of-five-surgical-treatments-in-prostate2026-10-19 https://evidence-hub.com/study/131558-photoselective-vaporization-with-green-laser-versus-monopolar2026-10-19 https://evidence-hub.com/study/131559-the-efficacy-of-tranexamic-acid-in-decreasing-bleeding-during2026-10-19 https://evidence-hub.com/study/131560-prostatic-artery-embolization-is-similarly-efficacious-to2026-10-19 https://evidence-hub.com/study/131561-greenlight-photoselective-laser-vaporisation-versus-transurethral2026-10-19 https://evidence-hub.com/study/131562-which-improvements-does-rezum-bring-to-bph-management-a-network-meta2026-10-19 https://evidence-hub.com/study/131563-efficacy-of-surgical-treatment-for-post-prostatectomy-urinary2026-10-19 https://evidence-hub.com/study/131565-ejaculatory-sparing-transurethral-prostatectomy-a-meta-analysis-of2026-10-19 https://evidence-hub.com/study/131566-low-power-versus-high-power-laser-for-holmium-laser-enucleation-of2026-10-19 https://evidence-hub.com/study/131567-a-comparative-study-of-thulium-fiber-laser-and-holmium-yag-laser-for2026-10-19 https://evidence-hub.com/study/131568-the-role-of-intraoperative-tranexamic-acid-in-transurethral-resection2026-10-19 https://evidence-hub.com/study/131569-infectious-factor-in-transuretral-surgery-of-benign-prostate2026-10-19 https://evidence-hub.com/study/131570-editorial-comment-on-antibiotic-prophylaxis-in-men-undergoing2026-10-19 https://evidence-hub.com/study/131572-medical-therapy-for-benign-prostatic-hyperplasia-and-lower-urinary2026-10-19 https://evidence-hub.com/study/131573-the-effect-of-chronic-distress-on-the-severity-of-lower-urinary-tract2026-10-19 https://evidence-hub.com/study/131574-health-technology-assessment-hta-of-prostatic-urethral-lift-pul-for2026-10-19 https://evidence-hub.com/study/131575-the-efficacy-and-optimal-timing-of-pelvic-floor-muscle-training-for2026-10-19 https://evidence-hub.com/study/131576-photoselective-sharp-enucleation-of-the-prostate-with-a-front-firing2026-10-19 https://evidence-hub.com/study/131577-editorial-comment-from-dr-funahashi-to-mirabegron-for-treatment-of2026-10-19 https://evidence-hub.com/study/131578-holmium-laser-xpeeda-vaporization-vs-greenlight-xps-vaporization-of2026-10-19 https://evidence-hub.com/study/131579-comparison-of-tamsulosin-hydrochloride-versus-tamsulosin2026-10-19 https://evidence-hub.com/study/131580-the-efficacy-of-pyridostigmine-therapy-after-transurethral-resection2026-10-19 https://evidence-hub.com/study/131581-efficacy-of-elaeagnus-multiflora-and-cynanchum-wilfordii-complex2026-10-19 https://evidence-hub.com/study/131582-efficacy-of-phlogenzyme-in-men-following-transurethral-laser2026-10-19 https://evidence-hub.com/study/131584-a-narrative-review-of-new-emerging-urological-interventions-for2026-10-19 https://evidence-hub.com/study/131585-5-alpha-reductase-inhibitors-5aris-monotherapy-and-combinations2026-10-19 https://evidence-hub.com/study/131586-efficacy-and-safety-of-low-power-holmium-laser-enucleation-of-the2026-10-19 https://evidence-hub.com/study/131587-comparison-of-holmium-laser-enucleation-of-the-prostate-with-bipolar2026-10-19 https://evidence-hub.com/study/131588-clinical-effect-of-phytosterol-enriched-saw-palmetto-extract-on2026-10-19 https://evidence-hub.com/study/131589-comparison-of-tamsulosin-versus-silodosin-for-treatment-of-patients2026-10-19 https://evidence-hub.com/study/131590-treating-overactive-bladder-symptoms-after-transurethral-prostatic2026-10-19 https://evidence-hub.com/study/131591-research-progress-on-ejaculatory-function-preservation-in-minimally2026-10-19 https://evidence-hub.com/study/131592-transurethral-diode-laser-ablation-of-prostate-vs-bipolar2026-10-19 https://evidence-hub.com/study/131594-a-50-year-journey-in-the-development-of-treatment-for-benign2026-10-19 https://evidence-hub.com/study/131595-clinical-analysis-of-transurethral-holmium-laser-enucleation-in-the2026-10-19 https://evidence-hub.com/study/131596-the-role-of-50-millesimal-potency-in-management-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131597-surgical-versus-minimally-invasive-therapies-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/131598-enhanced-clinical-decisions-for-management-of-benign-prostatic2026-10-19 https://evidence-hub.com/study/131599-synergistic-potential-of-herbal-polytherapy-in-benign-prostatic2026-10-19 https://evidence-hub.com/study/131600-urinary-retention-after-greenlight-laser-photoselective-vaporization2026-10-19 https://evidence-hub.com/study/131601-evaluation-of-the-efficacy-of-oxidized-cellulose-surgicel-in-reducing2026-10-19 https://evidence-hub.com/study/131603-a-comparative-clinical-study-of-kanchanar-guggulu-and-varuna-shigru2026-10-19 https://evidence-hub.com/study/131606-efficacy-and-safety-of-rezum-water-vapor-thermal-ablation-in-large2026-10-19 https://evidence-hub.com/study/131607-safety-and-efficacy-of-thulium-laser-enucleation-of-the-prostate2026-10-19 https://evidence-hub.com/study/131608-virtual-basket-mode-in-holep-reduced-early-dysuria-and-faster2026-10-19 https://evidence-hub.com/study/131609-efficacy-of-rezum-water-vapor-therapy-for-the-treatment-of-catheter2026-10-19 https://evidence-hub.com/study/131610-real-world-clinical-outcomes-of-transperineal-laser-ablation-in-bph-a2026-10-19 https://evidence-hub.com/study/131612-retrospective-study-on-prevention-of-bladder-neck-contracture-by2026-10-19 https://evidence-hub.com/study/131616-et-2022-book-of-abstracts2026-10-19 https://evidence-hub.com/study/131617-clinical-outcomes-of-holmium-laser-enucleation-of-the-prostate-a2026-10-19 https://evidence-hub.com/study/131618-clinical-effects-of-oral-supplementation-of-gamma-cyclodextrin2026-10-19 https://evidence-hub.com/study/131619-a-retrospective-cohort-study-on-the-improvement-of-urodynamic2026-10-19 https://evidence-hub.com/study/131620-quantitative-histogram-analysis-of-5-0t-multiparametric-mri-for2026-10-19 https://evidence-hub.com/study/131622-mp29-03-is-simple-prostatectomy-after-prior-minimally-invasive2026-10-19 https://evidence-hub.com/study/131623-efficacy-and-safety-of-the-sandwich-method-in-patients-with-benign2026-10-19 https://evidence-hub.com/study/131624-outcomes-of-rezum-water-vapor-therapy-for-benign-prostate-obstruction2026-10-19 https://evidence-hub.com/study/131626-efficacy-and-safety-evaluation-of-complete-intrafascial-prostatectomy2026-10-19 https://evidence-hub.com/study/131627-urinary-hsv2-mir-h9-to-hsa-mir-3659-ratio-is-an-effective-marker-for2026-10-19 https://evidence-hub.com/study/131630-safety-and-efficacy-of-wrist-ankle-acupuncture-in-treating-catheter2026-10-19 https://evidence-hub.com/study/131631-effectiveness-of-carbazochrome-sodium-sulfonate-in-reducing2026-10-19 https://evidence-hub.com/study/131632-innovative-use-of-rada16-self-assembling-peptide-purabond-as-a2026-10-19 https://evidence-hub.com/study/131633-the-effect-of-transurethral-holmium-laser-enucleation-of-the-prostate2026-10-19 https://evidence-hub.com/study/131634-minimally-invasive-surgical-approaches-for-bladder-outlet-obstruction2026-10-19 https://evidence-hub.com/study/131635-mir-638-upregulation-in-serum-and-tissues-functions-as-a-diagnostic2026-10-19 https://evidence-hub.com/study/131636-chronic-use-of-deslorelin-in-dogs-six-cases-2005-20222026-10-19 https://evidence-hub.com/study/131637-prevention-of-postoperative-urethral-strictures-by-irrigation-with-52026-10-19 https://evidence-hub.com/study/131638-transurethral-resection-of-prostate-a-continuing-battle-of-irrigating2026-10-19 https://evidence-hub.com/study/131640-comparison-of-pkrp-and-tuvp-in-the-treatment-of-high-risk-bph-and2026-10-19 https://evidence-hub.com/study/131641-how-is-high-power-200w-thulium-laser-vapoenucleation-of-the-prostate2026-10-19 https://evidence-hub.com/study/131642-the-first-experience-of-clinical-use-of-optical-urethral-catheter2026-10-19 https://evidence-hub.com/study/131644-the-combination-of-prostate-health-index-and-multiparametric-magnetic2026-10-19 https://evidence-hub.com/study/131645-efficacy-and-safety-of-low-power-holmium-laser-enucleation-of-the2026-10-19 https://evidence-hub.com/study/131646-modified-early-apical-release-vs-non-early-apical-release-in-holmium2026-10-19 https://evidence-hub.com/study/131647-endoscopic-management-of-bph-in-immunosuppressed-patients-awaiting2026-10-19 https://evidence-hub.com/study/131648-optilume-a-minimally-invasive-solution-for-bph-and-urethral-stricture2026-10-19 https://evidence-hub.com/study/131649-protection-of-nontarget-structures-in-prostatic-artery-embolization2026-10-19 https://evidence-hub.com/study/131650-sglt2-inhibitors-in-patients-with-urogenital-malformations-and2026-10-19 https://evidence-hub.com/study/131651-urethral-catheter-with-an-ultrasound-triggered-biopolymer-drug2026-10-19 https://evidence-hub.com/study/131653-asia-pacific-collaborative-consensus-statements-on-water-vapor2026-10-19 https://evidence-hub.com/study/131654-ep456-ece-2472-insulin-autoimmune-syndrome-in-a-caucasian-male-a-rare2026-10-19 https://evidence-hub.com/study/131659-surgical-management-of-bilateral-trapeziometacarpal-arthritis2026-10-19 https://evidence-hub.com/study/131660-botulinum-toxin-a-in-idiopathic-overactive-bladder-a-narrative-review2026-10-19 https://evidence-hub.com/study/131661-remdesivir-associated-asymptomatic-bradycardia-in-an-icu-patient-on2026-10-19 https://evidence-hub.com/study/131662-analysis-of-acute-genitourinary-toxicity-in-hypofractionated-proton2026-10-19 https://evidence-hub.com/study/131663-the-race-to-replace-pde5i-recent-advances-and-interventions-to-treat2026-10-19 https://evidence-hub.com/study/131664-multifaced-nature-of-yohimbine-a-promising-therapeutic-potential-or-a2026-10-19 https://evidence-hub.com/study/131665-drugs-currently-undergoing-preclinical-or-clinical-trials-for-the2026-10-19 https://evidence-hub.com/study/131666-nanotechnology-as-a-tool-to-advance-research-and-treatment-of-non2026-10-19 https://evidence-hub.com/study/131667-the-consequences-of-climate-change-and-male-reproductive-health-a2026-10-19 https://evidence-hub.com/study/131668-1-adrenergic-receptors-insights-into-potential-therapeutic2026-10-19 https://evidence-hub.com/study/131669-inhibition-of-phosphodiesterase-a-novel-therapeutic-target-for-the2026-10-19 https://evidence-hub.com/study/131670-molecular-mechanisms-of-neurogenic-lower-urinary-tract-dysfunction2026-10-19 https://evidence-hub.com/study/131671-study-designs-for-evaluation-of-combination-treatment-focus-on2026-10-19 https://evidence-hub.com/study/131676-association-of-cyp3a4-1b-cyp3a4-22-and-cyp3a5-3-polymorphisms2026-10-19 https://evidence-hub.com/study/131677-efficacy-of-a-novel-prophylactic-scheme-of-fosfomycin-trometamol-in2026-10-19 https://evidence-hub.com/study/131679-efficacy-of-the-rezum-system-for-lower-urinary-tract-symptoms-in2026-10-19 https://evidence-hub.com/study/131680-comparison-of-clinical-therapeutic-efficacy-between-tupkp-and-holep2026-10-19 https://evidence-hub.com/study/131681-clinical-radiomics-combination-model-for-predicting-the-short-term2026-10-19 https://evidence-hub.com/study/131682-five-step-vaporization-of-the-prostate-using-180-w-xps-greenlight2026-10-19 https://evidence-hub.com/study/131683-a-multi-center-randomized-open-label-two-arm-study-to-evaluate-safety2026-10-19 https://evidence-hub.com/study/131684-aquablation-vs-holmium-laser-enucleation-of-the-prostate-for-benign2026-10-19 https://evidence-hub.com/study/131685-the-efficacy-of-tamsulosin-0-4-mg-when-tamsulosin-0-2-mg-is2026-10-19 https://evidence-hub.com/study/131688-efficacy-and-safety-of-1470-nm-diode-laser-enucleation-of-the2026-10-19 https://evidence-hub.com/study/131689-comparison-of-the-efficacy-of-holep-and-turp-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/131690-effectiveness-of-transurethral-enucleation-with-bipolar-for-benign2026-10-19 https://evidence-hub.com/study/131693-the-effect-of-bladder-function-on-the-efficacy-of-transurethral2026-10-19 https://evidence-hub.com/study/131694-efficacy-and-safety-of-combination-therapy-with-alfuzosin-alfuprost2026-10-19 https://evidence-hub.com/study/131695-prostatic-artery-embolization-with-glue-for-benign-prostatic2026-10-19 https://evidence-hub.com/study/131696-ipp-and-changes-in-ipss-in-benign-prostatic-hyperplasia-bph-patients2026-10-19 https://evidence-hub.com/study/131697-effect-of-educational-guidelines-application-on-quality-of-life-among2026-10-19 https://evidence-hub.com/study/131698-the-silent-swell-epidemiology-clinical-profile-and-treatment-patterns2026-10-19 https://evidence-hub.com/study/131699-effect-of-tadalafil-in-comparison-with-clobetasol-ointment-in-induced2026-10-19 https://evidence-hub.com/study/131700-evaluation-of-the-effect-of-administration-of-tadalafil-on-gentamicin2026-10-19 https://evidence-hub.com/study/131701-effectiveness-and-safety-of-a-new-nutrient-fixed-combination2026-10-19 https://evidence-hub.com/study/131702-phosphodiesterase-5-inhibitors-tadalafil-and-sildenafil-potentiate2026-10-19 https://evidence-hub.com/study/131703-validated-uv-vis-spectrophotometric-method-for-routine-quality2026-10-19 https://evidence-hub.com/study/131704-animal-models-for-the-study-of-post-micturition-dribble-in-aged-male2026-10-19 https://evidence-hub.com/study/131705-tissue-kallikrein-protects-rat-prostate-against-the-inflammatory2026-10-19 https://evidence-hub.com/study/131706-peer-review-1-of-application-of-hydrophilic-polymers-for-the2026-10-19 https://evidence-hub.com/study/131707-inhibition-of-growth-and-contraction-in-human-prostate-stromal-cells2026-10-19 https://evidence-hub.com/study/131708-isoform-independent-promotion-of-contractility-and-proliferation-and2026-10-19 https://evidence-hub.com/study/131709-pua-sedentariety-congestion-infections-microcalcification-chronic2026-10-19 https://evidence-hub.com/study/131710-mechanisms-of-prostatic-inflammation-mediated-male-lower-urinary2026-10-19 https://evidence-hub.com/study/131711-renoprotective-effect-of-vardenafil-and-avanafil-in-contrast-induced2026-10-19 https://evidence-hub.com/study/131712-evaluating-the-impact-of-castration-on-canine-prostate-disease2026-10-19 https://evidence-hub.com/study/131713-the-efficacy-of-an-active-medicinal-alkaloid-berbamine-in-reducing2026-10-19 https://evidence-hub.com/study/131714-6-nitrodopamine-as-a-novel-mediator-of-prostatic-smooth-muscle2026-10-19 https://evidence-hub.com/study/131715-effect-of-pulmonary-arterial-hypertension-on-the-morphology-and2026-10-19 https://evidence-hub.com/study/131716-pcbp2-promotes-immune-evasion-via-cgas-sting-pathway-in-biochemical2026-10-19 https://evidence-hub.com/study/131717-efficacy-and-safety-of-pde5-inhibitors-in-middle-aged-and-old2026-10-19 https://evidence-hub.com/study/131718-there-is-a-relationship-between-inefficiency-of-external-urethral2026-10-19 https://evidence-hub.com/study/131719-the-efficacy-of-flogofilm-in-the-treatment-of-chronic-bacterial2026-10-19 https://evidence-hub.com/study/131720-treatment-with-the-soluble-guanylate-cyclase-activator-bay-60-27702026-10-19 https://evidence-hub.com/study/131721-efficacy-of-a-new-vacuum-erection-device-vigor-2020-for-erectile2026-10-19 https://evidence-hub.com/study/131722-intrakavernosal-sildenafilin-sicanlarda-dutasterid-tedavisi-sonrasi2026-10-19 https://evidence-hub.com/study/131723-extract-from-cucurbita-pepo-improves-bph-symptoms-without-affecting2026-10-19 https://evidence-hub.com/study/131724-characteristics-of-1-adrenoceptor-antagonists-induced-ejaculatory2026-10-19 https://evidence-hub.com/study/131725-bioactive-compounds-in-pumpkin-cucurbita-species-seeds-as-natural2026-10-19 https://evidence-hub.com/study/131726-chikusetsu-saponin-iva-induces-apoptosis-and-mitochondrial2026-10-19 https://evidence-hub.com/study/131728-prostate-cancer-death-progression-of-prostate-cancer-and-erectile2026-10-19 https://evidence-hub.com/study/131729-treatment-of-non-metastatic-castration-resistant-prostate-cancer2026-10-19 https://evidence-hub.com/study/131730-the-impact-of-an-oral-rehydration-clinical-pathway-in-a-paediatric2026-10-19 https://evidence-hub.com/study/131731-treatment-of-norovirus-infections-moving-antivirals-from-the-bench-to2026-10-19 https://evidence-hub.com/study/131732-a-novel-approach-to-the-rehydration-of-children-with-gastroenteritis2026-10-19 https://evidence-hub.com/study/131733-impact-of-emergency-department-probiotic-treatment-of-pediatric2026-10-19 https://evidence-hub.com/study/131734-health-care-utilization-and-clinical-management-of-all-cause-and2026-10-19 https://evidence-hub.com/study/131737-a-comparative-analysis-of-oral-vs-intravenous-rehydration-therapy-in2026-10-19 https://evidence-hub.com/study/131738-advanced-nursing-directives-integrating-validated-clinical-scoring2026-10-19 https://evidence-hub.com/study/131739-viral-gastroenteritis-clinical-manifestations-nursing-care-strategies2026-10-19 https://evidence-hub.com/study/131741-pediatric-emergency-medicine-optimizing-risk-assessment-and-safety2026-10-19 https://evidence-hub.com/study/131742-epidemiological-surveillance-of-mild-traumatic-brain-injury-mtbi-in2026-10-19 https://evidence-hub.com/study/131743-characterizing-hospitalizations-for-pediatric-concussion-and-trends2026-10-19 https://evidence-hub.com/study/131744-abstracts-of-the-2012-international-congress-of-the-european2026-10-19 https://evidence-hub.com/study/131745-rapid-enteric-testing-to-permit-targeted-antimicrobial-therapy-with2026-10-19 https://evidence-hub.com/study/131746-methods-used-to-account-for-caregivers-sex-and-gender-within-studies2026-10-19 https://evidence-hub.com/study/131747-hyperemesis-gravidarum-clinical-management-and-nursing-care-in2026-10-19 https://evidence-hub.com/study/131748-out-of-sight-out-of-mind-right-not-in-covid-19-shock-or-anaerobic-and2026-10-19 https://evidence-hub.com/study/131750-prevalence-of-key-potentially-inappropriate-drugs-use-in-pediatrics-a2026-10-19 https://evidence-hub.com/study/131752-a-time-to-die-patient-centered-priorities-incardiac-resuscitation2026-10-19 https://evidence-hub.com/study/131753-recurrent-vomiting-in-a-6-year-old-boy2026-10-19 https://evidence-hub.com/study/131755-cannabis-hyperemesis-syndrome-in-youth-clinical-insights-and-public2026-10-19 https://evidence-hub.com/study/131756-adherence-to-national-standard-treatment-guidelines-in-the-management2026-10-19 https://evidence-hub.com/study/131757-selected-abstracts-of-the-18th-international-workshop-on-neonatology2026-10-19 https://evidence-hub.com/study/131759-highlights-of-2025-print-issue2026-10-19 https://evidence-hub.com/study/131762-surveillance-epidemiologique-des-traumatismes-craniens-legers-tcl2026-10-19 https://evidence-hub.com/study/131763-other-articles-noted-nov-01-to-18-oct-022026-10-19 https://evidence-hub.com/study/131765-physical-health-of-patients-with-schizophrenia-findings-from-a-health2026-10-19 https://evidence-hub.com/study/131766-research-innovations-clinical-vignettes-competition-hospital-medicine2026-10-19 https://evidence-hub.com/study/131767-prevalence-of-clostridium-difficile-and-salmonella-spp-in-juvenile2026-10-19 https://evidence-hub.com/study/131768-small-bowel-review-part-ii2026-10-19 https://evidence-hub.com/study/131769-comparison-of-add-on-medications-for-persistent-storage-symptoms2026-10-19 https://evidence-hub.com/study/131770-network-meta-analysis-of-the-treatment-safety-and-efficacy-of2026-10-19 https://evidence-hub.com/study/131771-efficacy-of-transurethral-botulinum-toxin-a-injections-for-bladder2026-10-19 https://evidence-hub.com/study/131773-tranexamic-acid-for-reducing-blood-loss-in-bipolar-transurethral2026-10-19 https://evidence-hub.com/study/131774-shifting-trends-in-prostate-treatment-a-systematic-review-comparing2026-10-19 https://evidence-hub.com/study/131775-randomized-double-blind-active-controlled-phase-3-study-to-evaluate2026-10-19 https://evidence-hub.com/study/131776-zastaprazan-first-approval2026-10-19 https://evidence-hub.com/study/131777-cyp3a-mediated-metabolism-of-zastaprazan-in-humans-and-associated2026-10-19 https://evidence-hub.com/study/131778-gastroenterology-hepatology-what-you-may-have-missed-in-20242026-10-19 https://evidence-hub.com/study/131779-effectiveness-and-patient-satisfaction-with-zastaprazan-in-real-world2026-10-19 https://evidence-hub.com/study/131780-potassium-competitive-acid-blockers-for-erosive-reflux-disease-and2026-10-19 https://evidence-hub.com/study/131781-comparative-pharmacokinetics-and-safety-of-orally-disintegrating-and2026-10-19 https://evidence-hub.com/study/131787-ulcers-under-the-lens-mechanisms-management-and-modern-advances2026-10-19 https://evidence-hub.com/study/131788-phase-i-study-to-evaluate-the-safety-and-pharmacokinetics-of-jp-13662026-10-19 https://evidence-hub.com/study/131789-erosive-osophagitis-zastaprazan-ist-esomeprazol-nicht-unterlegen2026-10-19 https://evidence-hub.com/study/131793-potassium-competitive-acid-blockers-clinical-pearls-and-practical2026-10-19 https://evidence-hub.com/study/131794-evaluation-of-the-relationship-between-cytochrome-p450-cyp-1a2-gene2026-10-19 https://evidence-hub.com/study/131795-potassium-competitive-acid-blockers-and-esophagoprotective-agents-in2026-10-19 https://evidence-hub.com/study/131798-multifaceted-strategies-for-managing-gastroesophageal-reflux-disease2026-10-19 https://evidence-hub.com/study/131799-potassium-competitive-acid-blockers-versus-proton-pump-inhibitors2026-10-19 https://evidence-hub.com/study/131800-90y-radioembolization-versus-drug-eluting-bead-chemoembolization-for2026-10-19 https://evidence-hub.com/study/131801-convalescent-plasma-for-hospitalized-patients-with-covid-19-an-open2026-10-19 https://evidence-hub.com/study/131802-machine-learning-reduced-workload-with-minimal-risk-of-missing2026-10-19 https://evidence-hub.com/study/131803-physical-examination-indicated-cerclage-in-twin-pregnancy-a2026-10-19 https://evidence-hub.com/study/131804-mindfulness-training-reduces-loneliness-and-increases-social-contact2026-10-19 https://evidence-hub.com/study/131805-cognitive-behavioral-family-treatment-for-suicide-attempt-prevention2026-10-19 https://evidence-hub.com/study/131807-blocking-nocturnal-blue-light-for-insomnia-a-randomized-controlled2026-10-19 https://evidence-hub.com/study/131808-intact-intra-operative-fluorescence-angiography-to-prevent2026-10-19 https://evidence-hub.com/study/131809-antidepressant-efficacy-of-ketamine-in-treatment-resistant-major2026-10-19 https://evidence-hub.com/study/131811-a-randomized-controlled-trial-of-the-web-based-ourrelationship2026-10-19 https://evidence-hub.com/study/131812-the-effect-of-police-body-worn-cameras-on-use-of-force-and-citizens2026-10-19 https://evidence-hub.com/study/131815-a-multicenter-open-label-phase-ii-clinical-trial-of-combined-mek-plus2026-10-19 https://evidence-hub.com/study/131816-safety-of-g-csf-with-concurrent-chemo-radiotherapy-in-limited-stage2026-10-19 https://evidence-hub.com/study/131817-association-of-the-american-heart-association-s-new-life-s-essential2026-10-19 https://evidence-hub.com/study/131818-social-determinants-of-health-and-premature-death-among-adults-in-the2026-10-19 https://evidence-hub.com/study/131819-guideline-adherence-and-survival-of-patients-with-candidaemia-in2026-10-19 https://evidence-hub.com/study/131820-food-processing-and-cancer-risk-in-europe-results-from-the2026-10-19 https://evidence-hub.com/study/131821-artificial-intelligence-ai-for-breast-cancer-screening-breastscreen2026-10-19 https://evidence-hub.com/study/131822-genomic-characteristics-and-clinical-effect-of-the-emergent-sars-cov2026-10-19 https://evidence-hub.com/study/131823-acute-kidney-injury-persistent-kidney-disease-and-post-discharge2026-10-19 https://evidence-hub.com/study/131824-clinical-outcomes-in-biopsy-proven-nonalcoholic-fatty-liver-disease2026-10-19 https://evidence-hub.com/study/131825-diet-and-physical-activity-during-the-coronavirus-disease-2019-covid2026-10-19 https://evidence-hub.com/study/131826-virological-and-serological-kinetics-of-sars-cov-2-delta-variant2026-10-19 https://evidence-hub.com/study/131827-association-between-very-to-moderate-preterm-births-lung-function2026-10-19 https://evidence-hub.com/study/131828-remnant-cholesterol-and-the-risk-of-cardiovascular-disease-in-type-22026-10-19 https://evidence-hub.com/study/131830-annual-incidences-and-progressions-of-myopia-and-high-myopia-in2026-10-19 https://evidence-hub.com/study/131831-effectiveness-of-the-recombinant-zoster-vaccine-in-adults-aged-50-and2026-10-19 https://evidence-hub.com/study/131832-association-between-the-eat-lancet-diet-pattern-and-risk-of-type-22026-10-19 https://evidence-hub.com/study/131833-cohort-profile-the-dutch-famine-birth-cohort-dfbc-a-prospective-birth2026-10-19 https://evidence-hub.com/study/131834-fatigue-in-patients-with-chronic-disease-results-from-the-population2026-10-19 https://evidence-hub.com/study/131835-ambient-fine-particulate-matter-air-pollution-and-the-risk-of2026-10-19 https://evidence-hub.com/study/131836-childhood-neurodevelopmental-disorders-and-maternal-diabetes-a2026-10-19 https://evidence-hub.com/study/131837-lost-to-follow-up-in-the-norwegian-mother-father-and-child-cohort2026-10-19 https://evidence-hub.com/study/131838-assisted-reproductive-technology-and-birth-defects-in-a-chinese-birth2026-10-19 https://evidence-hub.com/study/131839-prenatal-exome-sequencing-analysis-in-fetal-structural-anomalies2026-10-19 https://evidence-hub.com/study/131840-impact-of-direct-acting-antivirals-for-hcv-on-mortality-in-a-large2026-10-19 https://evidence-hub.com/study/131841-severity-of-gastric-intestinal-metaplasia-predicts-the-risk-of2026-10-19 https://evidence-hub.com/study/131842-herpesvirus-infections-antiviral-treatment-and-the-risk-of-dementia-a2026-10-19 https://evidence-hub.com/study/131843-ultra-processed-foods-and-type-2-diabetes-risk-in-the-sun-project-a2026-10-19 https://evidence-hub.com/study/131844-diet-and-risk-of-incident-lung-cancer-a-large-prospective-cohort2026-10-19 https://evidence-hub.com/study/131845-egg-and-cholesterol-consumption-and-mortality-from-cardiovascular-and2026-10-19 https://evidence-hub.com/study/131846-recommended-physical-activity-and-all-cause-and-cause-specific2026-10-19 https://evidence-hub.com/study/131847-achondroplasia-natural-history-study-clarity-a-multicenter2026-10-19 https://evidence-hub.com/study/131848-immunogenicity-of-an-inactivated-sars-cov-2-vaccine-in-people-living2026-10-19 https://evidence-hub.com/study/131849-household-secondary-attack-rate-of-covid-19-and-associated2026-10-19 https://evidence-hub.com/study/131850-a-multidisciplinary-prematurity-research-cohort-study2026-10-19 https://evidence-hub.com/study/131851-pneumococcal-meningitis-in-adults-a-prospective-nationwide-cohort2026-10-19 https://evidence-hub.com/study/131852-30-day-mortality-in-patients-hospitalized-with-covid-19-during-the2026-10-19 https://evidence-hub.com/study/131853-nusinersen-in-adults-with-5q-spinal-muscular-atrophy-a-non2026-10-19 https://evidence-hub.com/study/131854-long-term-effects-of-pm2-5-on-neurological-disorders-in-the-american2026-10-19 https://evidence-hub.com/study/131855-opioid-agonist-treatment-and-risk-of-mortality-during-opioid-overdose2026-10-19 https://evidence-hub.com/study/131856-u-shaped-association-of-serum-uric-acid-with-all-cause-and-cause2026-10-19 https://evidence-hub.com/study/131857-septum-resection-in-women-with-a-septate-uterus-a-cohort-study2026-10-19 https://evidence-hub.com/study/131858-interpreting-covid-19-and-virtual-care-trends-cohort-study2026-10-19 https://evidence-hub.com/study/131859-cohort-profile-the-st-jude-lifetime-cohort-study-sjlife-for2026-10-19 https://evidence-hub.com/study/131860-clinicoanatomical-substrates-of-selfish-behaviour-in-amyotrophic2026-10-19 https://evidence-hub.com/study/131861-major-bleeding-and-risk-of-death-after-percutaneous-native-kidney2026-10-19 https://evidence-hub.com/study/131862-work-related-sexual-harassment-and-risk-of-suicide-and-suicide2026-10-19 https://evidence-hub.com/study/131863-a-second-population-based-cohort-study-in-cameroon-confirms-the2026-10-19 https://evidence-hub.com/study/131864-relation-between-surgeon-age-and-postoperative-outcomes-a-population2026-10-19 https://evidence-hub.com/study/131865-the-effect-of-erector-spinae-plane-block-on-respiratory-and-analgesic2026-10-19 https://evidence-hub.com/study/131866-oral-leukoplakia-and-risk-of-progression-to-oral-cancer-a-population2026-10-19 https://evidence-hub.com/study/131867-clinical-efficacy-of-intravenous-immunoglobulin-therapy-in-critical2026-10-19 https://evidence-hub.com/study/131868-factors-associated-with-the-duration-of-viral-shedding-in-adults-with2026-10-19 https://evidence-hub.com/study/131869-reasons-for-tooth-extractions-and-related-risk-factors-in-adult2026-10-19 https://evidence-hub.com/study/131870-sex-differences-in-long-term-survival-after-major-cardiac-surgery-a2026-10-19 https://evidence-hub.com/study/131871-allergic-diseases-and-long-term-risk-of-autoimmune-disorders2026-10-19 https://evidence-hub.com/study/131872-less-dementia-after-catheter-ablation-for-atrial-fibrillation-a2026-10-19 https://evidence-hub.com/study/131873-association-of-social-contact-with-dementia-and-cognition-28-year2026-10-19 https://evidence-hub.com/study/131874-efficacy-of-early-prone-position-for-covid-19-patients-with-severe2026-10-19 https://evidence-hub.com/study/131875-subtypes-of-physical-frailty-and-their-long-term-outcomes-a2026-10-19 https://evidence-hub.com/study/131876-factors-associated-with-duration-of-breastfeeding-in-spain-a-cohort2026-10-19 https://evidence-hub.com/study/131877-increased-risk-of-active-tuberculosis-during-pregnancy-and-postpartum2026-10-19 https://evidence-hub.com/study/131878-viral-suppression-and-hiv-transmission-in-serodiscordant-male-couples2026-10-19 https://evidence-hub.com/study/131879-circulating-liver-enzymes-and-risks-of-chronic-diseases-and-mortality2026-10-19 https://evidence-hub.com/study/131880-association-between-dietary-supplement-use-nutrient-intake-and2026-10-19 https://evidence-hub.com/study/131881-birth-outcomes-in-women-who-have-taken-adalimumab-in-pregnancy-a2026-10-19 https://evidence-hub.com/study/131882-transcriptomic-signatures-related-to-the-obesity-paradox-in-patients2026-10-19 https://evidence-hub.com/study/131885-lifetime-risk-of-atrial-fibrillation-according-to-optimal-borderline2026-10-19 https://evidence-hub.com/study/131886-population-based-rates-timing-and-causes-of-maternal-deaths2026-10-19 https://evidence-hub.com/study/131887-minimally-invasive-endoscopic-surgery-for-infantile-craniosynostosis2026-10-19 https://evidence-hub.com/study/131888-alterations-in-portal-vein-flow-and-intrarenal-venous-flow-are2026-10-19 https://evidence-hub.com/study/131889-health-inequities-in-the-diagnosis-and-outcome-of-sepsis-in-argentina2026-10-19 https://evidence-hub.com/study/131890-progressive-decline-in-estimated-gfr-in-patients-with-sickle-cell2026-10-19 https://evidence-hub.com/study/131892-cancer-risk-associated-with-chronic-diseases-and-disease-markers2026-10-19 https://evidence-hub.com/study/131893-nonheavy-drinking-and-worsening-of-noninvasive-fibrosis-markers-in2026-10-19 https://evidence-hub.com/study/131894-the-impact-of-the-covid-19-epidemic-on-mental-health-of-undergraduate2026-10-19 https://evidence-hub.com/study/131895-minor-to-moderate-side-effects-of-pfizer-biontech-covid-19-vaccine2026-10-19 https://evidence-hub.com/study/131896-identifying-the-hiccup-induced-esophagogastric-waveform-a-case-series2026-10-19 https://evidence-hub.com/study/131897-successful-treatment-of-a-cns-tumor-with-bcor-internal-tandem2026-10-19 https://evidence-hub.com/study/131898-transarterial-sinus-embolization-for-a-dural-arteriovenous-fistula-in2026-10-19 https://evidence-hub.com/study/131899-a-case-of-coil-embolization-for-a-ruptured-anterior-spinal-artery2026-10-19 https://evidence-hub.com/study/131900-implementation-of-an-educational-intervention-to-improve-hiv-pre2026-10-19 https://evidence-hub.com/study/131901-a-community-based-pre-exposure-prophylaxis-telehealth-program-focused2026-10-19 https://evidence-hub.com/study/131902-implementation-facilitators-and-barriers-for-primary-care-providers2026-10-19 https://evidence-hub.com/study/131903-optimizing-delivery-of-hiv-preexposure-prophylaxis-for-women-in-the2026-10-19 https://evidence-hub.com/study/131909-the-efficacy-and-safety-of-fexuprazan-in-treating-erosive-esophagitis2026-10-19 https://evidence-hub.com/study/131910-efficacy-and-safety-of-fexuprazan-in-patients-with-symptoms-and-signs2026-10-19 https://evidence-hub.com/study/131911-total-synthesis-of-fexuprazan2026-10-19 https://evidence-hub.com/study/131912-fexuprazan-mitigates-nsaid-induced-small-intestinal-injury-by2026-10-19 https://evidence-hub.com/study/131913-pharmacodynamics-and-pharmacokinetics-of-dwp14012-fexuprazan-in2026-10-19 https://evidence-hub.com/study/131914-comparison-of-the-anti-inflammatory-effects-of-esomeprazole-and2026-10-19 https://evidence-hub.com/study/131915-pharmacodynamic-and-pharmacokinetic-drug-interactions-between2026-10-19 https://evidence-hub.com/study/131916-scalable-synthesis-of-the-key-fexuprazan-intermediate-and2026-10-19 https://evidence-hub.com/study/131917-a-comparative-pharmacokinetic-study-of-fexuprazan-10-mg-demonstrating2026-10-19 https://evidence-hub.com/study/131918-efficacy-of-fexuprazan-compared-with-rebamipide-in-korean-patients2026-10-19 https://evidence-hub.com/study/131919-recurrent-fexuprazan-induced-liver-injury-following-unintentional-re2026-10-19 https://evidence-hub.com/study/131920-efficacy-of-fexuprazan-based-concomitant-therapy-for-helicobacter2026-10-19 https://evidence-hub.com/study/131921-randomized-multicenter-study-to-evaluate-the-efficacy-and-safety-of2026-10-19 https://evidence-hub.com/study/131922-preference-for-on-demand-fexuprazan-therapy-in-gastroesophageal2026-10-19 https://evidence-hub.com/study/131923-size-reduced-fexuprazan-20-mg-demonstrated-the-optimal2026-10-19 https://evidence-hub.com/study/131924-a-randomized-open-label-single-dose-study-to-evaluate-the-safety-and2026-10-19 https://evidence-hub.com/study/131926-pharmacological-safety-and-real-world-efficacy-of-the-potassium2026-10-19 https://evidence-hub.com/study/131927-safety-tolerability-pharmacodynamics-and-pharmacokinetics-of-dwp140122026-10-19 https://evidence-hub.com/study/131928-discovery-of-highly-selective-and-potent-cyp1b1-inhibitors-for2026-10-19 https://evidence-hub.com/study/131930-fexuprazan-for-upper-gastrointestinal-protection-in-patients-with2026-10-19 https://evidence-hub.com/study/131931-integrated-design-of-experiments-approach-for-a-stability-indicating2026-10-19 https://evidence-hub.com/study/131932-association-between-gastroesophageal-reflux-disease-and-chronic2026-10-19 https://evidence-hub.com/study/131934-comparative-pharmacokinetics-study-with-fexuprazan-10-mg-demonstrated2026-10-19 https://evidence-hub.com/study/131935-endoscopic-swab-sampling-as-a-novel-method-for-gastric-microbiome2026-10-19 https://evidence-hub.com/study/131936-evaluation-of-rabeprazole-for-gastrointestinal-protection-in-acute2026-10-19 https://evidence-hub.com/study/131937-pathophysiology-updates-gastroduodenal-injury-and-repair-mechanisms2026-10-19 https://evidence-hub.com/study/131938-comparative-efficacy-and-safety-of-vonoprazan-based-dual-therapy-vs2026-10-19 https://evidence-hub.com/study/131949-comparing-fexuprazan-and-rabeprazole-for-treating-peptic-ulcer-a2026-10-19 https://evidence-hub.com/study/131950-bioanalytical-method-development-and-validation-for-the-estimation-of2026-10-19 https://evidence-hub.com/study/131955-potassium-competitive-acid-blockers-p-cabs-as-a-new-breakthrough-in2026-10-19 https://evidence-hub.com/study/131956-editorial-deja-vu-all-over-again-let-the-p-cab-wars-begin-authors2026-10-19 https://evidence-hub.com/study/131957-an-open-label-multiple-dose-clinical-trial-to-evaluate-the-safety2026-10-19 https://evidence-hub.com/study/131958-a-single-center-phase-1-randomized-double-blind-placebo-controlled2026-10-19 https://evidence-hub.com/study/131959-a-randomized-open-label-three-sequence-three-period-multiple-dosing2026-10-19 https://evidence-hub.com/study/131960-a-randomized-open-label-study-to-evaluate-the-safety-tolerability-and2026-10-19 https://evidence-hub.com/study/131961-a-dose-block-randomized-double-blind-placebo-and-active-controlled2026-10-19 https://evidence-hub.com/study/131962-a-randomized-double-blind-placebo-controlled-multiple-dose-clinical2026-10-19 https://evidence-hub.com/study/131963-a-multi-center-randomized-double-blind-parallel-group-active2026-10-19 https://evidence-hub.com/study/131964-a-multi-center-randomized-double-blind-active-controlled-parallel2026-10-19 https://evidence-hub.com/study/131965-a-multi-center-randomized-open-label-study-to-evaluate-symptom-relief2026-10-19 https://evidence-hub.com/study/131966-a-multi-center-randomized-double-blind-active-controlled-phase-22026-10-19 https://evidence-hub.com/study/131969-novel-and-efficient-synthesis-of-potassium-competitive-acid-blocker2026-10-19 https://evidence-hub.com/study/131970-supplemental-material-for-research-article-efficacy-of-fexuprazan2026-10-19 https://evidence-hub.com/study/131971-evaluation-of-the-potential-drug-drug-interaction-between-aspirin-and2026-10-19 https://evidence-hub.com/study/131972-aqbd-assisted-development-and-validation-of-stability-indicating-rp2026-10-19 https://evidence-hub.com/study/131982-analytical-method-development-and-validation-of-gastrointestinal-drug2026-10-19 https://evidence-hub.com/study/131983-uptake-of-potassium-competitive-acid-blockers-following-its2026-10-19 https://evidence-hub.com/study/131984-prevalence-of-hyperthyroidism-hypothyroidism-and-euthyroidism-in2026-10-19 https://evidence-hub.com/study/131985-corticosteroid-nasal-spray-for-recovery-of-smell-sensation-in-covid2026-10-19 https://evidence-hub.com/study/131986-efficacy-of-blockers-on-hemodynamic-control-during-pheochromocytoma2026-10-19 https://evidence-hub.com/study/131987-should-asymptomatic-bacteriuria-be-systematically-treated-in-kidney2026-10-19 https://evidence-hub.com/study/131988-temporal-profiles-of-viral-load-in-posterior-oropharyngeal-saliva2026-10-19 https://evidence-hub.com/study/131989-effectiveness-of-mrna-bnt162b2-covid-19-vaccine-up-to-6-months-in-a2026-10-19 https://evidence-hub.com/study/131990-incident-autoimmune-diseases-in-association-with-sars-cov-2-infection2026-10-19 https://evidence-hub.com/study/131991-association-of-ultra-processed-food-intake-with-risk-of-inflammatory2026-10-19 https://evidence-hub.com/study/131992-physical-and-mental-health-3-months-after-sars-cov-2-infection-long2026-10-19 https://evidence-hub.com/study/131993-association-of-the-atherogenic-index-of-plasma-with-cardiovascular2026-10-19 https://evidence-hub.com/study/131994-immunogenicity-of-the-bnt162b2-covid-19-mrna-vaccine-and-early2026-10-19 https://evidence-hub.com/study/131995-quantifying-and-understanding-the-higher-risk-of-atherosclerotic2026-10-19 https://evidence-hub.com/study/131996-relationship-between-sars-cov-2-infection-and-the-incidence-of2026-10-19 https://evidence-hub.com/study/131997-perioperative-ctdna-based-molecular-residual-disease-detection-for2026-10-19 https://evidence-hub.com/study/131998-strong-reduction-of-colorectal-cancer-incidence-and-mortality-after2026-10-19 https://evidence-hub.com/study/131999-cancer-risk-in-patients-with-biopsy-confirmed-nonalcoholic-fatty2026-10-19 https://evidence-hub.com/study/132000-microbiome-signatures-of-progression-toward-celiac-disease-onset-in2026-10-19 https://evidence-hub.com/study/132001-treatment-and-prognostic-factors-for-long-term-outcome-in-patients2026-10-19 https://evidence-hub.com/study/132002-ethnic-and-socioeconomic-differences-in-sars-cov-2-infection2026-10-19 https://evidence-hub.com/study/132003-molecular-and-clinical-epidemiology-of-carbapenem-resistant2026-10-19 https://evidence-hub.com/study/132004-ultra-processed-food-consumption-and-type-2-diabetes-incidence-a2026-10-19 https://evidence-hub.com/study/132005-timing-of-high-efficacy-therapy-for-multiple-sclerosis-a2026-10-19 https://evidence-hub.com/study/132006-empiric-antibacterial-therapy-and-community-onset-bacterial2026-10-19 https://evidence-hub.com/study/132007-clinical-outcomes-of-covid-19-in-wuhan-china-a-large-cohort-study2026-10-19 https://evidence-hub.com/study/132008-risk-of-hepatocellular-carcinoma-in-patients-treated-with-entecavir2026-10-19 https://evidence-hub.com/study/132009-oral-anticoagulant-and-reduced-risk-of-dementia-in-patients-with2026-10-19 https://evidence-hub.com/study/132010-comorbidity-prevalence-among-cancer-patients-a-population-based2026-10-19 https://evidence-hub.com/study/132011-postsurgical-prescriptions-for-opioid-naive-patients-and-association2026-10-19 https://evidence-hub.com/study/132012-stress-related-disorders-and-risk-of-cardiovascular-disease2026-10-19 https://evidence-hub.com/study/132013-application-of-high-flow-nasal-cannula-in-hypoxemic-patients-with2026-10-19 https://evidence-hub.com/study/132014-perioperative-covert-stroke-in-patients-undergoing-non-cardiac2026-10-19 https://evidence-hub.com/study/132015-ultra-processed-food-consumption-is-associated-with-abdominal-obesity2026-10-19 https://evidence-hub.com/study/132017-dissecting-the-genetic-basis-of-focal-cortical-dysplasia-a-large2026-10-19 https://evidence-hub.com/study/132018-neutrophil-to-lymphocyte-ratio-predicts-poor-outcomes-after-acute2026-10-19 https://evidence-hub.com/study/132019-sex-and-survival-in-non-small-cell-lung-cancer-a-nationwide-cohort2026-10-19 https://evidence-hub.com/study/132020-blood-pressure-after-endovascular-therapy-for-ischemic-stroke-best-a2026-10-19 https://evidence-hub.com/study/132021-metallic-air-pollutants-and-breast-cancer-risk-in-a-nationwide-cohort2026-10-19 https://evidence-hub.com/study/132022-dislocation-of-the-fibular-head-in-an-unusual-sports-injury-a-case2026-10-19 https://evidence-hub.com/study/132023-psychological-stress-and-gut-microbiota-regulation-of-osteoarthritis2026-10-19 https://evidence-hub.com/study/132024-recurrent-non-variceal-upper-gastrointestinal-bleeding-among-patients2026-10-19 https://evidence-hub.com/study/132026-efficacy-and-safety-of-ckd-495-in-acute-and-chronic-gastritis-a-phase2026-10-19 https://evidence-hub.com/study/132027-comparing-vonoprazan-to-high-dose-proton-pump-inhibitors-for2026-10-19 https://evidence-hub.com/study/132028-analysis-of-clinical-characteristics-and-risk-factors-for-digestive2026-10-19 https://evidence-hub.com/study/132031-interactions-between-reproductive-biology-and-microbiomes-in-wild2026-10-19 https://evidence-hub.com/study/132032-towards-an-optimal-model-for-gastric-cancer-peritoneal-metastasis2026-10-19 https://evidence-hub.com/study/132033-physiologically-based-pharmacokinetic-modelling-to-predict2026-10-19 https://evidence-hub.com/study/132034-gut-microbiota-in-dysmenorrhea-causal-evidence-from-mendelian2026-10-19 https://evidence-hub.com/study/132035-15th-congress-of-the-european-association-for-clinical-pharmacology2026-10-19 https://evidence-hub.com/study/132036-comprehensive-review-of-diabetes-mellitus-pathophysiology-current2026-10-19 https://evidence-hub.com/study/132037-amprenavir-mitigates-pepsin-induced-transcriptomic-changes-in-normal2026-10-19 https://evidence-hub.com/study/132038-gastrin-and-cholecystokinin-2-receptor-and-gastrin-releasing-peptide2026-10-19 https://evidence-hub.com/study/132039-actualizacion-en-el-tratamiento-de-helicobacter-pylori-revision-del2026-10-19 https://evidence-hub.com/study/132040-diagnosis-of-onychomycosis-and-real-world-data-of-oral-fosravconazole2026-10-19 https://evidence-hub.com/study/132041-outcome-of-fosravuconazole-treatment-for-onychomycosis-refractory-to2026-10-19 https://evidence-hub.com/study/132042-treatment-outcome-with-fosravuconazole-for-onychomycosis2026-10-19 https://evidence-hub.com/study/132043-fosravuconazole-l-lysine-ethanolate-iii-efficacy-and-safety-of2026-10-19 https://evidence-hub.com/study/132044-new-regimens-of-benznidazole-monotherapy-and-in-combination-with2026-10-19 https://evidence-hub.com/study/132045-kidney-injury-associated-with-fosravuconazole-l-lysine-ethanolate2026-10-19 https://evidence-hub.com/study/132046-drug-properties-of-fosravuconazole-l-lysine-ethanolate-nailin2026-10-19 https://evidence-hub.com/study/132047-effects-of-additional-oral-fosravuconazole-l-lysine-ethanolate2026-10-19 https://evidence-hub.com/study/132048-a-case-of-tinea-faciei-tinea-corporis-and-tinea-unguium-with2026-10-19 https://evidence-hub.com/study/132049-development-of-e1224-by-leveraging-a-strategic-partnership-for-the2026-10-19 https://evidence-hub.com/study/132050-a-case-of-kerion-celsi-due-to-trichophyton-rubrum-successfully2026-10-19 https://evidence-hub.com/study/132051-treatment-outcome-with-fosravuconazole-l-lysine-ethanolate-f-rvcz-for2026-10-19 https://evidence-hub.com/study/132052-antifungal-selection-for-the-treatment-of-onychomycosis-patient2026-10-19 https://evidence-hub.com/study/132053-resistance-and-recalcitrance-in-dermatophytosis-mechanistic-and2026-10-19 https://evidence-hub.com/study/132054-onychomycosis-old-and-new2026-10-19 https://evidence-hub.com/study/132055-the-significance-of-mono-and-dual-effective-agents-in-the-development2026-10-19 https://evidence-hub.com/study/132056-treatment-options-for-onychomycosis-efficacy-side-effects-adherence2026-10-19 https://evidence-hub.com/study/132057-dermatophytomas-clinical-overview-and-treatment2026-10-19 https://evidence-hub.com/study/132058-the-pipeline-for-drugs-for-control-and-elimination-of-neglected2026-10-19 https://evidence-hub.com/study/132059-azole-combinations-and-multi-targeting-drugs-that-synergistically2026-10-19 https://evidence-hub.com/study/132060-genotyping-and-drug-susceptibility-profiling-of-prototheca-sp-strains2026-10-19 https://evidence-hub.com/study/132061-an-update-on-the-development-of-novel-antifungal-agents-for-eumycetoma2026-10-19 https://evidence-hub.com/study/132062-photochem-reference-chemical-database-for-the-development-of-new2026-10-19 https://evidence-hub.com/study/132063-recent-advances-in-therapies-for-onychomycosis-and-its-management2026-10-19 https://evidence-hub.com/study/132064-a-bibliometric-analysis-of-the-top-100-highly-cited-onychomycosis2026-10-19 https://evidence-hub.com/study/132065-halofantrine-hydrochloride-acts-as-an-antioxidant-ability-inhibitor2026-10-19 https://evidence-hub.com/study/132066-updated-perspectives-on-the-diagnosis-and-management-of-onychomycosis2026-10-19 https://evidence-hub.com/study/132067-nitrile-containing-pharmaceuticals-target-mechanism-of-action-and2026-10-19 https://evidence-hub.com/study/132068-tinea-barbae-due-to-trichophyton-rubrum-successfully-treated-using2026-10-19 https://evidence-hub.com/study/132069-erythro-papular-type-drug-eruption-caused-by-fosravuconazole-l-lysine2026-10-19 https://evidence-hub.com/study/132070-clinical-effectiveness-and-safety-of-fosravuconazole-l-lysine2026-10-19 https://evidence-hub.com/study/132072-a-study-of-25-cases-tested-with-the-dermatophyte-test-strip-after2026-10-19 https://evidence-hub.com/study/132073-epitope-spreading-possibly-from-bp230-to-the-nc16a-domain-of-bp1802026-10-19 https://evidence-hub.com/study/132074-treating-hard-to-heal-skin-and-nail-onychomycosis-of-diabetic-foot2026-10-19 https://evidence-hub.com/study/132075-a-randomized-double-blind-phase-ii-proof-of-concept-superiority-trial2026-10-19 https://evidence-hub.com/study/132077-changes-in-renal-function-during-oral-administration-of2026-10-19 https://evidence-hub.com/study/132079-tinea-capitis-caused-by-trichophyton-tonsurans-that-responded-to2026-10-19 https://evidence-hub.com/study/132080-efficacy-and-safety-of-fosravuconazole-in-patients-with-onychomycosis2026-10-19 https://evidence-hub.com/study/132081-kerion-celsi-due-to-microsporum-canis-in-an-adult-woman-treated2026-10-19 https://evidence-hub.com/study/132082-a-multicenter-retrospective-study-on-the-efficacy-and-safety-of2026-10-19 https://evidence-hub.com/study/132083-safety-and-effectiveness-of-fosravuconazole-for-the-treatment-of2026-10-19 https://evidence-hub.com/study/132085-retrospective-study-of-the-efficacy-and-safety-of-fosravuconazole2026-10-19 https://evidence-hub.com/study/132086-exploring-the-analgesic-potential-of-l-lysine-molecular-mechanisms2026-10-19 https://evidence-hub.com/study/132087-a-severe-case-of-trichophyton-rubrum-caused-dermatomycosis2026-10-19 https://evidence-hub.com/study/132088-new-and-investigational-treatment-options-for-dermatomycosis-in-the2026-10-19 https://evidence-hub.com/study/132090-onychomycosis-new-developments-in-diagnosis-treatment-and-antifungal2026-10-19 https://evidence-hub.com/study/132091-a-case-of-a-gibberellin-regulated-protein-positive-patient-allergic2026-10-19 https://evidence-hub.com/study/132092-screening-the-pandemic-response-box-identified-benzimidazole2026-10-19 https://evidence-hub.com/study/132093-biofilm-and-dermatophytoma2026-10-19 https://evidence-hub.com/study/132094-risk-factors-for-the-development-of-tinea-pedis-and-onychomycosis2026-10-19 https://evidence-hub.com/study/132095-sporotrichosis-an-update-on-epidemiology-and-in-vitro-antifungal2026-10-19 https://evidence-hub.com/study/132096-efficacy-and-safety-of-efinaconazole-10-topical-solution-for2026-10-19 https://evidence-hub.com/study/132097-10-clinical-effectiveness-of-efinaconazole-10-solution-for-treatment2026-10-19 https://evidence-hub.com/study/132098-antifungal-pulse-therapy-for-onychomycosis-a-narrative-review2026-10-19 https://evidence-hub.com/study/132099-cutaneous-fungal-infections-caused-by-dermatophytes-and-non2026-10-19 https://evidence-hub.com/study/132100-internet-questionnaire-of-attitude-survey-for-patients-with2026-10-19 https://evidence-hub.com/study/132101-molecular-docking-approaches-in-mycetoma-toward-improved-patient2026-10-19 https://evidence-hub.com/study/132102-eumycetoma-pathogenesis-current-treatments-and-the-search-for-new2026-10-19 https://evidence-hub.com/study/132103-updated-perspectives-on-the-diagnosis-management-and-novel-drug2026-10-19 https://evidence-hub.com/study/132104-progress-and-prospects-of-triazoles-in-advanced-therapies-for2026-10-19 https://evidence-hub.com/study/132105-innovation-in-the-discovery-of-the-hiv-1-attachment-inhibitor2026-10-19 https://evidence-hub.com/study/132106-azole-antifungals-and-dmi-fungicides-history-activity-synthesis2026-10-19 https://evidence-hub.com/study/132107-augmenting-azoles-with-drug-synergy-to-expand-the-antifungal-toolbox2026-10-19 https://evidence-hub.com/study/132108-nutraceuticals-and-phytoceuticals-in-the-treatment-of-schizophrenia-a2026-10-19 https://evidence-hub.com/study/132109-meta-analysis-of-fruit-waste-derived-single-cell-protein-for2026-10-19 https://evidence-hub.com/study/132110-6720-metabolomics-and-risk-of-vascular-complications-in-type-22026-10-19 https://evidence-hub.com/study/132111-impact-of-the-h3k27m-mutation-on-survival-in-pediatric-high-grade2026-10-19 https://evidence-hub.com/study/132112-effects-of-dietary-lysine-on-broiler-performance-and-carcass-yield2026-10-19 https://evidence-hub.com/study/132113-meta-analysis-of-genome-wide-association-studies-of-anxiety-disorders2026-10-19 https://evidence-hub.com/study/132114-pharmacological-interventions-for-the-prevention-of-bleeding-in2026-10-19 https://evidence-hub.com/study/132116-genetic-alterations-of-histone-lysine-methyltransferases-and-their2026-10-19 https://evidence-hub.com/study/132117-oxidative-gaseous-air-pollutant-exposure-interacts-with-pnpla3-i148m2026-10-19 https://evidence-hub.com/study/132118-lung-cancer-survival-prediction-and-biomarker-identification-with-an2026-10-19 https://evidence-hub.com/study/132119-abstract-2716-role-for-kmt2c-mutation-in-endometrial-cancer2026-10-19 https://evidence-hub.com/study/132121-nutritional-supplements-in-the-clinical-management-of-tendinopathy-a2026-10-19 https://evidence-hub.com/study/132122-loss-of-compartmentalization-causes-misregulation-of-lysine2026-10-19 https://evidence-hub.com/study/132123-in-vivo-magnetic-resonance-spectroscopy-for-ovarian-cancer2026-10-19 https://evidence-hub.com/study/132124-kat2b-polymorphism-identified-for-drug-abuse-in-african-americans2026-10-19 https://evidence-hub.com/study/132125-abstract-1954-black-white-differences-in-prospective-serum2026-10-19 https://evidence-hub.com/study/132126-potential-for-quality-protein-maize-for-reducing-proteinenergy2026-10-19 https://evidence-hub.com/study/132128-characterization-and-isolation-of-a-trypsin-like-serine-protease-from2026-10-19 https://evidence-hub.com/study/132129-a-polymorphic-residue-that-attenuates-the-antiviral-potential-of2026-10-19 https://evidence-hub.com/study/132135-patient-blood-management2026-10-19 https://evidence-hub.com/study/132137-re-the-role-of-international-partnerships-in-improving-urethral2026-10-19 https://evidence-hub.com/study/132138-genome-wide-association-study-gwas-identifies-a-significant-acute2026-10-19 https://evidence-hub.com/study/132144-nutritional-and-herbal-supplements-for-anxiety-and-anxiety-related2026-10-19 https://evidence-hub.com/study/132146-if-it-ain-t-broke-don-t-fix-it2026-10-19 https://evidence-hub.com/study/132147-17-challenges-and-implications-of-feeding-diets-with-excess2026-10-19 https://evidence-hub.com/study/132150-a-systematic-review-of-the-mechanisms-and-therapeutic-applications-of2026-10-19 https://evidence-hub.com/study/132152-comprehensive-safety-assessment-of-l-lysine-supplementation-from2026-10-19 https://evidence-hub.com/study/132154-evaluation-of-dietary-protein-and-amino-acid-requirements-a2026-10-19 https://evidence-hub.com/study/132156-the-application-of-magnetic-particles-for-cell-targeting-in2026-10-19 https://evidence-hub.com/study/132158-recent-advances-in-microbial-poly-l-lysine-fermentation-and-its2026-10-19 https://evidence-hub.com/study/132160-variability-in-distillers-co-product-compositions-and-their2026-10-19 https://evidence-hub.com/study/132161-recent-advances-in-the-industrial-production-of-l-lysine-by-bacteria2026-10-19 https://evidence-hub.com/study/132162-a-systematic-review-of-the-secretome-of-skeletal-muscle-cells2026-10-19 https://evidence-hub.com/study/132163-metabolomics-in-diabetic-retinopathy-a-systematic-review2026-10-19 https://evidence-hub.com/study/132166-the-regenerative-potential-of-ghk-cu-in-aesthetic-medicine2026-10-19 https://evidence-hub.com/study/132167-ghk-cu-tripeptide-a-multifunctional-cosmeceutical-agent-with-advanced2026-10-19 https://evidence-hub.com/study/132168-inhaled-aztreonam-and-an-adapted-delivery-device-in-the-treatment-of2026-10-19 https://evidence-hub.com/study/132169-large-scale-comparative-assessment-of-computational-predictors-for2026-10-19 https://evidence-hub.com/study/132170-combined-use-of-ketoprofen-solution-and-faryngazon-antiseptic-in2026-10-19 https://evidence-hub.com/study/132171-dietary-glycation-compounds-implications-for-human-health2026-10-19 https://evidence-hub.com/study/132172-protein-lactylation-in-health-and-diseases-molecular-mechanisms2026-10-19 https://evidence-hub.com/study/132173-advances-in-dendrimer-based-anti-infective-systems-in-vivo-insights2026-10-19 https://evidence-hub.com/study/132174-epileptic-encephalopathies-in-inborn-errors-of-metabolism-in-young2026-10-19 https://evidence-hub.com/study/132175-ghk-cu-as-a-bioactive-metallopeptide-and-drug-delivery-cargo2026-10-19 https://evidence-hub.com/study/132177-role-of-essential-amino-acids-in-age-induced-bone-loss2026-10-19 https://evidence-hub.com/study/132178-diet-and-psychosis-a-scoping-review2026-10-19 https://evidence-hub.com/study/132179-a-review-of-treatment-modalities-in-gyrate-atrophy-of-the-choroid-and2026-10-19 https://evidence-hub.com/study/132181-development-of-nanocapsules-containing-cytotoxic-agents-a-review2026-10-19 https://evidence-hub.com/study/132182-re-cystinuria-genetic-aspects-mouse-models-and-a-new-approach-to2026-10-19 https://evidence-hub.com/study/132184-aeromonas-an-unusual-cause-of-lower-gastrointestinal-bleed2026-10-19 https://evidence-hub.com/study/132185-use-of-tranexamic-acid-in-gastrointestinal-bleeding-and-patients-with2026-10-19 https://evidence-hub.com/study/132186-the-complexity-of-coagulopathy-pathogenesis-in-covid-192026-10-19 https://evidence-hub.com/study/132193-coexistence-of-glutamic-acid-decarboxylase-and-somatostatin-like2026-10-19 https://evidence-hub.com/study/132196-the-relationships-of-trehalose-and-its-metabolism-to-conidiation-in2026-10-19 https://evidence-hub.com/study/132197-efficacy-of-a-mouthwash-containing-poly-l-lysine-funme-peptides-and2026-10-19 https://evidence-hub.com/study/132198-acute-effects-of-mdma-mda-lysine-mdma-and-lysine-mda-in-a-randomized2026-10-19 https://evidence-hub.com/study/132199-effect-of-dried-ziziphus-jujube-consumption-on-plasma-insulin-blood2026-10-19 https://evidence-hub.com/study/132203-a-dietary-supplement-in-the-management-of-patients-with-lumbar2026-10-19 https://evidence-hub.com/study/132205-e2112-randomized-phase-iii-trial-of-endocrine-therapy-plus-entinostat2026-10-19 https://evidence-hub.com/study/132206-two-dose-levels-of-once-weekly-fosravuconazole-versus-daily2026-10-19 https://evidence-hub.com/study/132209-metabolic-plasticity-of-the-gut-microbiome-in-response-to-diets2026-10-19 https://evidence-hub.com/study/132210-improvement-of-skin-condition-and-intestinal-microbiota-via2026-10-19 https://evidence-hub.com/study/132211-physical-activity-and-markers-of-glycation-in-older-individuals-data2026-10-19 https://evidence-hub.com/study/132212-177lu-lu-dota-tate-versus-sunitinib-in-patients-with-metastatic2026-10-19 https://evidence-hub.com/study/132214-growth-responses-of-hybrid-catfish-hetero-clarias-juveniles-fed-all2026-10-19 https://evidence-hub.com/study/132217-blood-mrna-biomarkers-distinguish-variable-systemic-and-sputum2026-10-19 https://evidence-hub.com/study/132218-pulmonary-hypertension-following-l-lysine-ibuprofen-therapy-in-a2026-10-19 https://evidence-hub.com/study/132220-severe-hypouricemia-impairs-endothelium-dependent-vasodilatation-and2026-10-19 https://evidence-hub.com/study/132223-719-p-metabolomic-characteristics-associated-with-changes-in-fasting2026-10-19 https://evidence-hub.com/study/132226-circulating-nitric-oxide-pathway-metabolites-in-heart-failure-with2026-10-19 https://evidence-hub.com/study/132228-the-effect-of-a-diet-reduction-in-advanced-glycation-end-products-on2026-10-19 https://evidence-hub.com/study/132229-two-phase-3-placebo-controlled-trials-of-aztreonam-lysine-for2026-10-19 https://evidence-hub.com/study/132231-effect-of-dietary-sesame-sesame-indicum-l-seed-meal-level2026-10-19 https://evidence-hub.com/study/132233-investigating-the-interaction-between-a-polyphenol-rich-mediterranean2026-10-19 https://evidence-hub.com/study/132238-effects-of-lysine-deficiency-or-excess-on-growth-and-the-expression2026-10-19 https://evidence-hub.com/study/132240-investigating-the-impact-of-protein-supplementation-from-different2026-10-19 https://evidence-hub.com/study/132242-iadademstat-and-gilteritinib-for-the-treatment-of-flt3-mutated2026-10-19 https://evidence-hub.com/study/132244-impact-of-dietary-counselling-on-cardiometabolic-health-mental-health2026-10-19 https://evidence-hub.com/study/132245-effects-of-close-up-dietary-energy-level-and-supplementing-rumen2026-10-19 https://evidence-hub.com/study/132247-dietary-amino-acids-macronutrients-vaginal-birth-and-breastfeeding2026-10-19 https://evidence-hub.com/study/132249-effects-of-dietary-supplementation-with-lysine-yielding-bacillus2026-10-19 https://evidence-hub.com/study/132253-fibrinolysis-and-tranexamic-acid-mechanistic-principles2026-10-19 https://evidence-hub.com/study/132254-local-tranexamic-acid-reduces-surgical-blood-loss2026-10-19 https://evidence-hub.com/study/132256-effects-of-replacement-of-fish-meal-by-poultry-by-product-meal-on2026-10-19 https://evidence-hub.com/study/132257-nano-zinc-oxide-improves-performance-igf-i-mrna-expression-meat2026-10-19 https://evidence-hub.com/study/132258-associations-among-high-quality-protein-and-energy-intake-serum2026-10-19 https://evidence-hub.com/study/132259-dietary-advanced-glycation-end-products-ages-and-breast-cancer2026-10-19 https://evidence-hub.com/study/132260-a-phase-3-study-of-revumenib-plus-venetoclax-azacitidine-in-adults2026-10-19 https://evidence-hub.com/study/132262-the-impact-of-super-dosing-phytase-in-pig-diets-on-growth-performance2026-10-19 https://evidence-hub.com/study/132265-acute-lysine-supplementation-does-not-improve-hepatic-or-peripheral2026-10-19 https://evidence-hub.com/study/132267-effect-of-dietary-lysine-restriction-and-energy-density-on2026-10-19 https://evidence-hub.com/study/132268-abstract-6762-baseline-multiomics-and-chemotherapy-efficacy-in2026-10-19 https://evidence-hub.com/study/132269-efficacy-of-lisdexamfetamine-dimesylate-in-children-with-attention2026-10-19 https://evidence-hub.com/study/132274-effects-of-in-ovo-injection-of-amino-acids-on-hatching-performance2026-10-19 https://evidence-hub.com/study/132277-reducao-dos-niveis-de-proteina-e-suplementacao-aminoacidica-em-racoes2026-10-19 https://evidence-hub.com/study/132278-relative-bioavailability-of-organic-and-hydroxy-copper-sources-in2026-10-19 https://evidence-hub.com/study/132279-safety-of-a-probiotic-cheese-containing-lactobacillus-plantarum2026-10-19 https://evidence-hub.com/study/132280-superior-bioavailability-of-epa-and-dha-from-a-l-lysine-salt2026-10-19 https://evidence-hub.com/study/132281-clinical-evaluation-of-an-nvtia-gaba-lysine-calcium-preparation-for2026-10-19 https://evidence-hub.com/study/132282-steroids-and-l-lysine-aescinate-for-acute-radiculopathy-due-to-a2026-10-19 https://evidence-hub.com/study/132283-development-of-non-pyrogenic-magnetosome-minerals-coated-with-poly-l2026-10-19 https://evidence-hub.com/study/132284-s4-5b-a-randomized-double-blind-phase-ii-proof-of-concept-superiority2026-10-19 https://evidence-hub.com/study/132286-dipg-07-preclinical-and-case-study-results-underpinning-the-phase-ii2026-10-19 https://evidence-hub.com/study/132287-possibility-of-orally-administered-l-lysine-a-oxidase-internalization2026-10-19 https://evidence-hub.com/study/132288-clinical-experience-with-l-lysine-escinate-for-acute-and-chronic2026-10-19 https://evidence-hub.com/study/132290-the-use-of-poly-l-lysine-as-a-capture-agent-to-enhance-the-detection2026-10-19 https://evidence-hub.com/study/132291-resistant-potato-starch-supplementation-increases-serum-antioxidant2026-10-19 https://evidence-hub.com/study/132293-the-clinical-and-microbiological-utility-of-inhaled-aztreonam-lysine2026-10-19 https://evidence-hub.com/study/132294-evaluation-of-a-standardised-vi-poly-l-lysine-elisa-for-serology-of2026-10-19 https://evidence-hub.com/study/132295-a-mouse-human-phase-1-co-clinical-trial-of-a-protease-activated2026-10-19 https://evidence-hub.com/study/132296-risk-assessment-of-other-substances-l-lysine2026-10-19 https://evidence-hub.com/study/132297-autologous-aldrithiol-2-inactivated-hiv-1-combined-with-polyinosinic2026-10-19 https://evidence-hub.com/study/132298-enhancement-of-airway-gene-transfer-by-dna-nanoparticles-using-a-ph2026-10-19 https://evidence-hub.com/study/132307-relationship-between-plasma-l-lysine-concentrations-and-levels-of-hiv2026-10-19 https://evidence-hub.com/study/132310-phase-3-study-of-the-lysine-specific-demethylase-1-lsd1-inhibitor2026-10-19 https://evidence-hub.com/study/132312-a-comparative-clinical-trial-of-lymecycline2026-10-19 https://evidence-hub.com/study/132314-ps5-09-30-a-phase-1-2-trial-evaluating-the-safety-tolerability-and2026-10-19 https://evidence-hub.com/study/132315-lp2-a-cyclic-angiotensin-1-7-analog-extended-with-an-n-terminal-d2026-10-19 https://evidence-hub.com/study/132317-a-multi-site-break-through-cancer-trial-phase-ii-study-investigating2026-10-19 https://evidence-hub.com/study/132318-mezigdomide-is-effective-alone-and-in-combination-with-menin2026-10-19 https://evidence-hub.com/study/132319-dietary-lysine-requirements-of-older-adults-stratified-by-age-and-sex2026-10-19 https://evidence-hub.com/study/132320-therapeutic-immune-modulation-against-solid-cancers-with-intratumoral2026-10-19 https://evidence-hub.com/study/132321-efficacy-of-toothpaste-containing-polylysine-and-funme-peptide-on2026-10-19 https://evidence-hub.com/study/132324-abstract-ct146-azd0466-in-patients-with-advanced-non-hodgkin-lymphoma2026-10-19 https://evidence-hub.com/study/132325-a-phase-1-dose-escalation-and-dose-optimization-study-to-evaluate-the2026-10-19 https://evidence-hub.com/study/132326-vlx600-disrupts-homologous-recombination-and-synergizes-with-parp2026-10-19 https://evidence-hub.com/study/132327-birc5-promoter-driven-nanodrugs-suppress-birc5-positive-cancers2026-10-19 https://evidence-hub.com/study/132328-abstract-452-oric-944-a-prc2-inhibitor-with-best-in-class-properties2026-10-19 https://evidence-hub.com/study/132329-identification-and-optimization-of-a-ligand-efficient-benzoazepinone2026-10-19 https://evidence-hub.com/study/132330-covalent-fragment-screening-of-brd4-identifies-a-ligandable-site2026-10-19 https://evidence-hub.com/study/132331-abstract-6586-oric-944-a-potent-and-selective-allosteric-prc22026-10-19 https://evidence-hub.com/study/132332-phase-2-study-of-the-lysine-specific-demethylase-1-lsd1-inhibitor2026-10-19 https://evidence-hub.com/study/132333-abstract-lb360-targeted-degradation-of-p300-and-cbp-via-antibody-drug2026-10-19 https://evidence-hub.com/study/132334-abstract-lb245-collagen-remodeling-promotes-a-gpcr-mediated2026-10-19 https://evidence-hub.com/study/132335-association-of-lysine-pathway-metabolites-with-moyamoya-disease2026-10-19 https://evidence-hub.com/study/132336-the-menin-inhibitor-revumenib-in-kmt2a-rearranged-or-npm1-mutant2026-10-19 https://evidence-hub.com/study/132337-crispr-cas9-screen-reveals-that-inhibition-of-enhancer-of-zeste2026-10-19 https://evidence-hub.com/study/132339-safety-and-tolerability-of-azd0466-as-monotherapy-for-patients-with2026-10-19 https://evidence-hub.com/study/132341-role-of-angioprotective-therapy-in-comprehensive-postoperative2026-10-19 https://evidence-hub.com/study/132342-evaluate-wound-healing-time-and-infection-control-measures2026-10-19 https://evidence-hub.com/study/132343-a-short-term-diet-high-in-carboxymethyl-lysine-cml-increases-urinary2026-10-19 https://evidence-hub.com/study/132344-preclinical-activity-of-investigational-menin-inhibitor-dsp-53362026-10-19 https://evidence-hub.com/study/132345-transcriptional-analysis-revealing-the-improvement-of-poly-l-lysine2026-10-19 https://evidence-hub.com/study/132346-engineering-cell-adhesion-poly-l-lysine-induced-micro-and-nanoscale2026-10-19 https://evidence-hub.com/study/132347-integrative-transcriptome-and-proteome-revealed-high-yielding2026-10-19 https://evidence-hub.com/study/132348-ph-dependence-of-the-assembly-mechanism-and-properties-of-poly-l2026-10-19 https://evidence-hub.com/study/132349-improved-production-of-poly-l-lysine-in-streptomyces-albulus-using2026-10-19 https://evidence-hub.com/study/132350-transcriptome-and-metabolome-analysis-revealing-the-improved-poly-l2026-10-19 https://evidence-hub.com/study/132351-purification-and-structural-analysis-of-the-effective-anti-tmv2026-10-19 https://evidence-hub.com/study/132352-effect-of-phenothiazine-compounds-on-the-secondary-structure-and2026-10-19 https://evidence-hub.com/study/132353-conformation-determined-segmental-dynamics-in-poly-l-lysine2026-10-19 https://evidence-hub.com/study/132354-physiological-and-transcriptional-responses-of-streptomyces-albulus2026-10-19 https://evidence-hub.com/study/132355-effects-of-poly-l-lysine-on-vegetative-growth-pathogenicity-and-gene2026-10-19 https://evidence-hub.com/study/132357-draft-genome-sequence-of-the-most-traditional-poly-l-lysine-producer2026-10-19 https://evidence-hub.com/study/132358-global-lysine-succinylation-analysis-unveils-post-translational2026-10-19 https://evidence-hub.com/study/132362-distribution-of-poly-l-lysine-synthetases-in-coryneform-bacteria2026-10-19 https://evidence-hub.com/study/132364-pangenome-analysis-of-nocardia-brasiliensis-reveals-phylogenetic2026-10-19 https://evidence-hub.com/study/132372-genome-assembly-analysis-and-mining-of-kocuria-flava-nio-001-a2026-10-19 https://evidence-hub.com/study/132373-a-clinical-case-of-secondary-erythromelalgia2026-10-19 https://evidence-hub.com/study/132374-using-time-of-flight-secondary-ion-mass-spectroscopy-to-investigate2026-10-19 https://evidence-hub.com/study/132375-genomic-analysis-optimal-growth-conditions-gene-expression-and2026-10-19 https://evidence-hub.com/study/132376-genome-wide-profiling-of-histone-h3-lysine-4-k4-tri-methylation-me32026-10-19 https://evidence-hub.com/study/132377-c-terminal-lysine-residues-enhance-plasminogen-activation-by-inducing2026-10-19 https://evidence-hub.com/study/132378-mass-spectrometric-analysis-of-lysine-ubiquitylation-reveals2026-10-19 https://evidence-hub.com/study/132379-bioinformatic-analysis-and-post-translational-modification-crosstalk2026-10-19 https://evidence-hub.com/study/132380-de-novo-transcriptome-profiling-revealing-genes-involved-in-piperine2026-10-19 https://evidence-hub.com/study/132381-analysis-of-alkaloids-indole-alkaloids-isoquinoline-alkaloids-tropane2026-10-19 https://evidence-hub.com/study/132382-high-throughput-transcriptomic-analysis-of-circadian-rhythm-of2026-10-19 https://evidence-hub.com/study/132383-characterization-of-the-interaction-between-tartrazine-and2026-10-19 https://evidence-hub.com/study/132384-fak-targeting-microneedle-patch-promotes-uterine-regenerative-repair2026-10-19 https://evidence-hub.com/study/132385-genomic-insights-into-brevibacterium-sediminis-strain-ima-c3-isolated2026-10-19 https://evidence-hub.com/study/132386-in-situ-formation-of-nanoparticles-from-graft-copolypeptides-under2026-10-19 https://evidence-hub.com/study/132388-metabolic-perturbation-of-streptomyces-albulus-by-introducing-nadp2026-10-19 https://evidence-hub.com/study/132389-germline-lysine-specific-demethylase-1-lsd1-kdm1a-mutations-confer2026-10-19 https://evidence-hub.com/study/132390-iws1-positions-downstream-dna-to-globally-stimulate-pol-ii-elongation2026-10-19 https://evidence-hub.com/study/132391-comprehensive-profiling-of-lysine-ubiquitome-reveals-diverse2026-10-19 https://evidence-hub.com/study/132392-revumenib-for-patients-with-relapsed-or-refractory-r-r-nucleophosmin2026-10-19 https://evidence-hub.com/study/132393-physiological-and-molecular-mechanisms-of-medicago-ruthenica-in2026-10-19 https://evidence-hub.com/study/132394-a-landscape-analysis-of-human-sumoylation2026-10-19 https://evidence-hub.com/study/132395-metabolomics-provides-new-insights-into-the-mechanisms-of-wolbachia2026-10-19 https://evidence-hub.com/study/132396-ultrasensitive-raman-detection-of-biomolecular-conformation-at-the2026-10-19 https://evidence-hub.com/study/132397-analysis-of-metabolites-by-gc-ms-and-ftir-spectroscopy-techniques-to2026-10-19 https://evidence-hub.com/study/132398-plasticity-or-elasticity-relating-elastic-moduli-with-secondary2026-10-19 https://evidence-hub.com/study/132399-introducing-a-single-point-modification-to-the-cell-penetrating2026-10-19 https://evidence-hub.com/study/132400-the-role-of-feed-pretreatment-and-thermal-stress-in-the-development2026-10-19 https://evidence-hub.com/study/132401-amino-acid-and-secondary-metabolite-production-in-embryogenic-and-non2026-10-19 https://evidence-hub.com/study/132402-the-optimization-of-curcumin-capped-gold-nanoparticle-synthesis-for2026-10-19 https://evidence-hub.com/study/132403-transcriptional-activity-of-the-islet-cell-factor-pdx1-is-augmented2026-10-19 https://evidence-hub.com/study/132405-early-markers-of-liver-fibrosis-in-children-with-beta-thalassaemia2026-10-19 https://evidence-hub.com/study/132406-importance-of-n2ba-titin-in-maintaining-cardiac-homeostasis-and-its2026-10-19 https://evidence-hub.com/study/132407-chronometabolism-the-timing-of-the-consumption-of-meals-has-a-greater2026-10-19 https://evidence-hub.com/study/132408-evaluation-of-the-nutritional-mineral-and-lysine-content-of-the-root2026-10-19 https://evidence-hub.com/study/132410-comprehensive-evaluation-of-amino-acids-and-polyphenols-in-692026-10-19 https://evidence-hub.com/study/132412-analysis-of-lpi-causing-mutations-on-y-lat1-function-and-localization2026-10-19 https://evidence-hub.com/study/132413-optimizing-solid-state-fermentation-for-metabolite-enrichment-by2026-10-19 https://evidence-hub.com/study/132414-revumenib-for-patients-with-relapsed-or-refractory-r-r-kmt2ar-acute2026-10-19 https://evidence-hub.com/study/132415-the-impact-of-reducing-dietary-aflatoxin-exposure-on-child-linear2026-10-19 https://evidence-hub.com/study/132416-small-scale-heterogeneity-of-soil-properties-in-farmland-affected2026-10-19 https://evidence-hub.com/study/132418-deep-phenotyping-of-ehmt1-ankyrin-repeat-domain-missense-variants-in2026-10-19 https://evidence-hub.com/study/132420-residual-charge-dependence-of-spin-transport-in-chiral-biomolecules2026-10-19 https://evidence-hub.com/study/132422-use-of-secondary-enrichment-for-isolation-of-salmonella-from2026-10-19 https://evidence-hub.com/study/132423-phase-1-2-study-investigating-cc-90011-a-potent-selective-and2026-10-19 https://evidence-hub.com/study/132424-evaluating-the-therapeutic-efficacy-of-l-lysine-aescinat2026-10-19 https://evidence-hub.com/study/132425-dietary-advanced-glycation-end-products-may-increase-the-incidence-of2026-10-19 https://evidence-hub.com/study/132426-genetic-creutzfeldt-jakob-disease-linked-to-the-e200k-mutation-a2026-10-19 https://evidence-hub.com/study/132427-a-metabolomic-study-on-high-risk-stroke-patients-determines-low2026-10-19 https://evidence-hub.com/study/132428-n6-acetyl-l-lysine-and-p-cresol-as-key-metabolites-in-the2026-10-19 https://evidence-hub.com/study/132429-plasma-l-carnitine-and-l-lysine-concentrations-in-hiv-infected2026-10-19 https://evidence-hub.com/study/132430-lysine-degradation-related-metabolic-remodeling-in-sarcopenia2026-10-19 https://evidence-hub.com/study/132432-cognitive-and-neurological-outcome-of-patients-in-the-dutch2026-10-19 https://evidence-hub.com/study/132433-high-dietary-glycemic-load-is-associated-with-higher-concentrations2026-10-19 https://evidence-hub.com/study/132434-the-receptor-for-advanced-glycation-end-products-and-risk-of2026-10-19 https://evidence-hub.com/study/132435-serum-carboxymethyl-lysine-levels-inversely-correlate-with2026-10-19 https://evidence-hub.com/study/132436-integrated-transcriptomic-and-metabolomic-analysis-identifies-a-core2026-10-19 https://evidence-hub.com/study/132437-urinary-excretion-of-amino-acids-and-their-advanced-glycation-end2026-10-19 https://evidence-hub.com/study/132438-associations-of-dietary-advanced-glycation-end-products-and-the-risk2026-10-19 https://evidence-hub.com/study/132439-progression-of-prostate-cancer-reprograms-myc-mediated-lipid2026-10-19 https://evidence-hub.com/study/132440-the-potential-of-chromatographic-and-chemometric-profiling-as-early2026-10-19 https://evidence-hub.com/study/132442-pociredir-a-novel-oral-once-daily-fetal-hemoglobin-inducer-results2026-10-19 https://evidence-hub.com/study/132443-the-relationship-of-serum-soluble-receptor-for-advanced-glycation-end2026-10-19 https://evidence-hub.com/study/132445-virus-induced-changes-in-peroxisomal-markers-among-hiv-infected2026-10-19 https://evidence-hub.com/study/132446-immunohistochemical-study-of-n-epsilon-carboxymethyl-lysine-cml-in2026-10-19 https://evidence-hub.com/study/132448-metabolomic-profiling-of-patients-with-gestational-diabetes-mellitus2026-10-19 https://evidence-hub.com/study/132449-serum-carboxymethyl-lysine-an-advanced-glycation-end-product-and-age2026-10-19 https://evidence-hub.com/study/132450-patients-with-aml-with-an-idh2-r172k-mutation-have-improved-overall2026-10-19 https://evidence-hub.com/study/132451-or17-05-lysine-demethylase-kdm1a-and-ectopic-expression-of-gip2026-10-19 https://evidence-hub.com/study/132452-cumulative-lifetime-maternal-stress-and-epigenome-wide-placental-dna2026-10-19 https://evidence-hub.com/study/132453-glycation-metabolites-predict-incident-age-related-comorbidities-and2026-10-19 https://evidence-hub.com/study/132454-rare-de-novo-damaging-dna-variants-are-enriched-in-attention-deficit2026-10-19 https://evidence-hub.com/study/132455-phase-2-study-to-assess-the-safety-and-efficacy-of-bomedemstat-mk35432026-10-19 https://evidence-hub.com/study/132456-alterations-of-the-paired-maternal-fecal-microbiota-and-neonatal2026-10-19 https://evidence-hub.com/study/132457-revumenib-monotherapy-in-patients-with-relapsed-refractory-kmt2ar2026-10-19 https://evidence-hub.com/study/132458-metabolomic-machine-learning-predictor-for-the-diagnosis-of2026-10-19 https://evidence-hub.com/study/132459-integrated-proteomic-and-metabolomic-profiling-reveals-sex-stratified2026-10-19 https://evidence-hub.com/study/132460-updated-results-and-longer-follow-up-from-the-augment-101-phase-22026-10-19 https://evidence-hub.com/study/132461-identification-of-pyruvic-and-maleic-acid-as-potential-markers-for2026-10-19 https://evidence-hub.com/study/132462-menin-inhibition-with-revumenib-for-kmt2a-rearranged-relapsed-or2026-10-19 https://evidence-hub.com/study/132463-higher-dietary-advanced-glycation-products-intake-is-associated-with2026-10-19 https://evidence-hub.com/study/132464-the-human-ocular-surface-microbiome-and-its-associations-with-the2026-10-19 https://evidence-hub.com/study/132465-bomedemstat-mk3543-in-combination-with-ruxolitinib-in-patients-with2026-10-19 https://evidence-hub.com/study/132466-hepatic-fat-content-and-liver-enzymes-are-associated-with-circulating2026-10-19 https://evidence-hub.com/study/132467-dietary-intake-of-advanced-glycation-endproducts-is-associated-with2026-10-19 https://evidence-hub.com/study/132468-habitual-intake-of-dietary-l-arginine-in-relation-to-risk-of-type-22026-10-19 https://evidence-hub.com/study/132469-comparative-ckd-risk-prediction-using-homocitrulline-and-carbamylated2026-10-19 https://evidence-hub.com/study/132470-untargeted-metabolomics-identifies-trimethyllysine-a-tmao-producing2026-10-19 https://evidence-hub.com/study/132471-multiomics-analysis-of-plasma-proteomics-and-metabolomics-of-steroid2026-10-19 https://evidence-hub.com/study/132472-revumenib-monotherapy-in-patients-with-relapsed-refractory-kmt2ar2026-10-19 https://evidence-hub.com/study/132473-pulmonary-outcomes-associated-with-long-term-azithromycin-therapy-in2026-10-19 https://evidence-hub.com/study/132474-nimble-a-phase-i-ii-study-of-azd0466-monotherapy-or-in-combination-in2026-10-19 https://evidence-hub.com/study/132475-advanced-glycation-glycoxidation-endproduct-carboxymethyl-lysine-and2026-10-19 https://evidence-hub.com/study/132476-from-cdk4-6-to-cdk2-and-kat-evolving-therapeutic-approaches-in-hr2026-10-19 https://evidence-hub.com/study/132478-development-and-validation-of-a-novel-plasma-metabolomic-signature2026-10-19 https://evidence-hub.com/study/132479-integrated-nasopharyngeal-airway-metagenome-and-asthma-genetic-risk2026-10-19 https://evidence-hub.com/study/132480-epigenetic-regulators-of-clonal-hematopoiesis-control-cd8-t-cell2026-10-19 https://evidence-hub.com/study/132481-msl2-variants-lead-to-a-neurodevelopmental-syndrome-with-lack-of2026-10-19 https://evidence-hub.com/study/132482-setd1b-associated-neurodevelopmental-disorder2026-10-19 https://evidence-hub.com/study/132483-integrated-multiomics-reveals-gut-brain-axis-dysregulation-and2026-10-19 https://evidence-hub.com/study/132484-the-integration-of-plasma-non-target-metabolomics-and-lipidomics2026-10-19 https://evidence-hub.com/study/132485-metabolomics-profiles-and-prognostic-biomarkers-in-sepsis-survivors2026-10-19 https://evidence-hub.com/study/132486-the-effects-of-inhaled-aztreonam-on-the-cystic-fibrosis-lung2026-10-19 https://evidence-hub.com/study/132487-plasma-levels-of-advanced-glycation-endproducts-and-risk-of2026-10-19 https://evidence-hub.com/study/132488-322-or-delaying-progression-of-diabetic-retinopathy-worsens-the-risk2026-10-19 https://evidence-hub.com/study/132489-left-ventricular-remodeling-predictors-in-chronic-heart-failure-of2026-10-19 https://evidence-hub.com/study/132490-bnt162b2-mrna-vaccination-affects-the-gut-microbiome-composition-of2026-10-19 https://evidence-hub.com/study/132491-circulating-selenium-and-carboxymethyl-lysine-an-advanced-glycation2026-10-19 https://evidence-hub.com/study/132492-protection-from-retinopathy-and-other-complications-in-patients-with2026-10-19 https://evidence-hub.com/study/132493-flucloxacillin-hypersensitivity-patient-outcomes-in-a-multicenter2026-10-19 https://evidence-hub.com/study/132494-abstract-1736-elucidating-the-oncogenic-mechanisms-in-diffuse-midline2026-10-19 https://evidence-hub.com/study/132495-the-appetite-suppressant-and-glp-1-stimulating-effects-of-whey2026-10-19 https://evidence-hub.com/study/132497-a-prospective-study-of-soluble-receptor-for-advanced-glycation-end2026-10-19 https://evidence-hub.com/study/132499-6870-cardiac-imaging-and-metabolomics-studies-suggest-differential2026-10-19 https://evidence-hub.com/study/132500-steric-clash-in-the-set-domain-of-histone-methyltransferase-nsd1-as-a2026-10-19 https://evidence-hub.com/study/132501-characterization-of-kmt2a-matr3-fusion-in-a-patient-with-acute2026-10-19 https://evidence-hub.com/study/132502-decrease-in-sleep-depth-is-associated-with-higher-cerebrospinal-fluid2026-10-19 https://evidence-hub.com/study/132503-germline-encoded-amino-acid-binding-motifs-drive-immunodominant2026-10-19 https://evidence-hub.com/study/132504-onychomycosis-a-review2026-10-19 https://evidence-hub.com/study/132505-pharmacokinetics-and-pharmacodynamics-of-fosravuconazole-itraconazole2026-10-19 https://evidence-hub.com/study/132506-review-of-the-alternative-therapies-for-onychomycosis-and-superficial2026-10-19 https://evidence-hub.com/study/132507-population-pharmacokinetic-pharmacodynamic-analysis-of-benznidazole2026-10-19 https://evidence-hub.com/study/132508-long-term-follow-up-study-of-the-efficacy-of-fosravuconazole-in-the2026-10-19 https://evidence-hub.com/study/132509-review-on-experimental-treatment-strategies-against-trypanosoma-cruzi2026-10-19 https://evidence-hub.com/study/132510-transplantation-for-chagas-disease-closing-the-knowledge-gap2026-10-19 https://evidence-hub.com/study/132511-safety-and-efficacy-of-new-generation-azole-antifungals-in-the2026-10-19 https://evidence-hub.com/study/132512-evaluation-of-hepatic-and-renal-function-algorithms-for2026-10-19 https://evidence-hub.com/study/132513-empiric-antifungal-therapy-in-patients-with-cutaneous-and2026-10-19 https://evidence-hub.com/study/132514-fosravuconazole-to-treat-severe-onychomycosis-in-the-elderly2026-10-19 https://evidence-hub.com/study/132515-emerging-antifungal-resistant-onychomycosis-in-a-dermatology-clinic2026-10-19 https://evidence-hub.com/study/132516-dermatophytomas-in-onychomycosis-a-scoping-review-of-prevalence2026-10-19 https://evidence-hub.com/study/132517-quantifying-anti-trypanosomal-treatment-effects-in-chronic2026-10-19 https://evidence-hub.com/study/132518-exploratory-study-on-short-term-administration-of-oral2026-10-19 https://evidence-hub.com/study/132519-monotherapy-and-combination-chemotherapy-for-chagas-disease-treatment2026-10-19 https://evidence-hub.com/study/132520-clinical-management-of-antifungal-resistant-dermatophytosis-in-japan2026-10-19 https://evidence-hub.com/study/132521-high-multi-azole-resistant-malassezia-pachydermatis-clinical-isolates2026-10-19 https://evidence-hub.com/study/132522-impact-of-new-antifungal-medications-on-onychomycosis-prescriptions2026-10-19 https://evidence-hub.com/study/132523-topical-luliconazole-treatment-for-hyperkeratotic-tinea-pedis2026-10-19 https://evidence-hub.com/study/132524-onychomycosis-in-older-adults-prevalence-diagnosis-and-management2026-10-19 https://evidence-hub.com/study/132525-assessing-anti-t-cruzi-candidates-in-vitro-for-sterile-cidality2026-10-19 https://evidence-hub.com/study/132526-fungal-melanonychia-caused-by-candida-parapsilosis-successfully2026-10-19 https://evidence-hub.com/study/132527-the-current-landscape-of-repurposed-drugs-for-fungal-neglected2026-10-19 https://evidence-hub.com/study/132528-advances-in-the-treatment-of-mycetoma-the-emerging-role-of2026-10-19 https://evidence-hub.com/study/132529-a-balancing-act-navigating-the-advantages-and-challenges-of2026-10-19 https://evidence-hub.com/study/132530-receipt-survey-of-prescription-continuation-rates-for-patients-with2026-10-19 https://evidence-hub.com/study/132531-onychomycosis-caused-by-aspergillus-species-belonging-to-section2026-10-19 https://evidence-hub.com/study/132532-epidemiological-cut-off-values-for-itraconazole-and-ravuconazole-for2026-10-19 https://evidence-hub.com/study/132533-widespread-majocchi-s-granuloma-caused-by-multidrug-resistant2026-10-19 https://evidence-hub.com/study/132534-using-1-3-d-glucan-concentrations-in-serum-to-monitor-the-response-of2026-10-19 https://evidence-hub.com/study/132535-a-strategic-partnership-for-medicine-creation-and-access-to-medicine2026-10-19 https://evidence-hub.com/study/132536-quantifying-anti-trypanosomal-treatment-effects-in-chronic2026-10-19 https://evidence-hub.com/study/132537-the-efficacy-and-safety-of-benznidazole-in-adults-with-seropositive2026-10-19 https://evidence-hub.com/study/132538-repurposing-fda-approved-drugs-for-eumycetoma-treatment-homology2026-10-19 https://evidence-hub.com/study/132539-early-assessment-of-antibodies-decline-in-chagas-patients-following2026-10-19 https://evidence-hub.com/study/132541-a-drug-repurposing-screen-of-fda-and-ema-approved-drugs-identifies2026-10-19 https://evidence-hub.com/study/132542-evaluation-of-clinical-studies-of-patients-with-dermatophyte2026-10-19 https://evidence-hub.com/study/132543-advances-and-challenges-in-the-search-for-new-treatments-for-chagas2026-10-19 https://evidence-hub.com/study/132544-multitarget-therapeutic-strategies-for-chagas-disease-natural2026-10-19 https://evidence-hub.com/study/132545-stress-activated-protein-kinase-pathways-as-potential-targets-for-the2026-10-19 https://evidence-hub.com/study/132546-in-vitro-susceptibility-profiles-of-16-antifungal-drugs-against2026-10-19 https://evidence-hub.com/study/132547-a-global-chromoblastomycosis-strategy-and-development-of-the-global2026-10-19 https://evidence-hub.com/study/132548-parasitic-diseases-in-heart-transplantation-challenges-of2026-10-19 https://evidence-hub.com/study/132549-emerging-terbinafine-resistant-trichophyton-dermatophytosis-testing2026-10-19 https://evidence-hub.com/study/132550-clinical-isolate-of-a-multi-antifungal-resistant-trichophyton-rubrum2026-10-19 https://evidence-hub.com/study/132551-newer-therapies-in-dermatophytosis2026-10-19 https://evidence-hub.com/study/132552-the-outcome-of-aplastic-anaemia-associated-with-terbinafine-therapy2026-10-19 https://evidence-hub.com/study/132553-tinea-incognito-imitating-pustular-psoriasis-in-a-psoriatic-patient2026-10-19 https://evidence-hub.com/study/132554-eumycetoma-causative-agents-are-inhibited-in-vitro-by-luliconazole2026-10-19 https://evidence-hub.com/study/132555-neglected-tropical-diseases-recent-trends-and-challenges-associated2026-10-19 https://evidence-hub.com/study/132556-in-vitro-and-in-vivo-studies-on-the-activity-and-selectivity-of2026-10-19 https://evidence-hub.com/study/132557-diagnostic-capacities-and-treatment-practices-on-implantation-mycoses2026-10-19 https://evidence-hub.com/study/132558-dual-targeting-hybrid-antifungal-agents-targeting-candida-albicans-an2026-10-19 https://evidence-hub.com/study/132559-the-pipeline-for-drugs-for-control-and-elimination-of-neglected2026-10-19 https://evidence-hub.com/study/132560-in-vitro-profiling-of-trypanosoma-cruzi-inhibitors-identified-from2026-10-19 https://evidence-hub.com/study/132561-design-synthesis-and-biological-evaluation-of-2-phenylthiazole-cyp512026-10-19 https://evidence-hub.com/study/132562-cruzain-inhibitors-for-chagas-disease-anticorrelated-optimisation2026-10-19 https://evidence-hub.com/study/132563-association-of-torsade-de-pointes-and-qt-prolongation-with-antifungal2026-10-19 https://evidence-hub.com/study/132564-antifungal-drugs-for-the-treatment-of-invasive-fungal-infections-a2026-10-19 https://evidence-hub.com/study/132565-reconstructive-surgery-for-the-neglected-tropical-diseases-global2026-10-19 https://evidence-hub.com/study/132566-a-paradigm-shift-in-the-treatment-and-management-of-onychomycosis2026-10-19 https://evidence-hub.com/study/132567-new-regimens-of-benznidazole-for-the-treatment-of-chronic-chagas2026-10-19 https://evidence-hub.com/study/132568-drug-screening-and-development-cascade-for-chagas-disease-an-update2026-10-19 https://evidence-hub.com/study/132569-safety-and-efficacy-of-a-48-month-efinaconazole-10-solution-treatment2026-10-19 https://evidence-hub.com/study/132570-successful-treatment-of-lymphocutaneous-sporotrichosis-with2026-10-19 https://evidence-hub.com/study/132571-once-weekly-repurposed-fosravuconazole-versus-daily-itraconazole-with2026-10-19 https://evidence-hub.com/study/132572-treatment-of-fosravuconazole-for-tinea-ungium-of-toes-fingers-in2026-10-19 https://evidence-hub.com/study/132575-dermatophytoma-caused-by-terbinafine-resistant-trichophyton-rubrum2026-10-19 https://evidence-hub.com/study/132576-s4-5a-a-randomized-double-blind-phase-ii-proof-of-concept-superiority2026-10-19 https://evidence-hub.com/study/132577-successful-treatment-of-subcutaneous-purpureocillium-lilacinum2026-10-19 https://evidence-hub.com/study/132578-efficacy-and-safety-of-fosravuconazole-for-onychomycosis-in-elderly2026-10-19 https://evidence-hub.com/study/132579-tinea-capitis-caused-by-trichophyton-violaceum-successfully-treated2026-10-19 https://evidence-hub.com/study/132580-tinea-corporis-caused-by-terbinafine-resistant-trichophyton-rubrum2026-10-19 https://evidence-hub.com/study/132581-tinea-unguium-caused-by-terbinafine-resistant-trichophyton-rubrum2026-10-19 https://evidence-hub.com/study/132582-ungual-hyalohyphomycosis-caused-by-penicillium-citrinum-successfully2026-10-19 https://evidence-hub.com/study/132583-ungual-hyalohyphomycosis-caused-by-fusarium-proliferatum-successfully2026-10-19 https://evidence-hub.com/study/132584-case-of-onychomycosis-due-to-candida-tropicalis-successfully-treated2026-10-19 https://evidence-hub.com/study/132585-evaluation-of-the-new-oral-antifungal-agent-fosravuconazole-in2026-10-19 https://evidence-hub.com/study/132587-s4-5c-using-serum-beta-glucan-measurements-and-sequencing-of-the2026-10-19 https://evidence-hub.com/study/132588-s4-5d-comparing-the-diagnostic-performance-of-the-commonly-used2026-10-19 https://evidence-hub.com/study/132591-short-anagen-syndrome-a-unique-short-hair-syndrome-without-any2026-10-19 https://evidence-hub.com/study/132592-multiple-seborrheic-keratosis-like-lesions-of-mycosis-fungoides2026-10-19 https://evidence-hub.com/study/132594-antiprotozoal-drugs-challenges-and-opportunities2026-10-19 https://evidence-hub.com/study/132595-mycetoma-a-long-journey-from-neglect2026-10-19 https://evidence-hub.com/study/132596-an-atypical-case-of-cutaneous-candidiasis-caused-by-a-face-mask-with2026-10-19 https://evidence-hub.com/study/132598-advancing-drug-therapy-in-poverty-related-diseases2026-10-19 https://evidence-hub.com/study/132602-green-chemistry-approaches-in-the-analytical-validation-of2026-10-19 https://evidence-hub.com/study/132603-clinical-use-of-fosravuconazole-for-patients-with-onycomycosis-in-our2026-10-19 https://evidence-hub.com/study/132604-textbook-case-of-onychomycosis-caused-by-scopulariopsis-brevicaulis2026-10-19 https://evidence-hub.com/study/132605-correction-to-lancet-infect-dis-2021-21-1129-402026-10-19 https://evidence-hub.com/study/132608-molecular-docking-based-on-construction-of-4-a-sterol-demethylase2026-10-19 https://evidence-hub.com/study/132609-identifying-serum-amino-acid-as-biomarkers-of-gestational-diabetes2026-10-19 https://evidence-hub.com/study/132610-protein-content-and-amino-acid-composition-in-the-diet-of-danish2026-10-19 https://evidence-hub.com/study/132611-fecal-metabolomic-profiles-by-ldl-c-target-achievement-status-in2026-10-19 https://evidence-hub.com/study/132612-role-of-angiogenesis-and-endothelialmesenchymal-transition-in-bone2026-10-19 https://evidence-hub.com/study/132613-relations-of-advanced-glycation-endproducts-and-dicarbonyls-with2026-10-19 https://evidence-hub.com/study/132614-assessment-of-the-usefulness-of-red-cell-indices-as-a-screening-tool2026-10-19 https://evidence-hub.com/study/132615-deleting-titin-s-c-terminal-pevk-exons-increases-passive-stiffness2026-10-19 https://evidence-hub.com/study/132617-correlations-between-trimethylamine-n-oxide-megalin-lysine-and2026-10-19 https://evidence-hub.com/study/132618-plasma-advanced-glycation-products-are-associated-with-increased-risk2026-10-19 https://evidence-hub.com/study/132619-h3k18la-lactylation-promotes-cardiac-hypertrophy-through-activating2026-10-19 https://evidence-hub.com/study/132620-fluoride-exposure-disrupts-creatinine-homeostasis-and-undermines-the2026-10-19 https://evidence-hub.com/study/132621-association-between-advanced-glycation-end-products-and-depression2026-10-19 https://evidence-hub.com/study/132623-plasma-metabolomic-profiling-reveals-a-novel-circulating-biomarker2026-10-19 https://evidence-hub.com/study/132624-serum-carboxymethyl-lysine-a-dominant-advanced-glycation-end-product2026-10-19 https://evidence-hub.com/study/132625-amino-acid-intake-and-conformance-with-the-dietary-reference-intakes2026-10-19 https://evidence-hub.com/study/132626-the-relationships-between-plasma-advanced-glycation-end-products2026-10-19 https://evidence-hub.com/study/132627-associations-between-essential-amino-acid-intake-and-functional2026-10-19 https://evidence-hub.com/study/132628-identification-of-insulin-resistance-biomarkers-in-metabolic-syndrome2026-10-19 https://evidence-hub.com/study/132629-abnormalities-in-lysine-degradation-are-involved-in-early2026-10-19 https://evidence-hub.com/study/132630-novel-association-of-tm6sf2-rs58542926-genotype-with-increased-serum2026-10-19 https://evidence-hub.com/study/132631-association-of-p53-expression-with-clinicopathological-gradings-of2026-10-19 https://evidence-hub.com/study/132635-urea-cycle-and-arginine-metabolic-changes-in-covid-19-patients2026-10-19 https://evidence-hub.com/study/132636-abnormalities-in-lysine-degradation-are-involved-in-the-regulation-of2026-10-19 https://evidence-hub.com/study/132639-multi-omic-analysis-reveals-that-the-carns1-mediated-carnosine2026-10-19 https://evidence-hub.com/study/132642-habitual-sleep-quality-plasma-metabolites-and-risk-of-coronary-heart2026-10-19 https://evidence-hub.com/study/132644-1268-p-p-tau217-and-cognitive-function-in-long-duration-type-12026-10-19 https://evidence-hub.com/study/132646-metabolomic-investigation-of-blood-and-urinary-amino-acids-and2026-10-19 https://evidence-hub.com/study/132648-beneficial-effects-of-cod-protein-on-inflammatory-cell-accumulation2026-10-19 https://evidence-hub.com/study/132651-metabolism-and-global-protein-glycosylation-are-differentially2026-10-19 https://evidence-hub.com/study/132652-bilirubin-interference-in-plasma-amino-acid-analysis-by-ion-exchange2026-10-19 https://evidence-hub.com/study/132653-eating-right-for-a-healthier-heart-food-choice-contributes-to2026-10-19 https://evidence-hub.com/study/132654-prevalence-of-extended-spectrum-beta-lactamase-producing-bacteria2026-10-19 https://evidence-hub.com/study/132655-advanced-glycation-endproducts-and-dicarbonyls-in-end-stage-renal2026-10-19 https://evidence-hub.com/study/132656-advanced-glycation-end-products-and-their-circulating-receptors-and2026-10-19 https://evidence-hub.com/study/132661-serum-ages-in-black-south-african-patients-with-type-2-diabetes2026-10-19 https://evidence-hub.com/study/132662-increased-sow-nutrition-during-midgestation-affects-muscle-fiber2026-10-19 https://evidence-hub.com/study/132666-non-steroidal-mineralocorticoid-receptor-antagonist-finerenone2026-10-19 https://evidence-hub.com/study/132668-hemoglobin-genotypes-modulate-inflammatory-response-to-plasmodium2026-10-19 https://evidence-hub.com/study/132671-supramolecular-fluorophores-for-biological-studies-phenylene-vinylene2026-10-19 https://evidence-hub.com/study/132672-p0076homoarginine-associates-with-renal-and-cardiac-function-in-fabry2026-10-19 https://evidence-hub.com/study/132673-thwart-your-destiny-effect-of-nafld-genes-on-steatosis-liver-injury2026-10-19 https://evidence-hub.com/study/132678-a-lysine-based-2-1-aza-pseudopeptide-series-used-as-additives-in2026-10-19 https://evidence-hub.com/study/132681-mon-lb003-clinical-case-series-of-augmented-fertility-in-females2026-10-19 https://evidence-hub.com/study/132685-the-novel-t107i-inherited-prion-disease-can-present-as-a-clinical-and2026-10-19 https://evidence-hub.com/study/132688-chemical-and-biochemical-derivates-of-trans-3-methylglutaconyl-coa-a2026-10-19 https://evidence-hub.com/study/132689-exome-sequencing-identifies-frequent-mutation-of-the-swi-snf-complex2026-10-19 https://evidence-hub.com/study/132690-plaque-variant-trichoblastoma-an-unusually-aggressive-neoplasm2026-10-19 https://evidence-hub.com/study/132691-the-broad-spectrum-of-clinical-manifestations-observed-in-three2026-10-19 https://evidence-hub.com/study/132692-pyridoxine-dependent-epilepsy-in-zebrafish-caused-by-aldh7a12026-10-19 https://evidence-hub.com/study/132694-myxoid-glioneuronal-tumor-pdgfra-p-k385-mutant-clinical-radiologic2026-10-19 https://evidence-hub.com/study/132695-current-driven-organic-electrochemical-transistors-for-monitoring2026-10-19 https://evidence-hub.com/study/132697-protein-stabilization-and-the-hofmeister-effect-the-role-of2026-10-19 https://evidence-hub.com/study/132700-potent-non-hydroxamate-inhibitors-of-histone-deacetylase-8-role-and2026-10-19 https://evidence-hub.com/study/132701-thyroid-carcinomas-that-occur-in-familial-adenomatous-polyposis2026-10-19 https://evidence-hub.com/study/132702-na-independent-transport-of-basic-and-zwitterionic-amino-acids-in2026-10-19 https://evidence-hub.com/study/132704-theoretical-validation-of-in-chemico-skin-sensitization-assay-adra2026-10-19 https://evidence-hub.com/study/132707-clarification-of-ki67-expression-in-association-with-the-histological2026-10-19 https://evidence-hub.com/study/132708-facile-synthesis-of-multiamino-vinyl-poly-amino-acid-s-for-promising2026-10-19 https://evidence-hub.com/study/132713-acute-myeloid-leukaemia-with-maturation-demonstrates-persistent2026-10-19 https://evidence-hub.com/study/132714-dual-peptide-nucleic-acid-and-peptide-functionalized-shell2026-10-19 https://evidence-hub.com/study/132716-22026-10-19 https://evidence-hub.com/study/132719-anti-gq1b-igg-and-anti-gd1b-igg-positive-recurrent-miller-fisher2026-10-19 https://evidence-hub.com/study/132723-a-novel-tau-mutation-p-k317n-causes-globular-glial-tauopathy2026-10-19 https://evidence-hub.com/study/132727-role-of-immunohistochemical-markers-p53-and-ki-67-in-grading-of-glial2026-10-19 https://evidence-hub.com/study/132729-on-the-alkylation-of-amino-acid-residues-at-the-active-site-of2026-10-19 https://evidence-hub.com/study/132731-a-neonate-with-kluyvera-sepsis-a-case-report2026-10-19 https://evidence-hub.com/study/132735-trial-to-analyse-the-substrate-multiplicity-of-plasmin-by-using-a2026-10-19 https://evidence-hub.com/study/132757-l-lysine-in-herpesvirus-reactivation-after-chadox1-ncov-19-vaccine2026-10-19 https://evidence-hub.com/study/132758-l-lysine-therapy-to-control-the-clinical-evolution-of-pityriasis2026-10-19 https://evidence-hub.com/study/132759-accelerated-resolution-of-pacemaker-pocket-hematoma-with-adjunctive2026-10-19 https://evidence-hub.com/study/132760-actinic-hyperkeratosis-treated-with-retinol-combined-with-a2026-10-19 https://evidence-hub.com/study/132761-2585-life-threatening-hyperkalemia-and-metabolic-acidosis-after2026-10-19 https://evidence-hub.com/study/132762-case-report-adult-presentation-of-glutaric-aciduria-type-i2026-10-19 https://evidence-hub.com/study/132763-a-role-for-ehmt2-in-a-novel-autosomal-recessive-neurodevelopmental2026-10-19 https://evidence-hub.com/study/132764-enhanced-poly-l-lysine-production-in-streptomyces-albulus-through2026-10-19 https://evidence-hub.com/study/132765-ep762-ece-3163-variant-of-uncertain-significance-in-irs-2-gene-in2026-10-19 https://evidence-hub.com/study/132766-pityriasis-rosea-like-cutaneous-eruption-as-a-possible-dermatological2026-10-19 https://evidence-hub.com/study/132767-systematic-engineering-of-synechococcus-elongatus-utex-2973-for2026-10-19 https://evidence-hub.com/study/132768-unusual-aggregation-properties-of-single-amino-acid-l-lysine2026-10-19 https://evidence-hub.com/study/132769-structure-function-analyses-of-the-g729r-2-oxoadipate-dehydrogenase2026-10-19 https://evidence-hub.com/study/132774-case-report-of-a-63-year-old-patient-with-alzheimer-disease-and-a2026-10-19 https://evidence-hub.com/study/132777-transient-hyperkalemia-following-treatment-of-chronic-hypokalemia-a2026-10-19 https://evidence-hub.com/study/132778-metabolic-follow-up-of-a-croatian-patient-with-gyrate-atrophy-and-a2026-10-19 https://evidence-hub.com/study/132780-the-uptake-in-vitro-of-c14-labeled-glycine-l-leucine-and-l-lysine-by2026-10-19 https://evidence-hub.com/study/132781-a-novel-kmt2d-mutation-resulting-in-kabuki-syndrome-a-case-report2026-10-19 https://evidence-hub.com/study/132784-hypotrichosis-with-juvenile-macular-dystrophy-a-case-report-with2026-10-19 https://evidence-hub.com/study/132789-a-rare-genetic-disorder-caused-by-a-kat6b-mutation-phenotypic2026-10-19 https://evidence-hub.com/study/132791-sudden-hearing-loss-in-sickle-cell-disease-a-case-report2026-10-19 https://evidence-hub.com/study/132792-hemoglobin-agenogi-in-argentina-case-report2026-10-19 https://evidence-hub.com/study/132793-a-possible-ocular-biomarker-for-response-to-hyperornithinemia-in2026-10-19 https://evidence-hub.com/study/132797-influence-of-non-specific-surface-adhesion-on-the-shape-and2026-10-19 https://evidence-hub.com/study/132798-recognizing-and-treating-catatonia-in-kleefstra-syndrome2026-10-19 https://evidence-hub.com/study/132801-b64-45-from-local-to-systemic-ischemic-stroke-following-nebulized2026-10-19 https://evidence-hub.com/study/132802-multiple-endogenous-aldehydes-amplify-acetaminophen-induced-liver2026-10-19 https://evidence-hub.com/study/132803-atypical-variants-in-col1a1-and-col3a1-associated-with-classical-and2026-10-19 https://evidence-hub.com/study/132805-lactic-acidosis-rhabdomyolysis-and-hyperammonemia-atypical2026-10-19 https://evidence-hub.com/study/132806-abstract-or122-surf4-containing-classical-vesicles-mediate2026-10-19 https://evidence-hub.com/study/132807-generating-circularly-polarized-luminescence-from-clusterization2026-10-19 https://evidence-hub.com/study/132808-successful-nutritional-management-of-a-warmblood-horse-with-multiple2026-10-19 https://evidence-hub.com/study/132809-systematic-sequencing-of-renal-carcinoma-reveals-inactivation-of2026-10-19 https://evidence-hub.com/study/132810-1-3-4-oxadiazoles-as-inhibitors-of-the-atypical-member-of-the-bet2026-10-19 https://evidence-hub.com/study/132812-abstract-20-targeting-difficult-targets-with-lysine-covalent-ligands2026-10-19 https://evidence-hub.com/study/132813-site-specific-conjugation-of-the-indolinobenzodiazepine-dgn549-to2026-10-19 https://evidence-hub.com/study/132814-pitfalls-in-diagnosis-jmml-versus-kmt2a-rearranged-juvenile-aml2026-10-19 https://evidence-hub.com/study/132815-ziftomenib-in-combination-with-venetoclax-and-azacitidine-in-relapsed2026-10-19 https://evidence-hub.com/study/132816-b-378-mass-spectrometric-identification-of-tranexamic-acid-in2026-10-19 https://evidence-hub.com/study/132817-pdgfra-k385-mutants-in-myxoid-glioneuronal-tumors-promote-receptor2026-10-19 https://evidence-hub.com/study/132818-crystallographic-structure-of-a-small-molecule-sirt1-activator-enzyme2026-10-19 https://evidence-hub.com/study/132819-hyperornithinemia-hyperammonemia-homocitrullinuria-syndrome-in2026-10-19 https://evidence-hub.com/study/132823-quantification-of-tau-protein-lysine-methylation-in-aging-and2026-10-19 https://evidence-hub.com/study/132825-loss-of-histone-h3-trimethylation-on-lysine-27-and-nuclear-expression2026-10-19 https://evidence-hub.com/study/132829-detection-of-lisdexamfetamine-and-its-metabolite-d-amphetamine-in2026-10-19 https://evidence-hub.com/study/132831-eumycetoma-causative-agents-a-systematic-review-to-inform-the-world2026-10-19 https://evidence-hub.com/study/132832-benefits-and-harms-of-the-human-papillomavirus-hpv-vaccines2026-10-19 https://evidence-hub.com/study/132833-hepatectomy-followed-by-mfolfox6-versus-hepatectomy-alone-for-liver2026-10-19 https://evidence-hub.com/study/132834-robotic-versus-laparoscopic-ventral-hernia-repair-multicenter-blinded2026-10-19 https://evidence-hub.com/study/132835-cognitive-stimulation-program-in-mild-cognitive-impairment-a2026-10-19 https://evidence-hub.com/study/132836-individualized-home-based-exercise-and-nutrition-interventions2026-10-19 https://evidence-hub.com/study/132837-platelet-rich-plasma-versus-hyaluronic-acid-injections-for-the2026-10-19 https://evidence-hub.com/study/132838-prepare-presurgery-physiotherapy-for-patients-with-degenerative2026-10-19 https://evidence-hub.com/study/132839-a-phase-2-randomized-multicenter-placebo-controlled-proof-of-concept2026-10-19 https://evidence-hub.com/study/132840-emotional-awareness-and-expression-therapy-cognitive-behavioral2026-10-19 https://evidence-hub.com/study/132846-no-effect-of-digoxin-on-rosuvastatin-pharmacokinetics-in-healthy2026-10-19 https://evidence-hub.com/study/132847-broadening-the-spectrum-of-ivermectin-its-effect-on-trypanosoma-cruzi2026-10-19 https://evidence-hub.com/study/132848-cancer-mortality-after-low-dose-exposure-to-ionising-radiation-in2026-10-19 https://evidence-hub.com/study/132849-national-cohort-study-of-long-term-exposure-to-pm2-5-components-and2026-10-19 https://evidence-hub.com/study/132850-clinical-characteristics-and-predictors-of-human-mpox-outcome-during2026-10-19 https://evidence-hub.com/study/132851-associations-of-combined-phenotypic-ageing-and-genetic-risk-with2026-10-19 https://evidence-hub.com/study/132854-smoking-increases-the-risk-of-postoperative-wound-complications-a2026-10-19 https://evidence-hub.com/study/132855-use-of-whole-genome-sequencing-to-determine-genetic-basis-of2026-10-19 https://evidence-hub.com/study/132856-effects-of-a-major-deletion-in-the-sars-cov-2-genome-on-the-severity2026-10-19 https://evidence-hub.com/study/132857-digital-care-for-chronic-musculoskeletal-pain-10-000-participant2026-10-19 https://evidence-hub.com/study/132858-joint-association-of-urinary-sodium-and-potassium-excretion-with2026-10-19 https://evidence-hub.com/study/132859-breastfeeding-and-infections-in-early-childhood-a-cohort-study2026-10-19 https://evidence-hub.com/study/132860-dioxin-exposure-and-breast-cancer-risk-in-a-prospective-cohort-study2026-10-19 https://evidence-hub.com/study/132861-an-updated-list-of-eumycetoma-causative-agents-and-their-differences2026-10-19 https://evidence-hub.com/study/132862-nail-society-of-india-recommendations-for-treatment-of-onychomycosis2026-10-19 https://evidence-hub.com/study/132863-onychomycosis-caused-by-fusarium-species2026-10-19 https://evidence-hub.com/study/132864-clinical-features-of-mycetoma-and-the-appropriate-treatment-options2026-10-19 https://evidence-hub.com/study/132865-molecular-epidemiology-and-antifungal-susceptibility-of-trichophyton2026-10-19 https://evidence-hub.com/study/132866-mycetoma-a-common-yet-unrecognized-health-burden-in-central-india2026-10-19 https://evidence-hub.com/study/132867-mycetomas-an-epidemiological-etiological-clinical-laboratory-and2026-10-19 https://evidence-hub.com/study/132868-ungual-hyalohyphomycosis-caused-by-fusarium-cugenangense2026-10-19 https://evidence-hub.com/study/132869-system-based-insights-into-parasitological-and-clinical-treatment2026-10-19 https://evidence-hub.com/study/132870-a-review-of-antifungal-susceptibility-testing-for-dermatophyte-fungi2026-10-19 https://evidence-hub.com/study/132871-the-antifungal-potential-of-niclosamide-and-structurally-related2026-10-19 https://evidence-hub.com/study/132872-the-potential-role-and-mechanism-of-circrna-mirna-axis-in-cholesterol2026-10-19 https://evidence-hub.com/study/132873-chagas-disease-a-silent-threat-for-dogs-and-humans2026-10-19 https://evidence-hub.com/study/132874-mycetoma-development-of-diagnosis-and-treatment2026-10-19 https://evidence-hub.com/study/132875-aminopyridines-in-the-development-of-drug-candidates-against2026-10-19 https://evidence-hub.com/study/132876-antifungal-natural-products-originating-from-endophytic-and2026-10-19 https://evidence-hub.com/study/132877-potential-strategies-to-control-the-risk-of-antifungal-resistance-in2026-10-19 https://evidence-hub.com/study/132878-antifungal-resistance-in-dermatophytes-genetic-considerations2026-10-19 https://evidence-hub.com/study/132879-uncovering-the-mechanism-of-action-of-antiprotozoal-agents-a-survey2026-10-19 https://evidence-hub.com/study/132880-state-of-the-art-in-the-drug-discovery-pathway-for-chagas-disease-a2026-10-19 https://evidence-hub.com/study/132881-chagas-disease-perspectives-on-the-past-and-present-and-challenges-in2026-10-19 https://evidence-hub.com/study/132882-trypprotacs-unlocking-new-therapeutic-strategies-for-chagas-disease2026-10-19 https://evidence-hub.com/study/132883-discovery-development-inventions-and-patent-review-of-fexinidazole2026-10-19 https://evidence-hub.com/study/132884-skin-disease-in-the-tropics-and-the-lessons-that-can-be-learned-from2026-10-19 https://evidence-hub.com/study/132885-antifungal-activity-and-mechanism-of-action-of-natural-product2026-10-19 https://evidence-hub.com/study/132886-plant-terpenoids-as-hit-compounds-against-trypanosomiasis2026-10-19 https://evidence-hub.com/study/132887-anti-trypanosomatid-drug-discovery-progress-and-challenges2026-10-19 https://evidence-hub.com/study/132888-anti-trypanosomatid-drug-discovery-an-ongoing-challenge-and-a2026-10-19 https://evidence-hub.com/study/132889-new-antifungal-agents-with-azole-moieties2026-10-19 https://evidence-hub.com/study/132890-novel-1-2-4-triazoles-as-antifungal-agents2026-10-19 https://evidence-hub.com/study/132891-proposed-multidimensional-framework-for-understanding-chagas-disease2026-10-19 https://evidence-hub.com/study/132892-further-investigations-of-nitroheterocyclic-compounds-as-potential2026-10-19 https://evidence-hub.com/study/132893-challenges-and-recent-progress-in-drug-discovery-for-tropical-diseases2026-10-19 https://evidence-hub.com/study/132894-phaeohyphomycosis-in-china2026-10-19 https://evidence-hub.com/study/132895-onychomycosis-an-updated-review2026-10-19 https://evidence-hub.com/study/132896-experimental-and-clinical-treatment-of-chagas-disease-a-review2026-10-19 https://evidence-hub.com/study/132897-whf-iasc-roadmap-on-chagas-disease2026-10-19 https://evidence-hub.com/study/132898-ring-of-fire-the-global-rise-of-drug-resistant-ringworm-and-the-race2026-10-19 https://evidence-hub.com/study/132899-nail-dystrophy-caused-by-infectious-skin-diseases-a-narrative-review2026-10-19 https://evidence-hub.com/study/132900-fungal-melanonychia-a-systematic-review2026-10-19 https://evidence-hub.com/study/132901-use-of-benznidazole-to-treat-chronic-chagas-disease-an-updated2026-10-19 https://evidence-hub.com/study/132902-screening-for-trypanosoma-cruzi-infection-in-immigrants-and-refugees2026-10-19 https://evidence-hub.com/study/132903-impact-of-antiparasitic-therapy-on-cardiovascular-outcomes-in-chronic2026-10-19 https://evidence-hub.com/study/132905-pyrazoline-based-molecules-in-antimicrobial-research-a-systematic2026-10-19 https://evidence-hub.com/study/132906-tinea-capitis-in-older-adults-a-neglected-and-misdiagnosed-scalp2026-10-19 https://evidence-hub.com/study/132907-combating-multidrug-resistant-acinetobacter-baumannii-insights-from2026-10-19 https://evidence-hub.com/study/132908-why-the-mycetoma-patients-are-still-neglected2026-10-19 https://evidence-hub.com/study/132909-population-pharmacokinetic-modeling-of-benznidazole-in-brazilian2026-10-19 https://evidence-hub.com/study/132910-what-can-imaging-do-for-mycetoma-in-an-immunocompetent-patient-in2026-10-19 https://evidence-hub.com/study/132912-distribution-and-antifungal-susceptibility-profiles-of-candida2026-10-19 https://evidence-hub.com/study/132913-in-vitro-ravuconazole-susceptibility-of-anthropophilic-dermatophyte2026-10-19 https://evidence-hub.com/study/132914-parasitemia-and-antibody-response-to-benznidazole-treatment-in-a2026-10-19 https://evidence-hub.com/study/132915-assessing-antibody-decline-after-chemotherapy-of-early-chronic-chagas2026-10-19 https://evidence-hub.com/study/132916-case-report-reactivation-of-chagas-disease-in-a-patient-with-advanced2026-10-19 https://evidence-hub.com/study/132917-antifungal-susceptibility-pattern-of-candida-isolated-from-cutaneous2026-10-19 https://evidence-hub.com/study/132918-epidemiology-clinical-features-and-outcome-of-the-hospitalized2026-10-19 https://evidence-hub.com/study/132921-topical-antifungal-therapy-combined-with-nail-abrasion-for-the2026-10-19 https://evidence-hub.com/study/132922-s5-1b-antifungal-r-esistance2026-10-19 https://evidence-hub.com/study/132923-global-health-initiatives-and-mycetoma-management-the-unmet-promise2026-10-19 https://evidence-hub.com/study/132924-p4-covid19-associated-fungal-infections2026-10-19 https://evidence-hub.com/study/132925-pharmacokinetic-pharmacodynamic-modeling-of-benznidazole-and-its2026-10-19 https://evidence-hub.com/study/132926-treatment-with-benznidazole-and-pentoxifylline-regulates-microrna2026-10-19 https://evidence-hub.com/study/132927-antitrypanosomal-activity-of-1-2-3-triazole-based-hybrids-evaluated2026-10-19 https://evidence-hub.com/study/132928-iid432-a-parasite-selective-topoisomerase-ii-inhibitor-achieves-rapid2026-10-19 https://evidence-hub.com/study/132929-bioactivity-of-novel-pyrazole-thiazolines-scaffolds-against2026-10-19 https://evidence-hub.com/study/132930-in-vitro-susceptibility-testing-for-black-grain-eumycetoma-causative2026-10-19 https://evidence-hub.com/study/132931-short-course-combination-treatment-for-experimental-chronic-chagas2026-10-19 https://evidence-hub.com/study/132932-amiodarone-and-ravuconazole-combination-potentiates-chemotherapy2026-10-19 https://evidence-hub.com/study/132933-antifungal-combinations-against-candida-species-from-bench-to-bedside2026-10-19 https://evidence-hub.com/study/132934-hit-to-lead-optimization-of-a-2-aminobenzimidazole-series-as-new2026-10-19 https://evidence-hub.com/study/132935-precision-health-for-chagas-disease-integrating-parasite-and-host2026-10-19 https://evidence-hub.com/study/132936-a-profile-of-research-on-the-parasitic-trypanosomatids-and-the2026-10-19 https://evidence-hub.com/study/132937-screening-of-synthetic-1-2-3-triazolic-compounds-inspired-by-srpin3402026-10-19 https://evidence-hub.com/study/132938-benznidazole-treatment-time-and-dose-dependence-varies-with-the2026-10-19 https://evidence-hub.com/study/132939-localized-cardiac-small-molecule-trajectories-and-persistent-chemical2026-10-19 https://evidence-hub.com/study/132940-the-nairobi-declaration-2023-a-commitment-to-address-deadly-yet2026-10-19 https://evidence-hub.com/study/132941-perspectives-for-a-new-drug-candidate-for-chagas-disease-therapy2026-10-19 https://evidence-hub.com/study/132942-mechanisms-of-resistance-against-allylamine-and-azole-antifungals-in2026-10-19 https://evidence-hub.com/study/132943-leishmaniasis-and-chagas-disease-is-there-hope-in-nanotechnology-to2026-10-19 https://evidence-hub.com/study/132944-preclinical-data-do-not-support-the-use-of-amiodarone-or-dronedarone2026-10-19 https://evidence-hub.com/study/132945-pyrazole-imidazoline-derivative-prevents-cardiac-damage-and-mortality2026-10-19 https://evidence-hub.com/study/132946-comparing-in-vivo-bioluminescence-imaging-and-the-multi-cruzi2026-10-19 https://evidence-hub.com/study/132947-advancing-topical-posaconazole-delivery-box-behnken-design2026-10-19 https://evidence-hub.com/study/132948-solid-nanomedicines-of-nifurtimox-and-benznidazole-for-the-oral2026-10-19 https://evidence-hub.com/study/132949-the-translational-challenge-in-chagas-disease-drug-development2026-10-19 https://evidence-hub.com/study/132950-sandalwood-sesquiterpene-z-santalol-exhibits-in-vivo-efficacy-against2026-10-19 https://evidence-hub.com/study/132951-structure-guided-design-and-synthesis-of-a-pyridazinone-series-of2026-10-19 https://evidence-hub.com/study/132952-drug-repurposing-for-chagas-disease-in-vitro-assessment-of-nimesulide2026-10-19 https://evidence-hub.com/study/132953-chagas-disease-drug-discovery-in-latin-america-a-mini-review-of2026-10-19 https://evidence-hub.com/study/132954-possibility-of-re-purposing-antifungal-drugs-posaconazole2026-10-19 https://evidence-hub.com/study/132955-fungi-s-swiss-army-knife-pleiotropic-effect-of-melanin-in-fungal2026-10-19 https://evidence-hub.com/study/132957-enteric-nervous-system-regeneration-and-functional-cure-of2026-10-19 https://evidence-hub.com/study/132958-chagas-disease-from-discovery-to-a-worldwide-health-problem2026-10-19 https://evidence-hub.com/study/132959-metabolomic-profiling-for-the-identification-of-drug-targets-in2026-10-19 https://evidence-hub.com/study/132960-in-silico-in-vitro-and-pharmacokinetic-studies-of-ubmc-4-a-potential2026-10-19 https://evidence-hub.com/study/132961-intra-host-trypanosoma-cruzi-strain-dynamics-shape-disease2026-10-19 https://evidence-hub.com/study/132962-synthesis-and-anti-trypanosoma-cruzi-activity-of-3-cyanopyridine2026-10-19 https://evidence-hub.com/study/132963-tropical-infectious-diseases-and-the-skin-diagnostic-and-treatment2026-10-19 https://evidence-hub.com/study/132964-new-therapeutics-for-chagas-disease-charting-a-course-to-drug-approval2026-10-19 https://evidence-hub.com/study/132965-a-novel-hyphal-suspension-approach-for-mic-testing-of-mould-fungi2026-10-19 https://evidence-hub.com/study/132966-the-escalating-specter-of-antifungal-resistance-in-superficial-mycoses2026-10-19 https://evidence-hub.com/study/132967-new-global-targets-for-ntds-in-the-who-roadmap-2021-20302026-10-19 https://evidence-hub.com/study/132968-chagas-disease-comparison-of-therapy-with-nifurtimox-and-benznidazole2026-10-19 https://evidence-hub.com/study/132969-candida-glabrata-produces-a-melanin-like-pigment-that-protects2026-10-19 https://evidence-hub.com/study/132970-new-anti-parasitic-agents-trends-and-trials2026-10-19 https://evidence-hub.com/study/132974-benznidazole-anti-inflammatory-effects-in-murine-cardiomyocytes-and2026-10-19 https://evidence-hub.com/study/132975-benznidazole-treatment-leads-to-dna-damage-in-trypanosoma-cruzi-and2026-10-19 https://evidence-hub.com/study/132976-lippia-origanoides-essential-oil-or-thymol-in-combination-with2026-10-19 https://evidence-hub.com/study/132977-t-cell-specificity-a-great-challenge-in-chagas-disease2026-10-19 https://evidence-hub.com/study/132978-efficacy-and-safety-of-chagas-disease-drug-therapy-and-treatment2026-10-19 https://evidence-hub.com/study/132979-design-and-feasibility-of-an-implementation-strategy-to-address2026-10-19 https://evidence-hub.com/study/132980-trypanocidal-treatment-for-chronic-chagas-disease-past-present-and2026-10-19 https://evidence-hub.com/study/132981-assessment-and-management-of-chagas-disease-a-comprehensive-analysis2026-10-19 https://evidence-hub.com/study/132982-challenges-in-chagas-disease-drug-development2026-10-19 https://evidence-hub.com/study/132983-trypanosoma-cruzi-persisters-that-survive-benznidazole-treatment-in2026-10-19 https://evidence-hub.com/study/132984-identifying-novel-drugs-with-new-modes-of-action-for-neglected2026-10-19 https://evidence-hub.com/study/132985-optimization-of-1-4-naphthoquinone-hit-compound-a-computational2026-10-19 https://evidence-hub.com/study/132986-antifungal-pharmacokinetics-pharmacodynamics2026-10-19 https://evidence-hub.com/study/132987-neglected-tropical-diseases-ntd-in-worldwide-and-its-significance-in2026-10-19 https://evidence-hub.com/study/132988-treatments-and-the-perspectives-of-developing-a-vaccine-for-chagas2026-10-19 https://evidence-hub.com/study/132989-synthesis-and-anti-trypanosoma-cruzi-activity-of-new-pyrazole2026-10-19 https://evidence-hub.com/study/132990-sandalwood-oils-of-different-origins-are-active-in-vitro-against2026-10-19 https://evidence-hub.com/study/132991-structure-activity-relationships-of-1-5-dihydro-2h-benzo-b-1-42026-10-19 https://evidence-hub.com/study/132992-superior-anticancer-and-antifungal-activities-of-new-sulfanyl2026-10-19 https://evidence-hub.com/study/132993-the-combination-of-manogepix-and-itraconazole-is-synergistic-and2026-10-19 https://evidence-hub.com/study/132994-in-vitro-and-in-vivo-study-of-a-photostable-quinone-compound-with2026-10-19 https://evidence-hub.com/study/132995-optimization-of-an-in-vitro-drug-screening-assay-for-anti-trypanosoma2026-10-19 https://evidence-hub.com/study/132996-design-synthesis-and-trypanosomicidal-evaluation-of-eugenol-based2026-10-19 https://evidence-hub.com/study/132997-constant-voltage-iontophoresis-technique-to-deliver-terbinafine-via2026-10-19 https://evidence-hub.com/study/132998-antifungal-susceptibility-testing-for-microsporum-canis-from-cats-in2026-10-19 https://evidence-hub.com/study/132999-structural-optimization-and-biological-activity-of-pyrazole2026-10-19 https://evidence-hub.com/study/133000-exploring-the-antifungal-effectiveness-of-a-topical-innovative2026-10-19 https://evidence-hub.com/study/133001-atualizacao-da-esporotricose-felina-na-perspectiva-da-saude-unica2026-10-19 https://evidence-hub.com/study/133003-rapid-molecular-detection-of-terbinafine-resistant-dermatophytes2026-10-19 https://evidence-hub.com/study/133004-editorial-drug-discovery-for-leishmaniasis-and-chagas-disease2026-10-19 https://evidence-hub.com/study/133005-synthesis-electrochemical-properties-and-antioxidant-activity-of2026-10-19 https://evidence-hub.com/study/133006-challenges-and-opportunities-with-drug-repurposing-finding-strategies2026-10-19 https://evidence-hub.com/study/133007-potential-of-sulfur-selenium-isosteric-replacement-as-a-strategy-for2026-10-19 https://evidence-hub.com/study/133010-topical-efinaconazole-a-sequential-combination-therapy-with-oral2026-10-19 https://evidence-hub.com/study/133011-qbd-guided-formulation-and-evaluation-of-clove-oil-based2026-10-19 https://evidence-hub.com/study/133012-s5-1d-mechanisms-of-azole-antifungal-resistance-in-clinical-isolates2026-10-19 https://evidence-hub.com/study/133013-kinome-analysis-of-madurella-mycetomatis-identified-kinases-in-the2026-10-19 https://evidence-hub.com/study/133014-identification-of-microbial-based-natural-products-as-potential-cyp512026-10-19 https://evidence-hub.com/study/133015-part-a-ai-designed-protein-binders-tackle-a-century-old-challenge2026-10-19 https://evidence-hub.com/study/133018-transcriptomic-analysis-of-benznidazole-resistant-trypanosoma-cruzi2026-10-19 https://evidence-hub.com/study/133019-drug-repurposing-an-overview2026-10-19 https://evidence-hub.com/study/133021-repositioning-drug-strategy-against-trypanosoma-cruzi-lessons-learned2026-10-19 https://evidence-hub.com/study/133022-flavonoid-rich-albizia-niopoides-leaf-extract-shows-anti-trypanosoma2026-10-19 https://evidence-hub.com/study/133023-role-of-medicinal-plants-in-the-treatment-of-eumycetoma-a-review2026-10-19 https://evidence-hub.com/study/133024-translational-research-on-chagas-disease-focusing-on-drug-combination2026-10-19 https://evidence-hub.com/study/133025-development-of-novel-drugs-for-the-treatment-of-chagas-disease2026-10-19 https://evidence-hub.com/study/133026-parasite-compartments-and-molecules-trick-versus-treatment-on-chagas2026-10-19 https://evidence-hub.com/study/133027-sintese-e-avaliacao-da-atividade-tripanocida-e-leishmanicida-de-novos2026-10-19 https://evidence-hub.com/study/133028-treatment-with-suboptimal-dose-of-benznidazole-mitigates-immune2026-10-19 https://evidence-hub.com/study/133030-trypanosoma-cruzi-kdna-minicircle-sequences-integration-into-the2026-10-19 https://evidence-hub.com/study/133031-correlation-between-gut-bacteria-phascolarctobacterium-and-exogenous2026-10-19 https://evidence-hub.com/study/133032-a-pilot-case-control-study-on-the-association-between-n-acetyl2026-10-19 https://evidence-hub.com/study/133037-control-mechanisms-operative-in-a-natural-microbial-population2026-10-19 https://evidence-hub.com/study/133038-effect-of-alkali-chlorides-on-human-chromosomes-studied-by-the-method2026-10-19 https://evidence-hub.com/study/133040-enzyme-responsive-intracellular-controlled-release-using-silica2026-10-19 https://evidence-hub.com/study/133041-case-control-study-of-an-acute-aflatoxicosis-outbreak-kenya-20042026-10-19 https://evidence-hub.com/study/133042-a-study-of-the-passive-transfer-of-delayed-hypersensitivity-to-dnp2026-10-19 https://evidence-hub.com/study/133045-implications-of-supplementing-mid-lactation-multiparous-holstein-cows2026-10-19 https://evidence-hub.com/study/133046-regiocontrol-of-the-bulk-polymerization-of-lysine-ethyl-ester-by-the2026-10-19 https://evidence-hub.com/study/133048-short-chain-fatty-acids-propionate-and-butyrate-control-growth-and2026-10-19 https://evidence-hub.com/study/133049-phase-engineering-of-1t-mos2-via-organic-enwrapment2026-10-19 https://evidence-hub.com/study/133050-highly-adhesive-asynchronous-drug-releasing-membrane-for-facial-care2026-10-19 https://evidence-hub.com/study/133051-antiplasmodial-activity-of-pentyloxyamide-based-histone-deacetylase2026-10-19 https://evidence-hub.com/study/133053-beneficial-outcome-of-early-dietary-lysine-restriction-as-an-adjunct2026-10-19 https://evidence-hub.com/study/133054-characterising-the-leukaemic-microenvironment-in-a-mouse-model-of2026-10-19 https://evidence-hub.com/study/133055-viruses-and-amino-acids-in-pandemics-and-epidemics2026-10-19 https://evidence-hub.com/study/133056-association-of-aflatoxin-and-gallbladder-cancer2026-10-19 https://evidence-hub.com/study/133057-dimorphic-mechanisms-of-fragility-in-diabetes-mellitus-the-role-of2026-10-19 https://evidence-hub.com/study/133058-progress-in-the-development-of-an-advax-adjuvanted-protein-capsular2026-10-19 https://evidence-hub.com/study/133061-gold-nanoflower-for-selective-detection-of-single-arginine-effect-in2026-10-19 https://evidence-hub.com/study/133062-maternal-serum-amino-acid-levels-as-predictors-of-premature-rupture2026-10-19 https://evidence-hub.com/study/133063-identification-of-tecovirimat-resistance-associated-mutations-in2026-10-19 https://evidence-hub.com/study/133065-plasma-metabolomics-study-of-vogt-koyanagi-harada-disease-identifies2026-10-19 https://evidence-hub.com/study/133066-fish-and-bovine-collagen-promote-higher-migration-and-adhesion-of2026-10-19 https://evidence-hub.com/study/133067-synaptic-transcriptional-and-chromatin-genes-disrupted-in-autism2026-10-19 https://evidence-hub.com/study/133068-tet2-binds-the-androgen-receptor-and-loss-is-associated-with-prostate2026-10-19 https://evidence-hub.com/study/133071-new-cav1-2-channelopathy-with-high-functioning-autism-affective2026-10-19 https://evidence-hub.com/study/133072-increased-risk-of-rheumatoid-arthritis-among-mothers-with-children2026-10-19 https://evidence-hub.com/study/133073-resolution-of-the-council-of-experts-on-the-treatment-of2026-10-19 https://evidence-hub.com/study/133074-molecular-profiling-of-pediatric-and-young-adult-colorectal-cancer2026-10-19 https://evidence-hub.com/study/133077-gene-silencing-by-gold-nanoshell-mediated-delivery-and-laser2026-10-19 https://evidence-hub.com/study/133079-the-evolving-role-of-ubiquitin-modification-in-endoplasmic-reticulum2026-10-19 https://evidence-hub.com/study/133080-the-fusarium-graminearum-histone-h3-k27-methyltransferase-kmt62026-10-19 https://evidence-hub.com/study/133084-self-assembly-of-gold-nanoparticles-with-oppositely-charged-long2026-10-19 https://evidence-hub.com/study/133085-associations-of-genetic-polymorphisms-of-mtor-rs2295080-t-g-and2026-10-19 https://evidence-hub.com/study/133089-hyperbranched-poly-l-lysine-modified-titanium-surface-with-enhanced2026-10-19 https://evidence-hub.com/study/133092-single-dose-l-lysine-induced-pancreatitis-followed-by-pancreatic2026-10-19 https://evidence-hub.com/study/133093-therapeutic-effects-of-l-lysine-in-dahl-ss-rats-a-model-of-salt2026-10-19 https://evidence-hub.com/study/133094-drug-releasing-thermogel-for-osteoarthritis-induction-in-an-animal2026-10-19 https://evidence-hub.com/study/133095-poly-l-lysine-based-gal-glycoconjugates-for-treating-anti-gal-ige2026-10-19 https://evidence-hub.com/study/133096-red-propolis-and-l-lysine-on-angiogenesis-and-tumor-growth-in-a-new2026-10-19 https://evidence-hub.com/study/133097-photoactive-poly-l-lysine-gel-with-resveratrol-magnesium-metal2026-10-19 https://evidence-hub.com/study/133098-arginine-metabolism-and-nitric-oxide-turnover-in-the-zsf1-animal2026-10-19 https://evidence-hub.com/study/133099-dietary-l-lysine-requirement-of-coho-salmon-oncorhynchus-kisutch2026-10-19 https://evidence-hub.com/study/133101-anti-adhesive-effect-of-chondrocyte-derived-extracellular-matrix2026-10-19 https://evidence-hub.com/study/133102-l-lysine-confers-neuroprotection-by-suppressing-inflammatory-response2026-10-19 https://evidence-hub.com/study/133103-l-lysine-production-improvement-a-review-of-the-state-of-the-art-and2026-10-19 https://evidence-hub.com/study/133105-gold-nanoparticle-bioconjugated-aminoguanidine-inhibits-glycation2026-10-19 https://evidence-hub.com/study/133106-l-lysine-as-the-molecule-influencing-selective-brain-activity-in-pain2026-10-19 https://evidence-hub.com/study/133107-carcinogenesis-in-rats-subjected-to-a-new-model-ureterosigmoidostomy2026-10-19 https://evidence-hub.com/study/133108-hollow-alginate-poly-l-lysine-alginate-microspheres-promoted-an2026-10-19 https://evidence-hub.com/study/133109-preclinical-characterization-of-alginate-poly-l-lysine-encapsulated2026-10-19 https://evidence-hub.com/study/133111-the-combination-of-l-lysine-and-alloxan-induces-acute-necrotizing2026-10-19 https://evidence-hub.com/study/133116-treatment-of-pseudomonas-aeruginosa-biofilm-present-in-endotracheal2026-10-19 https://evidence-hub.com/study/133118-advanced-glycation-endproducts-are-increased-in-the-animal-model-of2026-10-19 https://evidence-hub.com/study/133120-potential-role-of-lsd1-inhibitors-in-the-treatment-of-sickle-cell2026-10-19 https://evidence-hub.com/study/133123-a-comprehensive-review-on-lysine-biochemical-properties-and-health2026-10-19 https://evidence-hub.com/study/133124-the-optimal-isoleucine-to-lysine-ratio-in-diets-for-postweaning2026-10-19 https://evidence-hub.com/study/133131-effect-of-l-lysine-on-nitric-oxide-production-in-ovine-endotoxaemia2026-10-19 https://evidence-hub.com/study/133134-does-poly-l-lysine-coating-of-the-middle-cerebral-artery-occlusion2026-10-19 https://evidence-hub.com/study/133136-the-suppression-of-prion-propagation-using-poly-l-lysine-by-targeting2026-10-19 https://evidence-hub.com/study/133139-maternal-immune-activation-alters-placental-histone-3-lysine-9-tri2026-10-19 https://evidence-hub.com/study/133140-glycated-bovine-serum-albumin-for-use-in-feeding-trials-with-animal2026-10-19 https://evidence-hub.com/study/133142-profile-of-urinary-amino-acids-and-their-post-translational2026-10-19 https://evidence-hub.com/study/133143-effect-of-supplementing-rumen-protected-methionine-lysine-and2026-10-19 https://evidence-hub.com/study/133144-biodegradable-lysine-derived-polyurethane-scaffolds-promote-healing2026-10-19 https://evidence-hub.com/study/133145-antibiotic-resistant-desulfovibrio-produces-h2s-from-supplements-for2026-10-19 https://evidence-hub.com/study/133146-intestinal-epithelial-dopamine-receptor-signaling-drives-sex-specific2026-10-19 https://evidence-hub.com/study/133149-evaluating-a-precision-feeding-decision-support-system-for-improving2026-10-19 https://evidence-hub.com/study/133150-inhibiting-with-no-lysine-kinases-enhances-k-cl-cotransporter-22026-10-19 https://evidence-hub.com/study/133151-new-applications-of-sustainable-scalable-standardized-and-cost2026-10-19 https://evidence-hub.com/study/133152-a-novel-biochemically-salvageable-animal-model-of-hyperammonemia2026-10-19 https://evidence-hub.com/study/133153-rapid-whole-mount-high-resolution-imaging-of-small-animal-vasculature2026-10-19 https://evidence-hub.com/study/133154-effect-of-dietary-amino-acids-l-arginine-and-lysine-on-implant2026-10-19 https://evidence-hub.com/study/133155-symbiotic-probiotic-communities-with-multiple-targets-successfully2026-10-19 https://evidence-hub.com/study/133156-intranasal-delivery-of-hydrophobic-ac5216-loaded-nanoemulsion-into2026-10-19 https://evidence-hub.com/study/133158-glatiramer-acetate-for-the-treatment-of-multiple-sclerosis-from-first2026-10-19 https://evidence-hub.com/study/133159-comparative-analysis-of-surface-coatings-for-human-neural-co-cultures2026-10-19 https://evidence-hub.com/study/133160-the-optimal-valine-to-lysine-ratio-for-performance-parameters-in2026-10-19 https://evidence-hub.com/study/133161-preclinical-evaluation-of-a-bioartificial-kidney-loaded-with2026-10-19 https://evidence-hub.com/study/133162-an-evidence-based-biomarker-framework-for-n-hexane-induced-neuropathy2026-10-19 https://evidence-hub.com/study/133163-evaluation-of-pda-pll-nanoparticles-for-sirna-delivery-and-ros2026-10-19 https://evidence-hub.com/study/133164-a-quaternary-ammonium-based-nanosystem-enables-delivery-of-crispr2026-10-19 https://evidence-hub.com/study/133165-safety-and-efficacy-of-approved-and-unapproved-peptide-therapies-for2026-10-19 https://evidence-hub.com/study/133166-high-glucose-induced-mitochondrial-fission-drives-pancreatic-cancer2026-10-19 https://evidence-hub.com/study/133170-the-tri-peptide-ghk-cu-complex-ameliorates-lipopolysaccharide-induced2026-10-19 https://evidence-hub.com/study/133171-trip12-ubiquitination-of-glucocerebrosidase-contributes-to2026-10-19 https://evidence-hub.com/study/133172-the-c-terminus-of-p53-binds-the-n-terminal-domain-of-mdm22026-10-19 https://evidence-hub.com/study/133179-a-review-on-therapeutic-effects-of-l-carnitine-an-update2026-10-19 https://evidence-hub.com/study/1331812026-10-19 https://evidence-hub.com/study/133183-in-response-not-all-acute-normovolemic-hemodilutions-are-created-equal2026-10-19 https://evidence-hub.com/study/133195-phase-1-trial-of-seclidemstat-sp-2577-in-patients-with-relapsed2026-10-19 https://evidence-hub.com/study/133196-phase-1-expansion-trial-of-the-lsd1-inhibitor-seclidemstat-sp-25772026-10-19 https://evidence-hub.com/study/133197-an-acetylated-tau-174-csf-biomarker-discriminates-between-tdp-43-and2026-10-19 https://evidence-hub.com/study/133198-epigenetic-profiling-identifies-markers-of-endocrine-resistance-and2026-10-19 https://evidence-hub.com/study/133199-abstract-334-propbd-adcs-optimization-of-therapeutic-potential-of2026-10-19 https://evidence-hub.com/study/133200-abstract-3217-discovery-of-novel-inhibitors-of-the-epigenetic2026-10-19 https://evidence-hub.com/study/133202-ryz101-225-ac-dotatate-in-patients-with-estrogen-receptor-positive2026-10-19 https://evidence-hub.com/study/133207-dot1l-a-key-target-in-normal-chromatin-remodelling-and-in-mixed2026-10-19 https://evidence-hub.com/study/133208-shorespan-007-phase-3-study-of-bomedemstat-versus-hydroxyurea-in2026-10-19 https://evidence-hub.com/study/133210-phase-1-1b-study-of-direct-intratumoral-injection-of-pleural2026-10-19 https://evidence-hub.com/study/133211-identification-of-a-novel-biomarker-for-pyridoxine-dependent-epilepsy2026-10-19 https://evidence-hub.com/study/133213-autx703-a-novel-and-potent-kat2a-and-kat2b-protein-degrader-induces2026-10-19 https://evidence-hub.com/study/133216-a-phase-3-randomized-double-blind-active-comparator-controlled-study2026-10-19 https://evidence-hub.com/study/133221-compound-loss-of-dnmt3a-and-kmt2c-in-myeloid-malignancies2026-10-19 https://evidence-hub.com/study/133223-suv39h1-represses-the-progression-of-mll-rearranged-myeloid-leukemia2026-10-19 https://evidence-hub.com/study/133227-abstract-1973-patients-with-operable-esophageal-cancer-and-improved2026-10-19 https://evidence-hub.com/study/133229-phase-2-trial-of-lu-177-dotatate-in-inoperable-pheochromocytoma2026-10-19 https://evidence-hub.com/study/133236-abnormal-fibrinolysis-recognized-by-thromboelastography-in-a-case-of2026-10-19 https://evidence-hub.com/study/133249-abstract-ct109-a-phase-i-dose-escalation-and-expansion-study-of2026-10-19 https://evidence-hub.com/study/133253-diffuse-hemispheric-glioma-h3-g34-mutant-genomic-landscape-of-a-new2026-10-19 https://evidence-hub.com/study/133255-protein-carbamylation-in-chronic-systolic-heart-failure-relation-to2026-10-19 https://evidence-hub.com/study/133261-identification-of-the-epigenetic-reader-cbx2-as-a-potential-drug2026-10-19 https://evidence-hub.com/study/133262-occurrence-of-b-cell-lymphomas-in-patients-with-activated2026-10-19 https://evidence-hub.com/study/133263-hypochloremia-and-diuretic-resistance-in-heart-failure-mechanistic2026-10-19 https://evidence-hub.com/study/133264-surface-area-of-detachment-proliferative-vitreoretinopathy-and-pulse2026-10-19 https://evidence-hub.com/study/133265-bruton-s-tyrosine-kinase-btk-is-a-novel-kmt2a-partner-gene2026-10-19 https://evidence-hub.com/study/133266-genetic-basis-of-hyperlysinemia2026-10-19 https://evidence-hub.com/study/133267-tumor-confirmed-follicular-lymphoma-mutations-are-detectable-in2026-10-19 https://evidence-hub.com/study/133271-genomic-analysis-of-oesophageal-carcinoma-ec-to-identify-recurrent2026-10-19 https://evidence-hub.com/study/133272-evaluation-of-metabolic-profile-in-monoclonal-gammopathy-of2026-10-19 https://evidence-hub.com/study/133275-comparison-of-er-pr-her2-neu-c-erb-b2-reactivity-pattern-with-various2026-10-19 https://evidence-hub.com/study/133276-serum-untargeted-metabolomics-reveal-potential-biomarkers-of2026-10-19 https://evidence-hub.com/study/133277-alterations-in-serum-amino-acid-profiles-in-children-with-attention2026-10-19 https://evidence-hub.com/study/133279-same-product-different-regulatory-approach-around-the-world2026-10-19 https://evidence-hub.com/study/133282-plasma-free-amino-acid-profile-in-hiv-positive-cases2026-10-19 https://evidence-hub.com/study/133283-chronic-cerebrovascular-disease-the-role-of-venous-disorders-and-the2026-10-19 https://evidence-hub.com/study/133284-equine-enteric-glial-culture-and-application-to-the-study-of-a-neural2026-10-19 https://evidence-hub.com/study/133285-serum-levels-of-advanced-glycation-end-products-ages-and-the-decoy2026-10-19 https://evidence-hub.com/study/133287-urine-nmr-metabolomics-for-precision-oncology-in-colorectal-cancer2026-10-19 https://evidence-hub.com/study/133288-evaluation-of-oxidative-stress-effects-on-different-macromolecules-in2026-10-19 https://evidence-hub.com/study/133289-disease-modifying-treatment-of-osteoarthritis-with-triple-combination2026-10-19 https://evidence-hub.com/study/133292-low-density-lipoprotein-receptor-gene-mutation-at-exon-2-and-4-in2026-10-19 https://evidence-hub.com/study/133297-human-otulin-haploinsufficiency-impairs-cell-intrinsic-immunity-to2026-10-19 https://evidence-hub.com/study/133302-active-and-prospective-latent-tuberculosis-are-associated-with2026-10-19 https://evidence-hub.com/study/133308-set7-9-represses-sirt1-to-induce-collagen-type-ii-expression-in-3d2026-10-19 https://evidence-hub.com/study/133311-dddr-17-clinical-response-to-the-pdgfra-kit-inhibitor-avapritinib-in2026-10-19 https://evidence-hub.com/study/133312-hgg-19-clinical-response-to-the-pdgfra-kit-inhibitor-avapritinib-in2026-10-19 https://evidence-hub.com/study/133313-abstract-5719-clinical-response-to-the-pdgfr-inhibitor-avapritinib-in2026-10-19 https://evidence-hub.com/study/133314-the-usefulness-of-tranexamic-acid-for-bleeding-symptoms-of-chronic2026-10-19 https://evidence-hub.com/study/133315-clinical-heterogeneity-of-mitochondrial-nad-kinase-deficiency-caused2026-10-19 https://evidence-hub.com/study/133316-intratumoral-poly-iclc-therapy-for-dogs-with-advanced-cancers-first2026-10-19 https://evidence-hub.com/study/133317-systemic-metabolomic-changes-in-blood-samples-of-lung-cancer-patients2026-10-19 https://evidence-hub.com/study/133318-structural-genomics-defines-pbrm1-bromodomain-variant-function-in2026-10-19 https://evidence-hub.com/study/133319-perception-and-experience-of-physicians-towards-the-use-of-a-targeted2026-10-19 https://evidence-hub.com/study/133320-inborn-errors-of-metabolism-in-adults-two-patients-with-movement2026-10-19 https://evidence-hub.com/study/133322-biochemical-characterization-of-patients-with-dihydrolipoamide2026-10-19 https://evidence-hub.com/study/133323-bomedemstat-img-7289-an-lsd1-inhibitor-manages-the-signs-and-symptoms2026-10-19 https://evidence-hub.com/study/133324-novel-variants-in-kat6b-spectrum-of-disorders-expand-our-knowledge-of2026-10-19 https://evidence-hub.com/study/133326-exogenous-stimulation-of-type-i-interferon-protects-mice-with-chronic2026-10-19 https://evidence-hub.com/study/133327-first-case-of-symmetric-drug-related-intertriginous-and-flexural2026-10-19 https://evidence-hub.com/study/133328-ezh2-codon-641-mutations-are-common-in-bcl2-rearranged-germinal2026-10-19 https://evidence-hub.com/study/133330-is-there-any-relationship-between-mutation-in-cps1-gene-and-pregnancy2026-10-19 https://evidence-hub.com/study/133332-reciprocal-atp5l-kmt2a-gene-fusion-in-a-paediatric-b-lymphoblastic2026-10-19 https://evidence-hub.com/study/133333-a-novel-kmt2d-mutation-in-kabuki-syndrome-with-elevated-liver-enzymes2026-10-19 https://evidence-hub.com/study/133337-dipg-37-transcriptional-epigenetic-and-immunological-features-of2026-10-19 https://evidence-hub.com/study/133338-bi-allelic-kars1-pathogenic-variants-affecting-functions-of-cytosolic2026-10-19 https://evidence-hub.com/study/133339-discovery-of-novel-recurrent-mutations-in-childhood-early-t-cell2026-10-19 https://evidence-hub.com/study/133340-gynaecological-cylindroma-in-association-with-cyld-gene-mutation2026-10-19 https://evidence-hub.com/study/133341-analytical-method-for-simultaneous-estimation-of-efonidipine2026-10-19 https://evidence-hub.com/study/133343-diagnosis-and-management-of-glutaric-aciduria-type-i-revised2026-10-19 https://evidence-hub.com/study/133344-consensus-guidelines-for-the-diagnosis-and-management-of-pyridoxine2026-10-19 https://evidence-hub.com/study/133345-p4608bet-inhibition-with-apabetalone-in-post-acs-patients-with2026-10-19 https://evidence-hub.com/study/133346-treatment-options-of-onychomycosis-review-article2026-10-19 https://evidence-hub.com/study/133347-post-traumatic-single-digit-onychomycosis2026-10-19 https://evidence-hub.com/study/133348-voriconazole-in-dermatophytic-infections-an-in-depth-examination-of2026-10-19 https://evidence-hub.com/study/133349-sequential-treatment-with-laser-therapy-and-nail-hydro-lacquer2026-10-19 https://evidence-hub.com/study/133350-advances-in-antifungal-therapy-for-onchomycosis-a-focus-on-emerging2026-10-19 https://evidence-hub.com/study/133351-onychomycosis-clinical-and-dermoscopic-characteristics-diagnosis-and2026-10-19 https://evidence-hub.com/study/133352-coated-microneedle-system-for-delivery-of-clotrimazole-in-deep-skin2026-10-19 https://evidence-hub.com/study/133353-onicomicoses-em-tempo-de-inovacao-tecnologias-alternativas2026-10-19 https://evidence-hub.com/study/133354-the-past-present-future-pathophysiology-diagnosis-and-treatment-of2026-10-19 https://evidence-hub.com/study/133355-terbinafine-resistance-in-trichophyton-mentagrophytes-and2026-10-19 https://evidence-hub.com/study/133356-new-drug-approvals-for-2022-synthesis-and-clinical-applications2026-10-19 https://evidence-hub.com/study/133357-efficacy-of-combination-therapy-with-minocycline-for-treating2026-10-20 https://evidence-hub.com/study/133365-genotypic-detection-of-qnra-and-qnrc-genes-in-citrobacter-koseri2026-10-20 https://evidence-hub.com/study/133366-characterization-and-antibiotic-susceptibility-of-streptococcus2026-10-20 https://evidence-hub.com/study/133367-application-of-fluoroquinolone-resistance-score-in-management-of2026-10-20 https://evidence-hub.com/study/133368-relationship-between-urinary-tract-infection-categorization-and2026-10-20 https://evidence-hub.com/study/133369-an-analysis-of-the-outbreak-situation-and-background-risk-factors-for2026-10-20 https://evidence-hub.com/study/133370-identification-and-clinical-significance-of-helcococcus-species-with2026-10-20 https://evidence-hub.com/study/133371-clinical-characteristics-and-risk-factors-of-patients-with-rheumatoid2026-10-20 https://evidence-hub.com/study/133372-management-of-antibacterial-therapy-of-infectious-and-inflammatory2026-10-20 https://evidence-hub.com/study/133373-characteristics-and-antibiotic-resistance-of-urinary-tract-pathogens2026-10-20 https://evidence-hub.com/study/133374-pattern-of-bacterial-uropathogens-and-multidrug-resistance-in2026-10-20 https://evidence-hub.com/study/133375-current-epidemiological-status-and-antibiotic-resistance-profile-of2026-10-20 https://evidence-hub.com/study/133376-distribution-and-drug-resistance-of-pathogenic-bacteria-and-prognosis2026-10-20